CA2646779A1 - Bioscience ix - Google Patents
Bioscience ix Download PDFInfo
- Publication number
- CA2646779A1 CA2646779A1 CA2646779A CA2646779A CA2646779A1 CA 2646779 A1 CA2646779 A1 CA 2646779A1 CA 2646779 A CA2646779 A CA 2646779A CA 2646779 A CA2646779 A CA 2646779A CA 2646779 A1 CA2646779 A1 CA 2646779A1
- Authority
- CA
- Canada
- Prior art keywords
- cndot
- cells
- fish
- melatonin
- maturation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 72
- 210000004027 cell Anatomy 0.000 claims description 62
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 54
- 210000000287 oocyte Anatomy 0.000 claims description 54
- 230000035800 maturation Effects 0.000 claims description 50
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims description 48
- 229960003987 melatonin Drugs 0.000 claims description 48
- 235000019688 fish Nutrition 0.000 claims description 46
- 108090000623 proteins and genes Proteins 0.000 claims description 43
- 235000013601 eggs Nutrition 0.000 claims description 42
- 210000001519 tissue Anatomy 0.000 claims description 42
- 241000239366 Euphausiacea Species 0.000 claims description 40
- 210000000130 stem cell Anatomy 0.000 claims description 40
- 241000251468 Actinopterygii Species 0.000 claims description 36
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 36
- 229940088597 hormone Drugs 0.000 claims description 36
- 239000005556 hormone Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 230000012010 growth Effects 0.000 claims description 34
- 230000000694 effects Effects 0.000 claims description 32
- 244000005700 microbiome Species 0.000 claims description 32
- 229940076279 serotonin Drugs 0.000 claims description 30
- 230000007613 environmental effect Effects 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 28
- 210000001672 ovary Anatomy 0.000 claims description 28
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 26
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 26
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 26
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 26
- 239000005557 antagonist Substances 0.000 claims description 26
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 26
- 210000002744 extracellular matrix Anatomy 0.000 claims description 26
- 235000000346 sugar Nutrition 0.000 claims description 26
- 229940024606 amino acid Drugs 0.000 claims description 24
- 235000001014 amino acid Nutrition 0.000 claims description 24
- 150000001413 amino acids Chemical class 0.000 claims description 24
- 241000195493 Cryptophyta Species 0.000 claims description 22
- 241000238557 Decapoda Species 0.000 claims description 22
- 229930003316 Vitamin D Natural products 0.000 claims description 22
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 22
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 22
- 201000010099 disease Diseases 0.000 claims description 22
- 210000001733 follicular fluid Anatomy 0.000 claims description 22
- 230000004044 response Effects 0.000 claims description 22
- 238000012360 testing method Methods 0.000 claims description 22
- 235000019166 vitamin D Nutrition 0.000 claims description 22
- 239000011710 vitamin D Substances 0.000 claims description 22
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 22
- 229940046008 vitamin d Drugs 0.000 claims description 22
- 241000283690 Bos taurus Species 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 20
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 20
- 230000000949 anxiolytic effect Effects 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 20
- 239000008280 blood Substances 0.000 claims description 20
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 20
- 229940106134 krill oil Drugs 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 230000035755 proliferation Effects 0.000 claims description 20
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 20
- 235000018102 proteins Nutrition 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 241000196324 Embryophyta Species 0.000 claims description 18
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 claims description 18
- 230000002611 ovarian Effects 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 18
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
- 238000009395 breeding Methods 0.000 claims description 16
- 230000001488 breeding effect Effects 0.000 claims description 16
- 238000011161 development Methods 0.000 claims description 16
- 230000018109 developmental process Effects 0.000 claims description 16
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 16
- 210000004185 liver Anatomy 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- 239000001301 oxygen Substances 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 210000002381 plasma Anatomy 0.000 claims description 16
- 201000000980 schizophrenia Diseases 0.000 claims description 16
- 230000001568 sexual effect Effects 0.000 claims description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 16
- 210000001550 testis Anatomy 0.000 claims description 16
- 241000206761 Bacillariophyta Species 0.000 claims description 14
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims description 14
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 14
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 14
- 239000000556 agonist Substances 0.000 claims description 14
- 230000003078 antioxidant effect Effects 0.000 claims description 14
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 14
- 210000001771 cumulus cell Anatomy 0.000 claims description 14
- 208000035475 disorder Diseases 0.000 claims description 14
- 239000000122 growth hormone Substances 0.000 claims description 14
- 230000001965 increasing effect Effects 0.000 claims description 14
- 210000004379 membrane Anatomy 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 14
- 201000006417 multiple sclerosis Diseases 0.000 claims description 14
- GLXSBZGTGMPDKH-UHFFFAOYSA-N n-(2-naphthalen-1-ylethyl)cyclobutanecarboxamide Chemical compound C=1C=CC2=CC=CC=C2C=1CCNC(=O)C1CCC1 GLXSBZGTGMPDKH-UHFFFAOYSA-N 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- 235000019155 vitamin A Nutrition 0.000 claims description 14
- 239000011719 vitamin A Substances 0.000 claims description 14
- 229940045997 vitamin a Drugs 0.000 claims description 14
- 239000002699 waste material Substances 0.000 claims description 14
- 239000011575 calcium Substances 0.000 claims description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 12
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 12
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 12
- 108020004414 DNA Proteins 0.000 claims description 12
- LUINDDOUWHRIPW-UHFFFAOYSA-N N-[2-(6-chloro-5-methoxy-1H-indol-3-yl)ethyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC2=C1NC=C2CCNC(C)=O LUINDDOUWHRIPW-UHFFFAOYSA-N 0.000 claims description 12
- NVUGEQAEQJTCIX-UHFFFAOYSA-N N-acetyltryptamine Chemical compound C1=CC=C2C(CCNC(=O)C)=CNC2=C1 NVUGEQAEQJTCIX-UHFFFAOYSA-N 0.000 claims description 12
- 206010028980 Neoplasm Diseases 0.000 claims description 12
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 12
- 235000013793 astaxanthin Nutrition 0.000 claims description 12
- 239000001168 astaxanthin Substances 0.000 claims description 12
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 12
- 229940022405 astaxanthin Drugs 0.000 claims description 12
- 235000013734 beta-carotene Nutrition 0.000 claims description 12
- 239000011648 beta-carotene Substances 0.000 claims description 12
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 12
- 229960002747 betacarotene Drugs 0.000 claims description 12
- 150000001720 carbohydrates Chemical class 0.000 claims description 12
- 235000014633 carbohydrates Nutrition 0.000 claims description 12
- 230000001684 chronic effect Effects 0.000 claims description 12
- 210000003016 hypothalamus Anatomy 0.000 claims description 12
- 230000001939 inductive effect Effects 0.000 claims description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 230000036651 mood Effects 0.000 claims description 12
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 12
- 210000000056 organ Anatomy 0.000 claims description 12
- 150000003904 phospholipids Chemical group 0.000 claims description 12
- 230000011664 signaling Effects 0.000 claims description 12
- 230000000638 stimulation Effects 0.000 claims description 12
- 210000000221 suprachiasmatic nucleus Anatomy 0.000 claims description 12
- 230000004083 survival effect Effects 0.000 claims description 12
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 12
- -1 retinol ester Chemical class 0.000 claims description 11
- 241000091587 Attheya Species 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- 244000146553 Ceiba pentandra Species 0.000 claims description 10
- 235000003301 Ceiba pentandra Nutrition 0.000 claims description 10
- 102000002322 Egg Proteins Human genes 0.000 claims description 10
- 108010000912 Egg Proteins Proteins 0.000 claims description 10
- 102000009025 Endorphins Human genes 0.000 claims description 10
- 108010049140 Endorphins Proteins 0.000 claims description 10
- 102000006771 Gonadotropins Human genes 0.000 claims description 10
- 108010086677 Gonadotropins Proteins 0.000 claims description 10
- 206010062767 Hypophysitis Diseases 0.000 claims description 10
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 10
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 10
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 10
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 10
- WVVXBPKOIZGVNS-UHFFFAOYSA-N N-[2-[2-(phenylmethyl)-1H-indol-3-yl]ethyl]acetamide Chemical compound N1C2=CC=CC=C2C(CCNC(=O)C)=C1CC1=CC=CC=C1 WVVXBPKOIZGVNS-UHFFFAOYSA-N 0.000 claims description 10
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 10
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 claims description 10
- 229960003767 alanine Drugs 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 235000006708 antioxidants Nutrition 0.000 claims description 10
- 239000000164 antipsychotic agent Substances 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- 239000001569 carbon dioxide Substances 0.000 claims description 10
- 230000001413 cellular effect Effects 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 10
- 230000001086 cytosolic effect Effects 0.000 claims description 10
- 229960003638 dopamine Drugs 0.000 claims description 10
- 229940011871 estrogen Drugs 0.000 claims description 10
- 239000000262 estrogen Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 230000003325 follicular Effects 0.000 claims description 10
- 229940049906 glutamate Drugs 0.000 claims description 10
- 229930195712 glutamate Natural products 0.000 claims description 10
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 10
- 229960002743 glutamine Drugs 0.000 claims description 10
- 235000004554 glutamine Nutrition 0.000 claims description 10
- 239000002622 gonadotropin Substances 0.000 claims description 10
- 230000003054 hormonal effect Effects 0.000 claims description 10
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 239000007924 injection Substances 0.000 claims description 10
- 230000003834 intracellular effect Effects 0.000 claims description 10
- 230000013011 mating Effects 0.000 claims description 10
- 235000013372 meat Nutrition 0.000 claims description 10
- 230000011278 mitosis Effects 0.000 claims description 10
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 10
- 235000015097 nutrients Nutrition 0.000 claims description 10
- 235000016709 nutrition Nutrition 0.000 claims description 10
- 230000001817 pituitary effect Effects 0.000 claims description 10
- 210000003635 pituitary gland Anatomy 0.000 claims description 10
- 239000000186 progesterone Substances 0.000 claims description 10
- 229960003387 progesterone Drugs 0.000 claims description 10
- 230000018612 quorum sensing Effects 0.000 claims description 10
- 239000007845 reactive nitrogen species Substances 0.000 claims description 10
- 102000005962 receptors Human genes 0.000 claims description 10
- 108020003175 receptors Proteins 0.000 claims description 10
- 230000008929 regeneration Effects 0.000 claims description 10
- 238000011069 regeneration method Methods 0.000 claims description 10
- 230000001932 seasonal effect Effects 0.000 claims description 10
- 241000894007 species Species 0.000 claims description 10
- 239000013589 supplement Substances 0.000 claims description 10
- 230000002381 testicular Effects 0.000 claims description 10
- 229960003604 testosterone Drugs 0.000 claims description 10
- 229960004799 tryptophan Drugs 0.000 claims description 10
- 230000001018 virulence Effects 0.000 claims description 10
- MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 claims description 8
- 102000015735 Beta-catenin Human genes 0.000 claims description 8
- 108060000903 Beta-catenin Proteins 0.000 claims description 8
- 208000020925 Bipolar disease Diseases 0.000 claims description 8
- 108010051696 Growth Hormone Proteins 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 208000002193 Pain Diseases 0.000 claims description 8
- RGCVKNLCSQQDEP-UHFFFAOYSA-N Perphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 RGCVKNLCSQQDEP-UHFFFAOYSA-N 0.000 claims description 8
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 8
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 8
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 claims description 8
- 102100038803 Somatotropin Human genes 0.000 claims description 8
- 241000282887 Suidae Species 0.000 claims description 8
- 235000004279 alanine Nutrition 0.000 claims description 8
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 8
- 229940005529 antipsychotics Drugs 0.000 claims description 8
- 238000009360 aquaculture Methods 0.000 claims description 8
- 244000144974 aquaculture Species 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- 230000001419 dependent effect Effects 0.000 claims description 8
- 206010012601 diabetes mellitus Diseases 0.000 claims description 8
- 210000002969 egg yolk Anatomy 0.000 claims description 8
- 210000004186 follicle cell Anatomy 0.000 claims description 8
- 239000000499 gel Substances 0.000 claims description 8
- 229960003180 glutathione Drugs 0.000 claims description 8
- 210000002503 granulosa cell Anatomy 0.000 claims description 8
- 210000002216 heart Anatomy 0.000 claims description 8
- 238000000338 in vitro Methods 0.000 claims description 8
- 230000006698 induction Effects 0.000 claims description 8
- 150000002500 ions Chemical class 0.000 claims description 8
- 230000021121 meiosis Effects 0.000 claims description 8
- 230000004060 metabolic process Effects 0.000 claims description 8
- 230000004770 neurodegeneration Effects 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 230000031787 nutrient reservoir activity Effects 0.000 claims description 8
- 230000007170 pathology Effects 0.000 claims description 8
- 230000002062 proliferating effect Effects 0.000 claims description 8
- 229930002330 retinoic acid Natural products 0.000 claims description 8
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 8
- 230000033764 rhythmic process Effects 0.000 claims description 8
- 230000035938 sexual maturation Effects 0.000 claims description 8
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- 229960001727 tretinoin Drugs 0.000 claims description 8
- 229940094720 viagra Drugs 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 239000003643 water by type Substances 0.000 claims description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 8
- GBBSUAFBMRNDJC-MRXNPFEDSA-N (5R)-zopiclone Chemical compound C1CN(C)CCN1C(=O)O[C@@H]1C2=NC=CN=C2C(=O)N1C1=CC=C(Cl)C=N1 GBBSUAFBMRNDJC-MRXNPFEDSA-N 0.000 claims description 7
- 239000003446 ligand Substances 0.000 claims description 7
- 229960000820 zopiclone Drugs 0.000 claims description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 6
- CMWHGNOBFVLNTC-JYJNAYRXSA-N (2s)-n-[2-[[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-5-oxopyrrolidine-2-carboxamide Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C(=O)CNC(=O)[C@@H]1CCC(=O)N1 CMWHGNOBFVLNTC-JYJNAYRXSA-N 0.000 claims description 6
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 6
- 108010052053 4-pyroglutamyl-glycyl-arginyl-phenylalaninamide Proteins 0.000 claims description 6
- 241000791841 Alectis ciliaris Species 0.000 claims description 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 6
- 235000004480 Bombax malabaricum Nutrition 0.000 claims description 6
- 208000015879 Cerebellar disease Diseases 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 6
- 241000223782 Ciliophora Species 0.000 claims description 6
- 206010009944 Colon cancer Diseases 0.000 claims description 6
- 108050004812 Dopamine receptor Proteins 0.000 claims description 6
- 102000015554 Dopamine receptor Human genes 0.000 claims description 6
- PLDUPXSUYLZYBN-UHFFFAOYSA-N Fluphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 PLDUPXSUYLZYBN-UHFFFAOYSA-N 0.000 claims description 6
- 206010017553 Furuncle Diseases 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 102000002254 Glycogen Synthase Kinase 3 Human genes 0.000 claims description 6
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 claims description 6
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 claims description 6
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 claims description 6
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 6
- 102000004877 Insulin Human genes 0.000 claims description 6
- 108090001061 Insulin Proteins 0.000 claims description 6
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- 108090001030 Lipoproteins Proteins 0.000 claims description 6
- 102000004895 Lipoproteins Human genes 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- 102000001419 Melatonin receptor Human genes 0.000 claims description 6
- 108050009605 Melatonin receptor Proteins 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- MPZVHKLZCUEJFO-UHFFFAOYSA-N N-[3-(2-acetamidoethyl)-1H-indol-5-yl]carbamic acid methyl ester Chemical compound COC(=O)NC1=CC=C2NC=C(CCNC(C)=O)C2=C1 MPZVHKLZCUEJFO-UHFFFAOYSA-N 0.000 claims description 6
- 238000005481 NMR spectroscopy Methods 0.000 claims description 6
- 230000018199 S phase Effects 0.000 claims description 6
- 241000277331 Salmonidae Species 0.000 claims description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 6
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 6
- 239000004473 Threonine Substances 0.000 claims description 6
- 102000040945 Transcription factor Human genes 0.000 claims description 6
- 108091023040 Transcription factor Proteins 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- 108050003627 Wnt Proteins 0.000 claims description 6
- 102000013814 Wnt Human genes 0.000 claims description 6
- 239000000674 adrenergic antagonist Substances 0.000 claims description 6
- 229960002629 agomelatine Drugs 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 6
- 239000000427 antigen Substances 0.000 claims description 6
- 108091007433 antigens Proteins 0.000 claims description 6
- 102000036639 antigens Human genes 0.000 claims description 6
- 229960001230 asparagine Drugs 0.000 claims description 6
- 235000009582 asparagine Nutrition 0.000 claims description 6
- 229940127236 atypical antipsychotics Drugs 0.000 claims description 6
- 230000008901 benefit Effects 0.000 claims description 6
- 239000002551 biofuel Substances 0.000 claims description 6
- 230000008499 blood brain barrier function Effects 0.000 claims description 6
- 210000001218 blood-brain barrier Anatomy 0.000 claims description 6
- 210000004556 brain Anatomy 0.000 claims description 6
- 201000011510 cancer Diseases 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 230000015556 catabolic process Effects 0.000 claims description 6
- 241001233037 catfish Species 0.000 claims description 6
- 230000004663 cell proliferation Effects 0.000 claims description 6
- 235000013330 chicken meat Nutrition 0.000 claims description 6
- 229960001076 chlorpromazine Drugs 0.000 claims description 6
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 claims description 6
- 229940117229 cialis Drugs 0.000 claims description 6
- 239000002361 compost Substances 0.000 claims description 6
- 230000007850 degeneration Effects 0.000 claims description 6
- 230000008021 deposition Effects 0.000 claims description 6
- 235000005911 diet Nutrition 0.000 claims description 6
- 230000037213 diet Effects 0.000 claims description 6
- 239000003210 dopamine receptor blocking agent Substances 0.000 claims description 6
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 229930182833 estradiol Natural products 0.000 claims description 6
- 230000004720 fertilization Effects 0.000 claims description 6
- 239000003337 fertilizer Substances 0.000 claims description 6
- 235000021323 fish oil Nutrition 0.000 claims description 6
- 229940013317 fish oils Drugs 0.000 claims description 6
- 230000006870 function Effects 0.000 claims description 6
- 208000003512 furunculosis Diseases 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 210000002816 gill Anatomy 0.000 claims description 6
- 210000004907 gland Anatomy 0.000 claims description 6
- 210000002149 gonad Anatomy 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000009931 harmful effect Effects 0.000 claims description 6
- 208000006454 hepatitis Diseases 0.000 claims description 6
- 210000002865 immune cell Anatomy 0.000 claims description 6
- 230000002757 inflammatory effect Effects 0.000 claims description 6
- 229940125396 insulin Drugs 0.000 claims description 6
- 210000003734 kidney Anatomy 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 150000002632 lipids Chemical group 0.000 claims description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 6
- 229960003646 lysine Drugs 0.000 claims description 6
- 230000007246 mechanism Effects 0.000 claims description 6
- 239000002207 metabolite Substances 0.000 claims description 6
- 229930182817 methionine Natural products 0.000 claims description 6
- 229960004452 methionine Drugs 0.000 claims description 6
- 230000001537 neural effect Effects 0.000 claims description 6
- 230000035764 nutrition Effects 0.000 claims description 6
- 230000016087 ovulation Effects 0.000 claims description 6
- 230000036407 pain Effects 0.000 claims description 6
- 210000000496 pancreas Anatomy 0.000 claims description 6
- 230000035515 penetration Effects 0.000 claims description 6
- 230000003389 potentiating effect Effects 0.000 claims description 6
- 230000001172 regenerating effect Effects 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 210000004761 scalp Anatomy 0.000 claims description 6
- 208000012672 seasonal affective disease Diseases 0.000 claims description 6
- 229960001153 serine Drugs 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 150000008163 sugars Chemical class 0.000 claims description 6
- 208000024891 symptom Diseases 0.000 claims description 6
- WOXKDUGGOYFFRN-IIBYNOLFSA-N tadalafil Chemical compound C1=C2OCOC2=CC([C@@H]2C3=C(C4=CC=CC=C4N3)C[C@H]3N2C(=O)CN(C3=O)C)=C1 WOXKDUGGOYFFRN-IIBYNOLFSA-N 0.000 claims description 6
- 229960005333 tetrabenazine Drugs 0.000 claims description 6
- 229960002898 threonine Drugs 0.000 claims description 6
- 235000008521 threonine Nutrition 0.000 claims description 6
- 230000035897 transcription Effects 0.000 claims description 6
- 238000013518 transcription Methods 0.000 claims description 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 6
- 229960004295 valine Drugs 0.000 claims description 6
- 239000004474 valine Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 230000006614 vitellogenesis Effects 0.000 claims description 6
- 230000036642 wellbeing Effects 0.000 claims description 6
- WFPIAZLQTJBIFN-DVZOWYKESA-N zuclopenthixol Chemical compound C1CN(CCO)CCN1CC\C=C\1C2=CC(Cl)=CC=C2SC2=CC=CC=C2/1 WFPIAZLQTJBIFN-DVZOWYKESA-N 0.000 claims description 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 5
- 229960003036 amisulpride Drugs 0.000 claims description 5
- NTJOBXMMWNYJFB-UHFFFAOYSA-N amisulpride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=C(N)C=C1OC NTJOBXMMWNYJFB-UHFFFAOYSA-N 0.000 claims description 5
- GBBSUAFBMRNDJC-INIZCTEOSA-N eszopiclone Chemical compound C1CN(C)CCN1C(=O)O[C@H]1C2=NC=CN=C2C(=O)N1C1=CC=C(Cl)C=N1 GBBSUAFBMRNDJC-INIZCTEOSA-N 0.000 claims description 5
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 claims description 5
- 210000003205 muscle Anatomy 0.000 claims description 5
- RQYIUGOJQFWLAZ-UHFFFAOYSA-N n-[2-(2-methoxy-6h-isoindolo[2,1-a]indol-11-yl)ethyl]butanamide Chemical compound C12=CC=C(OC)C=C2C(CCNC(=O)CCC)=C2N1CC1=CC=CC=C12 RQYIUGOJQFWLAZ-UHFFFAOYSA-N 0.000 claims description 5
- 229960005190 phenylalanine Drugs 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 150000003180 prostaglandins Chemical class 0.000 claims description 5
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 claims description 4
- ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 claims description 4
- QAOOAZRWKHFUHK-UHFFFAOYSA-N 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridec-12-enyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)=C)(C)CCC2=C1C QAOOAZRWKHFUHK-UHFFFAOYSA-N 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 4
- 108700028369 Alleles Proteins 0.000 claims description 4
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 208000019901 Anxiety disease Diseases 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 4
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 claims description 4
- 241000238421 Arthropoda Species 0.000 claims description 4
- 108060006004 Ascorbate peroxidase Proteins 0.000 claims description 4
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims description 4
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 4
- 241000972773 Aulopiformes Species 0.000 claims description 4
- HIYAVKIYRIFSCZ-CVXKHCKVSA-N Calcimycin Chemical compound CC([C@H]1OC2([C@@H](C[C@H]1C)C)O[C@H]([C@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-CVXKHCKVSA-N 0.000 claims description 4
- 241000252229 Carassius auratus Species 0.000 claims description 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 4
- 241000723418 Carya Species 0.000 claims description 4
- 102000016938 Catalase Human genes 0.000 claims description 4
- 108010053835 Catalase Proteins 0.000 claims description 4
- 241000227752 Chaetoceros Species 0.000 claims description 4
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims description 4
- 244000241235 Citrullus lanatus Species 0.000 claims description 4
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 108010037139 Cryptochromes Proteins 0.000 claims description 4
- 241001596774 Epinephelus akaara Species 0.000 claims description 4
- 241001217936 Epinephelus lanceolatus Species 0.000 claims description 4
- 208000001640 Fibromyalgia Diseases 0.000 claims description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 241001417516 Haemulidae Species 0.000 claims description 4
- 208000032969 Hemorrhagic Septicemia Diseases 0.000 claims description 4
- 241000167880 Hirundinidae Species 0.000 claims description 4
- 208000023105 Huntington disease Diseases 0.000 claims description 4
- 241000257303 Hymenoptera Species 0.000 claims description 4
- 208000000269 Hyperkinesis Diseases 0.000 claims description 4
- 208000005615 Interstitial Cystitis Diseases 0.000 claims description 4
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- 241001417534 Lutjanidae Species 0.000 claims description 4
- 206010025323 Lymphomas Diseases 0.000 claims description 4
- 241000238555 Malacostraca Species 0.000 claims description 4
- 206010026749 Mania Diseases 0.000 claims description 4
- 208000016285 Movement disease Diseases 0.000 claims description 4
- 240000005561 Musa balbisiana Species 0.000 claims description 4
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 claims description 4
- 102100034404 Nuclear factor of activated T-cells, cytoplasmic 1 Human genes 0.000 claims description 4
- 101710151542 Nuclear factor of activated T-cells, cytoplasmic 1 Proteins 0.000 claims description 4
- 208000014645 Pasteurella hemorrhagic septicemia Diseases 0.000 claims description 4
- KPKZJLCSROULON-QKGLWVMZSA-N Phalloidin Chemical compound N1C(=O)[C@@H]([C@@H](O)C)NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H](C2)NC(=O)[C@H](C)NC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H]1CSC1=C2C2=CC=CC=C2N1 KPKZJLCSROULON-QKGLWVMZSA-N 0.000 claims description 4
- ZGUGWUXLJSTTMA-UHFFFAOYSA-N Promazinum Chemical compound C1=CC=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZGUGWUXLJSTTMA-UHFFFAOYSA-N 0.000 claims description 4
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 201000004681 Psoriasis Diseases 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 4
- 241001290266 Sciaenops ocellatus Species 0.000 claims description 4
- 208000003954 Spinal Muscular Atrophies of Childhood Diseases 0.000 claims description 4
- 241000500840 Spondyliosoma cantharus Species 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 4
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 4
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 claims description 4
- GFBKORZTTCHDGY-UWVJOHFNSA-N Thiothixene Chemical compound C12=CC(S(=O)(=O)N(C)C)=CC=C2SC2=CC=CC=C2\C1=C\CCN1CCN(C)CC1 GFBKORZTTCHDGY-UWVJOHFNSA-N 0.000 claims description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 4
- 208000000323 Tourette Syndrome Diseases 0.000 claims description 4
- 208000016620 Tourette disease Diseases 0.000 claims description 4
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims description 4
- 208000026487 Triploidy Diseases 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- 206010052428 Wound Diseases 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 238000009825 accumulation Methods 0.000 claims description 4
- 206010000496 acne Diseases 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 230000001154 acute effect Effects 0.000 claims description 4
- 208000018254 acute transverse myelitis Diseases 0.000 claims description 4
- 229940087168 alpha tocopherol Drugs 0.000 claims description 4
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 claims description 4
- 239000003098 androgen Substances 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 4
- 239000000935 antidepressant agent Substances 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 229960003121 arginine Drugs 0.000 claims description 4
- 235000009697 arginine Nutrition 0.000 claims description 4
- 229940009098 aspartate Drugs 0.000 claims description 4
- 239000003693 atypical antipsychotic agent Substances 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 208000018300 basal ganglia disease Diseases 0.000 claims description 4
- 210000002469 basement membrane Anatomy 0.000 claims description 4
- 230000009286 beneficial effect Effects 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 4
- 230000029918 bioluminescence Effects 0.000 claims description 4
- 238000005415 bioluminescence Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 230000036772 blood pressure Effects 0.000 claims description 4
- 210000000133 brain stem Anatomy 0.000 claims description 4
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 claims description 4
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 claims description 4
- HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000028956 calcium-mediated signaling Effects 0.000 claims description 4
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims description 4
- 229950011318 cannabidiol Drugs 0.000 claims description 4
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims description 4
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 4
- 230000022131 cell cycle Effects 0.000 claims description 4
- 210000000170 cell membrane Anatomy 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 210000003169 central nervous system Anatomy 0.000 claims description 4
- 230000002490 cerebral effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000001805 chlorine compounds Chemical class 0.000 claims description 4
- 239000000812 cholinergic antagonist Substances 0.000 claims description 4
- NJMYODHXAKYRHW-DVZOWYKESA-N cis-flupenthixol Chemical compound C1CN(CCO)CCN1CC\C=C\1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C2/1 NJMYODHXAKYRHW-DVZOWYKESA-N 0.000 claims description 4
- 238000003776 cleavage reaction Methods 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 208000029742 colonic neoplasm Diseases 0.000 claims description 4
- 229940088505 compazine Drugs 0.000 claims description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 230000003210 demyelinating effect Effects 0.000 claims description 4
- 239000003599 detergent Substances 0.000 claims description 4
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims description 4
- 229960000394 droperidol Drugs 0.000 claims description 4
- RMEDXOLNCUSCGS-UHFFFAOYSA-N droperidol Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CC=C(N2C(NC3=CC=CC=C32)=O)CC1 RMEDXOLNCUSCGS-UHFFFAOYSA-N 0.000 claims description 4
- 210000002257 embryonic structure Anatomy 0.000 claims description 4
- 230000002996 emotional effect Effects 0.000 claims description 4
- 210000000981 epithelium Anatomy 0.000 claims description 4
- 238000009313 farming Methods 0.000 claims description 4
- 206010016256 fatigue Diseases 0.000 claims description 4
- 210000003608 fece Anatomy 0.000 claims description 4
- 229960002419 flupentixol Drugs 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229960001031 glucose Drugs 0.000 claims description 4
- 230000001456 gonadotroph Effects 0.000 claims description 4
- 229940094892 gonadotropins Drugs 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 231100000283 hepatitis Toxicity 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 230000036737 immune function Effects 0.000 claims description 4
- 238000009399 inbreeding Methods 0.000 claims description 4
- 230000009027 insemination Effects 0.000 claims description 4
- 230000003993 interaction Effects 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 229940001447 lactate Drugs 0.000 claims description 4
- 230000003902 lesion Effects 0.000 claims description 4
- 229960003136 leucine Drugs 0.000 claims description 4
- 239000010871 livestock manure Substances 0.000 claims description 4
- 238000012423 maintenance Methods 0.000 claims description 4
- 210000001161 mammalian embryo Anatomy 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 4
- 229940042053 methotrimeprazine Drugs 0.000 claims description 4
- 229960004503 metoclopramide Drugs 0.000 claims description 4
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 claims description 4
- 210000003470 mitochondria Anatomy 0.000 claims description 4
- 230000000394 mitotic effect Effects 0.000 claims description 4
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims description 4
- LTYWTNUOUBBVNZ-UHFFFAOYSA-N n-[2-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)ethyl]acetamide Chemical compound C1=C2OCCC2=C2N(CCNC(=O)C)CCC2=C1 LTYWTNUOUBBVNZ-UHFFFAOYSA-N 0.000 claims description 4
- MUQOTEHRXIKHKR-UHFFFAOYSA-N n-[2-(2-benzyl-5-methoxy-1h-indol-3-yl)ethyl]acetamide Chemical compound CC(=O)NCCC=1C2=CC(OC)=CC=C2NC=1CC1=CC=CC=C1 MUQOTEHRXIKHKR-UHFFFAOYSA-N 0.000 claims description 4
- IKEWSFJJQOLSPU-UHFFFAOYSA-N n-[2-(6,7-dichloro-5-methoxy-2-methyl-1h-indol-3-yl)ethyl]acetamide Chemical compound ClC1=C(Cl)C(OC)=CC2=C1NC(C)=C2CCNC(C)=O IKEWSFJJQOLSPU-UHFFFAOYSA-N 0.000 claims description 4
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 4
- 239000006014 omega-3 oil Substances 0.000 claims description 4
- 210000002394 ovarian follicle Anatomy 0.000 claims description 4
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 4
- 229960002296 paroxetine Drugs 0.000 claims description 4
- 239000004031 partial agonist Substances 0.000 claims description 4
- 230000037361 pathway Effects 0.000 claims description 4
- 229960000762 perphenazine Drugs 0.000 claims description 4
- YVUQSNJEYSNKRX-UHFFFAOYSA-N pimozide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1CCC(N2C(NC3=CC=CC=C32)=O)CC1 YVUQSNJEYSNKRX-UHFFFAOYSA-N 0.000 claims description 4
- 210000004560 pineal gland Anatomy 0.000 claims description 4
- 239000013612 plasmid Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 claims description 4
- 229960001289 prazosin Drugs 0.000 claims description 4
- 239000002243 precursor Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- DSKIOWHQLUWFLG-SPIKMXEPSA-N prochlorperazine maleate Chemical compound [H+].[H+].[H+].[H+].[O-]C(=O)\C=C/C([O-])=O.[O-]C(=O)\C=C/C([O-])=O.C1CN(C)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 DSKIOWHQLUWFLG-SPIKMXEPSA-N 0.000 claims description 4
- 230000002035 prolonged effect Effects 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 claims description 4
- 208000009954 pyoderma gangrenosum Diseases 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 238000011160 research Methods 0.000 claims description 4
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 claims description 4
- 230000000284 resting effect Effects 0.000 claims description 4
- 235000019515 salmon Nutrition 0.000 claims description 4
- 230000007017 scission Effects 0.000 claims description 4
- 230000003248 secreting effect Effects 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 claims description 4
- 239000010865 sewage Substances 0.000 claims description 4
- 230000035939 shock Effects 0.000 claims description 4
- 230000019491 signal transduction Effects 0.000 claims description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 4
- 239000002689 soil Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 230000010009 steroidogenesis Effects 0.000 claims description 4
- 230000035882 stress Effects 0.000 claims description 4
- 210000001779 taste bud Anatomy 0.000 claims description 4
- 229960000984 tocofersolan Drugs 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 108700012359 toxins Proteins 0.000 claims description 4
- 230000032258 transport Effects 0.000 claims description 4
- 208000009174 transverse myelitis Diseases 0.000 claims description 4
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 claims description 4
- ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 claims description 4
- 230000001960 triggered effect Effects 0.000 claims description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 4
- 229960004441 tyrosine Drugs 0.000 claims description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 4
- 230000002792 vascular Effects 0.000 claims description 4
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 claims description 4
- 230000000007 visual effect Effects 0.000 claims description 4
- MVWVFYHBGMAFLY-UHFFFAOYSA-N ziprasidone Chemical compound C1=CC=C2C(N3CCN(CC3)CCC3=CC=4CC(=O)NC=4C=C3Cl)=NSC2=C1 MVWVFYHBGMAFLY-UHFFFAOYSA-N 0.000 claims description 4
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 claims description 4
- 229960004141 zuclopenthixol Drugs 0.000 claims description 4
- 235000004835 α-tocopherol Nutrition 0.000 claims description 4
- 239000002076 α-tocopherol Substances 0.000 claims description 4
- 108010088547 ARNTL Transcription Factors Proteins 0.000 claims description 3
- 102000008867 ARNTL Transcription Factors Human genes 0.000 claims description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 3
- 241000351413 Epinephelus malabaricus Species 0.000 claims description 3
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 229940012618 lunesta Drugs 0.000 claims description 3
- 108010038421 metabotropic glutamate receptor 2 Proteins 0.000 claims description 3
- 229940061368 sonata Drugs 0.000 claims description 3
- 229960004010 zaleplon Drugs 0.000 claims description 3
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 claims description 3
- 229960001475 zolpidem Drugs 0.000 claims description 3
- CEMAWMOMDPGJMB-UHFFFAOYSA-N (+-)-Oxprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1OCC=C CEMAWMOMDPGJMB-UHFFFAOYSA-N 0.000 claims description 2
- KTGRHKOEFSJQNS-BDQAORGHSA-N (1s)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;oxalic acid Chemical compound OC(=O)C(O)=O.C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 KTGRHKOEFSJQNS-BDQAORGHSA-N 0.000 claims description 2
- ZERWDZDNDJBYKA-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)ON1C(=O)CCC1=O ZERWDZDNDJBYKA-UHFFFAOYSA-N 0.000 claims description 2
- TWOCGDPFRZVWCV-SNTHTSBGSA-N (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid (2S)-2,5-diamino-5-oxopentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CC1=CNC=N1.OC(=O)[C@@H](N)CSSC[C@H](N)C(O)=O TWOCGDPFRZVWCV-SNTHTSBGSA-N 0.000 claims description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 claims description 2
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 claims description 2
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 claims description 2
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 claims description 2
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 claims description 2
- PMXMIIMHBWHSKN-LJQANCHMSA-N (R)-paliperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCC[C@@H](O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-LJQANCHMSA-N 0.000 claims description 2
- VSWBSWWIRNCQIJ-GJZGRUSLSA-N (R,R)-asenapine Chemical compound O1C2=CC=CC=C2[C@@H]2CN(C)C[C@H]2C2=CC(Cl)=CC=C21 VSWBSWWIRNCQIJ-GJZGRUSLSA-N 0.000 claims description 2
- WSPOMRSOLSGNFJ-AUWJEWJLSA-N (Z)-chlorprothixene Chemical compound C1=C(Cl)C=C2C(=C/CCN(C)C)\C3=CC=CC=C3SC2=C1 WSPOMRSOLSGNFJ-AUWJEWJLSA-N 0.000 claims description 2
- KSDMISMEMOGBFU-UHFFFAOYSA-N (all-Z)-7,10,13-Eicosatrienoic acid Natural products CCCCCCC=CCC=CCC=CCCCCCC(O)=O KSDMISMEMOGBFU-UHFFFAOYSA-N 0.000 claims description 2
- IFLZPECPTYCEBR-VIEYUMQNSA-N (z)-but-2-enedioic acid;(2r)-3-(2-methoxyphenothiazin-10-yl)-n,n,2-trimethylpropan-1-amine Chemical compound OC(=O)\C=C/C(O)=O.C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1 IFLZPECPTYCEBR-VIEYUMQNSA-N 0.000 claims description 2
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 claims description 2
- WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WSEQXVZVJXJVFP-UHFFFAOYSA-N 0.000 claims description 2
- APXRHPDHORGIEB-UHFFFAOYSA-N 1H-pyrazolo[4,3-d]pyrimidine Chemical class N1=CN=C2C=NNC2=C1 APXRHPDHORGIEB-UHFFFAOYSA-N 0.000 claims description 2
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 claims description 2
- KCYOZNARADAZIZ-CWBQGUJCSA-N 2-[(2e,4e,6e,8e,10e,12e,14e)-15-(4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-2-yl)-6,11-dimethylhexadeca-2,4,6,8,10,12,14-heptaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol Chemical compound O1C2(C)CC(O)CC(C)(C)C2=CC1C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C1C=C2C(C)(C)CCCC2(C)O1 KCYOZNARADAZIZ-CWBQGUJCSA-N 0.000 claims description 2
- NOFBOJZLPLKNHT-WSTBAARBSA-N 2-aminoacetic acid;(2s)-2-amino-3-hydroxypropanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound NCC(O)=O.OC[C@H](N)C(O)=O.OC(=O)[C@@H]1CCCN1 NOFBOJZLPLKNHT-WSTBAARBSA-N 0.000 claims description 2
- XGAFNQNJGUJDIN-UHFFFAOYSA-N 2-chloro-n-(4-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C12=CC=CC=C2C(NC(=O)CCl)CCC1C1=CC=CC=C1 XGAFNQNJGUJDIN-UHFFFAOYSA-N 0.000 claims description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 claims description 2
- ZGEGOFCLSWVVKG-UHFFFAOYSA-N 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5-propan-2-ylimidazo[1,5-a]quinoxalin-4-one Chemical compound C=12C(=O)N(C(C)C)C3=CC=CC=C3N2C=NC=1C(N=1)=NOC=1C1CC1 ZGEGOFCLSWVVKG-UHFFFAOYSA-N 0.000 claims description 2
- AKUVRZKNLXYTJX-UHFFFAOYSA-N 3-benzylazetidine Chemical compound C=1C=CC=CC=1CC1CNC1 AKUVRZKNLXYTJX-UHFFFAOYSA-N 0.000 claims description 2
- LFQXEZVYNCBVDO-PBJLWWPKSA-N 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC=C(C)C)C)CC=C21 LFQXEZVYNCBVDO-PBJLWWPKSA-N 0.000 claims description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 2
- 108010072564 5-HT2A Serotonin Receptor Proteins 0.000 claims description 2
- KEEYRKYKLYARHO-UHFFFAOYSA-N 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine Chemical compound C1=C(OC)C(OC)=CC(C)=C1CC1=CN=C(N)N=C1N KEEYRKYKLYARHO-UHFFFAOYSA-N 0.000 claims description 2
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 claims description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims description 2
- MKJIEFSOBYUXJB-UHFFFAOYSA-N 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2CC(CC(C)C)C(=O)CC2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-UHFFFAOYSA-N 0.000 claims description 2
- 241000264348 Acanthopagrus berda Species 0.000 claims description 2
- 241000269814 Acanthopagrus latus Species 0.000 claims description 2
- 241000825902 Acanthopagrus sivicolus Species 0.000 claims description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 2
- 241000881711 Acipenser sturio Species 0.000 claims description 2
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 241000186361 Actinobacteria <class> Species 0.000 claims description 2
- 241000193792 Aerococcus viridans Species 0.000 claims description 2
- 241000607534 Aeromonas Species 0.000 claims description 2
- 241000607525 Aeromonas salmonicida Species 0.000 claims description 2
- 206010001497 Agitation Diseases 0.000 claims description 2
- 208000007848 Alcoholism Diseases 0.000 claims description 2
- 201000004384 Alopecia Diseases 0.000 claims description 2
- 241001343292 Anadenanthera Species 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 241000272525 Anas platyrhynchos Species 0.000 claims description 2
- 206010002329 Aneurysm Diseases 0.000 claims description 2
- 241000252073 Anguilliformes Species 0.000 claims description 2
- 241000238426 Anostraca Species 0.000 claims description 2
- 241000013005 Anthias Species 0.000 claims description 2
- 241000243813 Arenicola Species 0.000 claims description 2
- 241000480037 Argyrosomus japonicus Species 0.000 claims description 2
- 102000014654 Aromatase Human genes 0.000 claims description 2
- 108010078554 Aromatase Proteins 0.000 claims description 2
- 208000006820 Arthralgia Diseases 0.000 claims description 2
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 claims description 2
- 241000238017 Astacoidea Species 0.000 claims description 2
- 241001491696 Asterionella Species 0.000 claims description 2
- 241000258957 Asteroidea Species 0.000 claims description 2
- 206010003591 Ataxia Diseases 0.000 claims description 2
- 206010003594 Ataxia telangiectasia Diseases 0.000 claims description 2
- 201000001320 Atherosclerosis Diseases 0.000 claims description 2
- 241000758732 Attheya decora Species 0.000 claims description 2
- 241000758729 Attheya longicornis Species 0.000 claims description 2
- 241001307898 Attheya septentrionalis Species 0.000 claims description 2
- 208000023275 Autoimmune disease Diseases 0.000 claims description 2
- 102000007527 Autoreceptors Human genes 0.000 claims description 2
- 108010071131 Autoreceptors Proteins 0.000 claims description 2
- 101100275685 Bacillus thuringiensis cry2Ad gene Proteins 0.000 claims description 2
- 241001379106 Bacteriastrum Species 0.000 claims description 2
- 208000023328 Basedow disease Diseases 0.000 claims description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 2
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 2
- 229940123513 Beta-catenin antagonist Drugs 0.000 claims description 2
- 239000002028 Biomass Substances 0.000 claims description 2
- 241001626737 Boleophthalmus pectinirostris Species 0.000 claims description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 208000011691 Burkitt lymphomas Diseases 0.000 claims description 2
- YGJDBILYJRDXJX-UHFFFAOYSA-L CC(C([O-])=O)O.CC(C([O-])=O)O.CC(C(O)=O)O.CC(C(O)=O)O.[Ca+2] Chemical compound CC(C([O-])=O)O.CC(C([O-])=O)O.CC(C(O)=O)O.CC(C(O)=O)O.[Ca+2] YGJDBILYJRDXJX-UHFFFAOYSA-L 0.000 claims description 2
- 102000000905 Cadherin Human genes 0.000 claims description 2
- 108050007957 Cadherin Proteins 0.000 claims description 2
- 235000021318 Calcifediol Nutrition 0.000 claims description 2
- 241000282472 Canis lupus familiaris Species 0.000 claims description 2
- 201000009030 Carcinoma Diseases 0.000 claims description 2
- 244000132059 Carica parviflora Species 0.000 claims description 2
- 235000014653 Carica parviflora Nutrition 0.000 claims description 2
- 241000269333 Caudata Species 0.000 claims description 2
- 241000283153 Cetacea Species 0.000 claims description 2
- 241001379148 Chaetoceros diadema Species 0.000 claims description 2
- 241000227750 Chaetocerotaceae Species 0.000 claims description 2
- 241001147109 Chanos chanos Species 0.000 claims description 2
- 101000936911 Chionoecetes opilio Sarcoplasmic/endoplasmic reticulum calcium ATPase Proteins 0.000 claims description 2
- 241000973198 Choerodon schoenleinii Species 0.000 claims description 2
- 206010008748 Chorea Diseases 0.000 claims description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 claims description 2
- 241001478778 Cladophora Species 0.000 claims description 2
- 241000252203 Clupea harengus Species 0.000 claims description 2
- 241000555825 Clupeidae Species 0.000 claims description 2
- 208000006561 Cluster Headache Diseases 0.000 claims description 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 claims description 2
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 claims description 2
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 claims description 2
- 241000270722 Crocodylidae Species 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 241000922680 Cromileptes altivelis Species 0.000 claims description 2
- 241000199913 Crypthecodinium Species 0.000 claims description 2
- KCYOZNARADAZIZ-PPBBKLJYSA-N Cryptochrome Natural products O[C@@H]1CC(C)(C)C=2[C@@](C)(O[C@H](/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(\C)/[C@H]3O[C@@]4(C)C(C(C)(C)CCC4)=C3)/C)\C)/C)C=2)C1 KCYOZNARADAZIZ-PPBBKLJYSA-N 0.000 claims description 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 claims description 2
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 claims description 2
- 241000252233 Cyprinus carpio Species 0.000 claims description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 2
- 101150049660 DRD2 gene Proteins 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 206010012289 Dementia Diseases 0.000 claims description 2
- 206010067889 Dementia with Lewy bodies Diseases 0.000 claims description 2
- 201000004624 Dermatitis Diseases 0.000 claims description 2
- 241001636070 Didymosphenia geminata Species 0.000 claims description 2
- 201000010374 Down Syndrome Diseases 0.000 claims description 2
- 208000005171 Dysmenorrhea Diseases 0.000 claims description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 claims description 2
- 241000949274 Edwardsiella ictaluri Species 0.000 claims description 2
- 241001522629 Eleutheronema tetradactylum Species 0.000 claims description 2
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 2
- 102400001368 Epidermal growth factor Human genes 0.000 claims description 2
- 241000968096 Epinephelus amblycephalus Species 0.000 claims description 2
- 241001643859 Epinephelus awoara Species 0.000 claims description 2
- 241000357444 Epinephelus coioides Species 0.000 claims description 2
- 241000981812 Epinephelus fario Species 0.000 claims description 2
- 241001149251 Epinephelus fuscoguttatus Species 0.000 claims description 2
- 241001149247 Epinephelus maculatus Species 0.000 claims description 2
- 241001656472 Epinephelus morio Species 0.000 claims description 2
- 241001182436 Epinephelus tauvina Species 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 241000239370 Euphausia superba Species 0.000 claims description 2
- 241000630499 Evynnis cardinalis Species 0.000 claims description 2
- 241000282326 Felis catus Species 0.000 claims description 2
- 208000024412 Friedreich ataxia Diseases 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 241000703448 Girella melanichthys Species 0.000 claims description 2
- 241000353198 Girella punctata Species 0.000 claims description 2
- 208000010412 Glaucoma Diseases 0.000 claims description 2
- 241001200316 Glossogobius giuris Species 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 241000001014 Gnathanodon speciosus Species 0.000 claims description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims description 2
- 208000015023 Graves' disease Diseases 0.000 claims description 2
- 108010023302 HDL Cholesterol Proteins 0.000 claims description 2
- 241001596816 Halieutaea stellata Species 0.000 claims description 2
- 241001347229 Hapalogenys nigripinnis Species 0.000 claims description 2
- 101150027313 Has2 gene Proteins 0.000 claims description 2
- 206010019233 Headaches Diseases 0.000 claims description 2
- 208000032843 Hemorrhage Diseases 0.000 claims description 2
- 208000017604 Hodgkin disease Diseases 0.000 claims description 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 2
- 241000251511 Holothuroidea Species 0.000 claims description 2
- 241001125931 Hoplias malabaricus Species 0.000 claims description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 2
- 244000141009 Hypericum perforatum Species 0.000 claims description 2
- 206010020772 Hypertension Diseases 0.000 claims description 2
- 208000001953 Hypotension Diseases 0.000 claims description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 2
- CBIAWPMZSFFRGN-UHFFFAOYSA-N Indiplon Chemical compound CC(=O)N(C)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C(=O)C=2SC=CC=2)=C1 CBIAWPMZSFFRGN-UHFFFAOYSA-N 0.000 claims description 2
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 206010022489 Insulin Resistance Diseases 0.000 claims description 2
- 108010002350 Interleukin-2 Proteins 0.000 claims description 2
- 102000008133 Iron-Binding Proteins Human genes 0.000 claims description 2
- 108010035210 Iron-Binding Proteins Proteins 0.000 claims description 2
- 241001149911 Isopoda Species 0.000 claims description 2
- 241000256602 Isoptera Species 0.000 claims description 2
- 241000567769 Isurus oxyrinchus Species 0.000 claims description 2
- 241000758789 Juglans Species 0.000 claims description 2
- 235000013757 Juglans Nutrition 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims description 2
- 235000009496 Juglans regia Nutrition 0.000 claims description 2
- 241000755266 Kathetostoma giganteum Species 0.000 claims description 2
- 208000006264 Korsakoff syndrome Diseases 0.000 claims description 2
- 241000353176 Kyphosus Species 0.000 claims description 2
- 241000353180 Kyphosus cinerascens Species 0.000 claims description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- 108010028554 LDL Cholesterol Proteins 0.000 claims description 2
- 238000008214 LDL Cholesterol Methods 0.000 claims description 2
- 241000442132 Lactarius lactarius Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 241001596950 Larimichthys crocea Species 0.000 claims description 2
- 201000008197 Laryngitis Diseases 0.000 claims description 2
- 241000269795 Lateolabrax japonicus Species 0.000 claims description 2
- 241000269779 Lates calcarifer Species 0.000 claims description 2
- 241001071853 Lethrinus nebulosus Species 0.000 claims description 2
- 208000009829 Lewy Body Disease Diseases 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 241001417539 Liza Species 0.000 claims description 2
- 241001590999 Liza macrolepis Species 0.000 claims description 2
- 241001550330 Lutjanus argentimaculatus Species 0.000 claims description 2
- 241001550339 Lutjanus erythropterus Species 0.000 claims description 2
- 241001622900 Lutjanus malabaricus Species 0.000 claims description 2
- 241000616508 Lutjanus sebae Species 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 102000043136 MAP kinase family Human genes 0.000 claims description 2
- 108091054455 MAP kinase family Proteins 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 241000060460 Mesopristes argenteus Species 0.000 claims description 2
- 102100036837 Metabotropic glutamate receptor 2 Human genes 0.000 claims description 2
- 206010027476 Metastases Diseases 0.000 claims description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 2
- 102000002151 Microfilament Proteins Human genes 0.000 claims description 2
- 108010040897 Microfilament Proteins Proteins 0.000 claims description 2
- 108010092801 Midkine Proteins 0.000 claims description 2
- 102000016776 Midkine Human genes 0.000 claims description 2
- 208000019695 Migraine disease Diseases 0.000 claims description 2
- 241000961010 Miichthys miiuy Species 0.000 claims description 2
- 241000699670 Mus sp. Species 0.000 claims description 2
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- RCYLUNPFECYGDW-UHFFFAOYSA-N N-(4-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propanamide Chemical compound C12=CC=CC=C2CC(NC(=O)CC)CC1C1=CC=CC=C1 RCYLUNPFECYGDW-UHFFFAOYSA-N 0.000 claims description 2
- RVIGBTUDFAGRTQ-UHFFFAOYSA-N N-(8-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)propanamide Chemical compound C1=CC(OC)=C2CC(NC(=O)CC)CCC2=C1 RVIGBTUDFAGRTQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000003047 N-acetyl group Chemical group 0.000 claims description 2
- MVAWJSIDNICKHF-UHFFFAOYSA-N N-acetylserotonin Chemical compound C1=C(O)C=C2C(CCNC(=O)C)=CNC2=C1 MVAWJSIDNICKHF-UHFFFAOYSA-N 0.000 claims description 2
- JNNOSTQEZICQQP-UHFFFAOYSA-N N-desmethylclozapine Chemical compound N=1C2=CC(Cl)=CC=C2NC2=CC=CC=C2C=1N1CCNCC1 JNNOSTQEZICQQP-UHFFFAOYSA-N 0.000 claims description 2
- RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001204 N-oxides Chemical class 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- 206010029113 Neovascularisation Diseases 0.000 claims description 2
- 108090000189 Neuropeptides Proteins 0.000 claims description 2
- 102000003797 Neuropeptides Human genes 0.000 claims description 2
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- 108090000913 Nitrate Reductases Proteins 0.000 claims description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 claims description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 claims description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 2
- 102000017954 Nuclear factor of activated T cells (NFAT) Human genes 0.000 claims description 2
- 108050007058 Nuclear factor of activated T cells (NFAT) Proteins 0.000 claims description 2
- 101710163270 Nuclease Proteins 0.000 claims description 2
- 208000008589 Obesity Diseases 0.000 claims description 2
- 208000022873 Ocular disease Diseases 0.000 claims description 2
- 241000283201 Odobenidae Species 0.000 claims description 2
- 241000277334 Oncorhynchus Species 0.000 claims description 2
- 241000353171 Oplegnathus punctatus Species 0.000 claims description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 claims description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 208000001132 Osteoporosis Diseases 0.000 claims description 2
- 239000004100 Oxytetracycline Substances 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 241001277085 Pagrus auratus Species 0.000 claims description 2
- 241001282110 Pagrus major Species 0.000 claims description 2
- 206010033799 Paralysis Diseases 0.000 claims description 2
- 208000018737 Parkinson disease Diseases 0.000 claims description 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 claims description 2
- 241000238550 Penaeidae Species 0.000 claims description 2
- 229930182555 Penicillin Natural products 0.000 claims description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 241000395565 Periophthalmus barbarus Species 0.000 claims description 2
- 241000206744 Phaeodactylum tricornutum Species 0.000 claims description 2
- 108010009711 Phalloidine Proteins 0.000 claims description 2
- 201000007100 Pharyngitis Diseases 0.000 claims description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 2
- 241000283216 Phocidae Species 0.000 claims description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 2
- 102000015439 Phospholipases Human genes 0.000 claims description 2
- 108010064785 Phospholipases Proteins 0.000 claims description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 241001607823 Pinnularia Species 0.000 claims description 2
- 235000015266 Plantago major Nutrition 0.000 claims description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
- 241001274186 Platax orbicularis Species 0.000 claims description 2
- 241000269908 Platichthys flesus Species 0.000 claims description 2
- 241000988170 Plebejus Species 0.000 claims description 2
- 241000778501 Plectorhinchus Species 0.000 claims description 2
- 241001396956 Plectorhinchus pictus Species 0.000 claims description 2
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 claims description 2
- 241000321455 Plectropomus leopardus Species 0.000 claims description 2
- 206010035664 Pneumonia Diseases 0.000 claims description 2
- 241000738818 Polydactylus sexfilis Species 0.000 claims description 2
- 241000616956 Polynemus Species 0.000 claims description 2
- 208000020584 Polyploidy Diseases 0.000 claims description 2
- 241001396958 Pomadasys kaakan Species 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 241000372567 Protonibea diacanthus Species 0.000 claims description 2
- 208000032225 Proximal spinal muscular atrophy type 1 Diseases 0.000 claims description 2
- 208000033526 Proximal spinal muscular atrophy type 3 Diseases 0.000 claims description 2
- 241001468939 Psettodes erumei Species 0.000 claims description 2
- 208000028017 Psychotic disease Diseases 0.000 claims description 2
- 206010037660 Pyrexia Diseases 0.000 claims description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 2
- 241001253210 Rachycentron canadum Species 0.000 claims description 2
- 208000005587 Refsum Disease Diseases 0.000 claims description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 claims description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 claims description 2
- 208000005793 Restless legs syndrome Diseases 0.000 claims description 2
- 241001063988 Rhabdosargus sarba Species 0.000 claims description 2
- 229930001406 Ryanodine Natural products 0.000 claims description 2
- 241000277288 Salmo trutta Species 0.000 claims description 2
- 241000233658 Saprolegniaceae Species 0.000 claims description 2
- 244000191542 Sarcobatus vermiculatus Species 0.000 claims description 2
- 241001274197 Scatophagus argus Species 0.000 claims description 2
- 241000233671 Schizochytrium Species 0.000 claims description 2
- 241000269821 Scombridae Species 0.000 claims description 2
- 241000242583 Scyphozoa Species 0.000 claims description 2
- 206010039966 Senile dementia Diseases 0.000 claims description 2
- 206010040047 Sepsis Diseases 0.000 claims description 2
- 241000276699 Seriola Species 0.000 claims description 2
- 241001417495 Serranidae Species 0.000 claims description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 claims description 2
- 241001274981 Siganus canaliculatus Species 0.000 claims description 2
- 241000289346 Siganus fuscescens Species 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 241000073173 Sillago sihama Species 0.000 claims description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 2
- 206010041250 Social phobia Diseases 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 208000010112 Spinocerebellar Degenerations Diseases 0.000 claims description 2
- 208000011641 Spinocerebellar disease Diseases 0.000 claims description 2
- 244000272474 Stenocereus stellatus Species 0.000 claims description 2
- 241001494106 Stenotomus chrysops Species 0.000 claims description 2
- 229930182558 Sterol Natural products 0.000 claims description 2
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 claims description 2
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 claims description 2
- 241000222562 Suillus Species 0.000 claims description 2
- 206010042573 Superovulation Diseases 0.000 claims description 2
- 230000006044 T cell activation Effects 0.000 claims description 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 2
- 241001441722 Takifugu rubripes Species 0.000 claims description 2
- 206010043118 Tardive Dyskinesia Diseases 0.000 claims description 2
- 206010043269 Tension headache Diseases 0.000 claims description 2
- 208000008548 Tension-Type Headache Diseases 0.000 claims description 2
- 241000353141 Terapon jarbua Species 0.000 claims description 2
- 241000270666 Testudines Species 0.000 claims description 2
- 208000035199 Tetraploidy Diseases 0.000 claims description 2
- 241001491687 Thalassiosira pseudonana Species 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 206010044314 Tracheobronchitis Diseases 0.000 claims description 2
- 241000070796 Trachinotus blochii Species 0.000 claims description 2
- 206010052779 Transplant rejections Diseases 0.000 claims description 2
- 241000869417 Trematodes Species 0.000 claims description 2
- 206010044688 Trisomy 21 Diseases 0.000 claims description 2
- 208000025865 Ulcer Diseases 0.000 claims description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 2
- 208000001407 Vascular Headaches Diseases 0.000 claims description 2
- 241000200212 Vaucheria Species 0.000 claims description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 2
- 239000004164 Wax ester Substances 0.000 claims description 2
- 201000008485 Wernicke-Korsakoff syndrome Diseases 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 claims description 2
- 230000036579 abiotic stress Effects 0.000 claims description 2
- 238000002679 ablation Methods 0.000 claims description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims description 2
- 229960004373 acetylcholine Drugs 0.000 claims description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 230000030120 acrosome reaction Effects 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 210000001789 adipocyte Anatomy 0.000 claims description 2
- 210000000577 adipose tissue Anatomy 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 230000001919 adrenal effect Effects 0.000 claims description 2
- 208000030597 adult Refsum disease Diseases 0.000 claims description 2
- 230000008484 agonism Effects 0.000 claims description 2
- 230000036626 alertness Effects 0.000 claims description 2
- 230000005791 algae growth Effects 0.000 claims description 2
- 230000003113 alkalizing effect Effects 0.000 claims description 2
- JRTIDHTUMYMPRU-UHFFFAOYSA-N alpidem Chemical compound N1=C2C=CC(Cl)=CN2C(CC(=O)N(CCC)CCC)=C1C1=CC=C(Cl)C=C1 JRTIDHTUMYMPRU-UHFFFAOYSA-N 0.000 claims description 2
- 229950008673 alpidem Drugs 0.000 claims description 2
- 229940094070 ambien Drugs 0.000 claims description 2
- 229960000836 amitriptyline Drugs 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 2
- 239000001166 ammonium sulphate Substances 0.000 claims description 2
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 2
- 230000003698 anagen phase Effects 0.000 claims description 2
- 230000036592 analgesia Effects 0.000 claims description 2
- 230000001548 androgenic effect Effects 0.000 claims description 2
- 230000033115 angiogenesis Effects 0.000 claims description 2
- 210000002226 anterior horn cell Anatomy 0.000 claims description 2
- 230000001430 anti-depressive effect Effects 0.000 claims description 2
- 230000000561 anti-psychotic effect Effects 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 229940005513 antidepressants Drugs 0.000 claims description 2
- 230000000890 antigenic effect Effects 0.000 claims description 2
- 230000036506 anxiety Effects 0.000 claims description 2
- 239000003048 aphrodisiac agent Substances 0.000 claims description 2
- 230000002509 aphrodisiac effect Effects 0.000 claims description 2
- 238000003782 apoptosis assay Methods 0.000 claims description 2
- 230000006907 apoptotic process Effects 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- 229960004372 aripiprazole Drugs 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 238000013528 artificial neural network Methods 0.000 claims description 2
- 229960005245 asenapine Drugs 0.000 claims description 2
- 208000006673 asthma Diseases 0.000 claims description 2
- 229960002274 atenolol Drugs 0.000 claims description 2
- 230000003190 augmentative effect Effects 0.000 claims description 2
- 230000002567 autonomic effect Effects 0.000 claims description 2
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 2
- 210000004227 basal ganglia Anatomy 0.000 claims description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims description 2
- KCYOZNARADAZIZ-XZOHMNSDSA-N beta-cryptochrome Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C3OC4(C)CCCC(C)(C)C4=C3 KCYOZNARADAZIZ-XZOHMNSDSA-N 0.000 claims description 2
- 229950009087 bifeprunox Drugs 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 230000004790 biotic stress Effects 0.000 claims description 2
- 235000005770 birds nest Nutrition 0.000 claims description 2
- 210000002459 blastocyst Anatomy 0.000 claims description 2
- 230000000740 bleeding effect Effects 0.000 claims description 2
- 230000000903 blocking effect Effects 0.000 claims description 2
- 230000023555 blood coagulation Effects 0.000 claims description 2
- 230000036765 blood level Effects 0.000 claims description 2
- 230000004641 brain development Effects 0.000 claims description 2
- 230000003925 brain function Effects 0.000 claims description 2
- 238000013547 bright light therapy Methods 0.000 claims description 2
- 229960001058 bupropion Drugs 0.000 claims description 2
- FFSAXUULYPJSKH-UHFFFAOYSA-N butyrophenone Chemical class CCCC(=O)C1=CC=CC=C1 FFSAXUULYPJSKH-UHFFFAOYSA-N 0.000 claims description 2
- 235000012682 canthaxanthin Nutrition 0.000 claims description 2
- 239000001659 canthaxanthin Substances 0.000 claims description 2
- 229940008033 canthaxanthin Drugs 0.000 claims description 2
- 208000001969 capillary hemangioma Diseases 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 108010089934 carbohydrase Proteins 0.000 claims description 2
- 230000036996 cardiovascular health Effects 0.000 claims description 2
- 108700021031 cdc Genes Proteins 0.000 claims description 2
- 229940047493 celexa Drugs 0.000 claims description 2
- 230000021164 cell adhesion Effects 0.000 claims description 2
- 230000018486 cell cycle phase Effects 0.000 claims description 2
- 230000011712 cell development Effects 0.000 claims description 2
- 230000024245 cell differentiation Effects 0.000 claims description 2
- 210000002421 cell wall Anatomy 0.000 claims description 2
- 230000033077 cellular process Effects 0.000 claims description 2
- 230000036755 cellular response Effects 0.000 claims description 2
- 230000005754 cellular signaling Effects 0.000 claims description 2
- 210000001638 cerebellum Anatomy 0.000 claims description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 229960001657 chlorpromazine hydrochloride Drugs 0.000 claims description 2
- 229960001552 chlorprothixene Drugs 0.000 claims description 2
- 235000012000 cholesterol Nutrition 0.000 claims description 2
- 229960001231 choline Drugs 0.000 claims description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 2
- 210000001136 chorion Anatomy 0.000 claims description 2
- 230000002759 chromosomal effect Effects 0.000 claims description 2
- 230000008632 circadian clock Effects 0.000 claims description 2
- 229960001653 citalopram Drugs 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000010367 cloning Methods 0.000 claims description 2
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 claims description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims description 2
- 239000003026 cod liver oil Substances 0.000 claims description 2
- 235000012716 cod liver oil Nutrition 0.000 claims description 2
- 230000003920 cognitive function Effects 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 210000002808 connective tissue Anatomy 0.000 claims description 2
- 239000000356 contaminant Substances 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims description 2
- 208000029078 coronary artery disease Diseases 0.000 claims description 2
- 230000002596 correlated effect Effects 0.000 claims description 2
- 230000001054 cortical effect Effects 0.000 claims description 2
- 230000002594 corticospinal effect Effects 0.000 claims description 2
- 235000019788 craving Nutrition 0.000 claims description 2
- 229960003624 creatine Drugs 0.000 claims description 2
- 239000006046 creatine Substances 0.000 claims description 2
- 229940109239 creatinine Drugs 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 229940029644 cymbalta Drugs 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 230000007711 cytoplasmic localization Effects 0.000 claims description 2
- 230000034994 death Effects 0.000 claims description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 2
- 230000007423 decrease Effects 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 230000002950 deficient Effects 0.000 claims description 2
- 208000017004 dementia pugilistica Diseases 0.000 claims description 2
- 230000030609 dephosphorylation Effects 0.000 claims description 2
- 238000006209 dephosphorylation reaction Methods 0.000 claims description 2
- 238000001784 detoxification Methods 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims description 2
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 208000009190 disseminated intravascular coagulation Diseases 0.000 claims description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 2
- 239000002934 diuretic Substances 0.000 claims description 2
- 230000001882 diuretic effect Effects 0.000 claims description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims description 2
- 229960001253 domperidone Drugs 0.000 claims description 2
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 claims description 2
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims description 2
- 230000003291 dopaminomimetic effect Effects 0.000 claims description 2
- 229960002866 duloxetine Drugs 0.000 claims description 2
- 208000000718 duodenal ulcer Diseases 0.000 claims description 2
- 230000004064 dysfunction Effects 0.000 claims description 2
- 208000024732 dysthymic disease Diseases 0.000 claims description 2
- 229940098766 effexor Drugs 0.000 claims description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 2
- 229940011681 elavil Drugs 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 230000002124 endocrine Effects 0.000 claims description 2
- 229940116977 epidermal growth factor Drugs 0.000 claims description 2
- 210000002919 epithelial cell Anatomy 0.000 claims description 2
- 229960004341 escitalopram Drugs 0.000 claims description 2
- WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 claims description 2
- 239000003797 essential amino acid Substances 0.000 claims description 2
- 235000020776 essential amino acid Nutrition 0.000 claims description 2
- 230000029142 excretion Effects 0.000 claims description 2
- 238000004299 exfoliation Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 210000001508 eye Anatomy 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 claims description 2
- 235000020988 fatty fish Nutrition 0.000 claims description 2
- 239000006052 feed supplement Substances 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 230000035558 fertility Effects 0.000 claims description 2
- 239000012894 fetal calf serum Substances 0.000 claims description 2
- 210000003754 fetus Anatomy 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 229930003935 flavonoid Natural products 0.000 claims description 2
- 150000002215 flavonoids Chemical class 0.000 claims description 2
- 235000017173 flavonoids Nutrition 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 229960002464 fluoxetine Drugs 0.000 claims description 2
- 229960002690 fluphenazine Drugs 0.000 claims description 2
- 229960001258 fluphenazine hydrochloride Drugs 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 2
- 239000000446 fuel Substances 0.000 claims description 2
- 210000003976 gap junction Anatomy 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 230000014509 gene expression Effects 0.000 claims description 2
- 230000002068 genetic effect Effects 0.000 claims description 2
- 229940003380 geodon Drugs 0.000 claims description 2
- 230000000762 glandular Effects 0.000 claims description 2
- 150000002303 glucose derivatives Chemical class 0.000 claims description 2
- 229960002449 glycine Drugs 0.000 claims description 2
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical class C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 claims description 2
- 208000024908 graft versus host disease Diseases 0.000 claims description 2
- 230000003676 hair loss Effects 0.000 claims description 2
- 239000000380 hallucinogen Substances 0.000 claims description 2
- 229960003878 haloperidol Drugs 0.000 claims description 2
- 230000012447 hatching Effects 0.000 claims description 2
- 231100000869 headache Toxicity 0.000 claims description 2
- 230000007407 health benefit Effects 0.000 claims description 2
- 230000036074 healthy skin Effects 0.000 claims description 2
- 208000019622 heart disease Diseases 0.000 claims description 2
- 208000014617 hemorrhoid Diseases 0.000 claims description 2
- 230000002440 hepatic effect Effects 0.000 claims description 2
- 210000000514 hepatopancreas Anatomy 0.000 claims description 2
- 235000019514 herring Nutrition 0.000 claims description 2
- 239000000833 heterodimer Substances 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 235000014304 histidine Nutrition 0.000 claims description 2
- 239000003668 hormone analog Substances 0.000 claims description 2
- 229940099552 hyaluronan Drugs 0.000 claims description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 2
- 229940014041 hyaluronate Drugs 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 2
- 230000003483 hypokinetic effect Effects 0.000 claims description 2
- 230000036543 hypotension Effects 0.000 claims description 2
- 230000002267 hypothalamic effect Effects 0.000 claims description 2
- 229960001680 ibuprofen Drugs 0.000 claims description 2
- 150000005232 imidazopyridines Chemical class 0.000 claims description 2
- 229960004801 imipramine Drugs 0.000 claims description 2
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 claims description 2
- XZZXIYZZBJDEEP-UHFFFAOYSA-N imipramine hydrochloride Chemical compound [Cl-].C1CC2=CC=CC=C2N(CCC[NH+](C)C)C2=CC=CC=C21 XZZXIYZZBJDEEP-UHFFFAOYSA-N 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 230000028993 immune response Effects 0.000 claims description 2
- 210000000987 immune system Anatomy 0.000 claims description 2
- 208000026278 immune system disease Diseases 0.000 claims description 2
- 238000002513 implantation Methods 0.000 claims description 2
- 230000001976 improved effect Effects 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 229950003867 indiplon Drugs 0.000 claims description 2
- 208000027866 inflammatory disease Diseases 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 230000000977 initiatory effect Effects 0.000 claims description 2
- 206010022437 insomnia Diseases 0.000 claims description 2
- 230000004073 interleukin-2 production Effects 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 230000037231 joint health Effects 0.000 claims description 2
- 201000004815 juvenile spinal muscular atrophy Diseases 0.000 claims description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- ICAKDTKJOYSXGC-UHFFFAOYSA-K lanthanum(iii) chloride Chemical compound Cl[La](Cl)Cl ICAKDTKJOYSXGC-UHFFFAOYSA-K 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 210000000265 leukocyte Anatomy 0.000 claims description 2
- 210000004558 lewy body Anatomy 0.000 claims description 2
- 229940054157 lexapro Drugs 0.000 claims description 2
- 229920005610 lignin Polymers 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 230000003908 liver function Effects 0.000 claims description 2
- 241000238565 lobster Species 0.000 claims description 2
- 230000004807 localization Effects 0.000 claims description 2
- 230000007774 longterm Effects 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 claims description 2
- 210000005265 lung cell Anatomy 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 claims description 2
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 claims description 2
- 235000009498 luteolin Nutrition 0.000 claims description 2
- 210000004698 lymphocyte Anatomy 0.000 claims description 2
- 230000000527 lymphocytic effect Effects 0.000 claims description 2
- 235000020640 mackerel Nutrition 0.000 claims description 2
- 210000002540 macrophage Anatomy 0.000 claims description 2
- 230000036210 malignancy Effects 0.000 claims description 2
- 230000003211 malignant effect Effects 0.000 claims description 2
- 240000004308 marijuana Species 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- IMYZQPCYWPFTAG-IQJOONFLSA-N mecamylamine Chemical compound C1C[C@@H]2C(C)(C)[C@@](NC)(C)[C@H]1C2 IMYZQPCYWPFTAG-IQJOONFLSA-N 0.000 claims description 2
- 229960002525 mecamylamine Drugs 0.000 claims description 2
- 238000002483 medication Methods 0.000 claims description 2
- 230000003340 mental effect Effects 0.000 claims description 2
- SLVMESMUVMCQIY-UHFFFAOYSA-N mesoridazine Chemical compound CN1CCCCC1CCN1C2=CC(S(C)=O)=CC=C2SC2=CC=CC=C21 SLVMESMUVMCQIY-UHFFFAOYSA-N 0.000 claims description 2
- 229960000300 mesoridazine Drugs 0.000 claims description 2
- 230000002503 metabolic effect Effects 0.000 claims description 2
- VRQVVMDWGGWHTJ-CQSZACIVSA-N methotrimeprazine Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1 VRQVVMDWGGWHTJ-CQSZACIVSA-N 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 238000013508 migration Methods 0.000 claims description 2
- 229960001785 mirtazapine Drugs 0.000 claims description 2
- 230000002438 mitochondrial effect Effects 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 238000009343 monoculture Methods 0.000 claims description 2
- 210000001616 monocyte Anatomy 0.000 claims description 2
- 230000003551 muscarinic effect Effects 0.000 claims description 2
- 201000000585 muscular atrophy Diseases 0.000 claims description 2
- 201000005962 mycosis fungoides Diseases 0.000 claims description 2
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 2
- YNMJUMQDPHRKTA-UHFFFAOYSA-N n-(4-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide Chemical compound C12=CC=CC=C2CC(NC(=O)C)CC1C1=CC=CC=C1 YNMJUMQDPHRKTA-UHFFFAOYSA-N 0.000 claims description 2
- CYOQJCSHEFAKNY-UHFFFAOYSA-N n-[(6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazol-4-yl)methyl]acetamide Chemical compound C1CCC(CNC(C)=O)C2=C1N(C)C1=CC=C(OC)C=C12 CYOQJCSHEFAKNY-UHFFFAOYSA-N 0.000 claims description 2
- 229960004127 naloxone Drugs 0.000 claims description 2
- RGPDIGOSVORSAK-STHHAXOLSA-N naloxone hydrochloride Chemical compound Cl.O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C RGPDIGOSVORSAK-STHHAXOLSA-N 0.000 claims description 2
- YRMLUAGKHYADKJ-UHFFFAOYSA-N necopidem Chemical compound C1=CC(CC)=CC=C1C1=C(CN(C)C(=O)CC(C)C)N2C=C(C)C=CC2=N1 YRMLUAGKHYADKJ-UHFFFAOYSA-N 0.000 claims description 2
- 229950002306 necopidem Drugs 0.000 claims description 2
- 230000001338 necrotic effect Effects 0.000 claims description 2
- 210000000653 nervous system Anatomy 0.000 claims description 2
- 230000000926 neurological effect Effects 0.000 claims description 2
- 210000002569 neuron Anatomy 0.000 claims description 2
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 claims description 2
- 150000002823 nitrates Chemical class 0.000 claims description 2
- 229960001158 nortriptyline Drugs 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 230000030648 nucleus localization Effects 0.000 claims description 2
- 235000014571 nuts Nutrition 0.000 claims description 2
- 235000020824 obesity Nutrition 0.000 claims description 2
- 235000021032 oily fish Nutrition 0.000 claims description 2
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 claims description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 claims description 2
- 230000034004 oogenesis Effects 0.000 claims description 2
- 229940127240 opiate Drugs 0.000 claims description 2
- 239000003401 opiate antagonist Substances 0.000 claims description 2
- 229940109739 orap Drugs 0.000 claims description 2
- 229960003068 ormetoprim Drugs 0.000 claims description 2
- 210000003101 oviduct Anatomy 0.000 claims description 2
- 210000004681 ovum Anatomy 0.000 claims description 2
- 230000004792 oxidative damage Effects 0.000 claims description 2
- 230000036542 oxidative stress Effects 0.000 claims description 2
- 229960004570 oxprenolol Drugs 0.000 claims description 2
- 229960000625 oxytetracycline Drugs 0.000 claims description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims description 2
- 235000019366 oxytetracycline Nutrition 0.000 claims description 2
- 208000021090 palsy Diseases 0.000 claims description 2
- 229940055692 pamelor Drugs 0.000 claims description 2
- 229950007032 panadiplon Drugs 0.000 claims description 2
- 244000045947 parasite Species 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 238000009931 pascalization Methods 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 229940049954 penicillin Drugs 0.000 claims description 2
- 208000028169 periodontal disease Diseases 0.000 claims description 2
- 208000030613 peripheral artery disease Diseases 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims description 2
- 230000035699 permeability Effects 0.000 claims description 2
- 210000002824 peroxisome Anatomy 0.000 claims description 2
- 229940107333 phenergan Drugs 0.000 claims description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 2
- 230000009120 phenotypic response Effects 0.000 claims description 2
- 229960001999 phentolamine Drugs 0.000 claims description 2
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 claims description 2
- 239000003016 pheromone Substances 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 230000000243 photosynthetic effect Effects 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 229960003634 pimozide Drugs 0.000 claims description 2
- 230000008635 plant growth Effects 0.000 claims description 2
- 230000036470 plasma concentration Effects 0.000 claims description 2
- 238000007747 plating Methods 0.000 claims description 2
- 235000021018 plums Nutrition 0.000 claims description 2
- 210000004508 polar body Anatomy 0.000 claims description 2
- 229920000768 polyamine Polymers 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 230000001242 postsynaptic effect Effects 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 230000035935 pregnancy Effects 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 230000037452 priming Effects 0.000 claims description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims description 2
- 229960004919 procaine Drugs 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- WIKYUJGCLQQFNW-UHFFFAOYSA-N prochlorperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 WIKYUJGCLQQFNW-UHFFFAOYSA-N 0.000 claims description 2
- 229960003111 prochlorperazine Drugs 0.000 claims description 2
- 229940002612 prodrug Drugs 0.000 claims description 2
- 239000000651 prodrug Substances 0.000 claims description 2
- 230000005522 programmed cell death Effects 0.000 claims description 2
- 230000000750 progressive effect Effects 0.000 claims description 2
- 229960003598 promazine Drugs 0.000 claims description 2
- 229960003910 promethazine Drugs 0.000 claims description 2
- 229960003712 propranolol Drugs 0.000 claims description 2
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 claims description 2
- 229940116540 protein supplement Drugs 0.000 claims description 2
- 235000005974 protein supplement Nutrition 0.000 claims description 2
- 229940035613 prozac Drugs 0.000 claims description 2
- 229940124811 psychiatric drug Drugs 0.000 claims description 2
- 229940076788 pyruvate Drugs 0.000 claims description 2
- 229960004431 quetiapine Drugs 0.000 claims description 2
- URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 claims description 2
- ZTHJULTYCAQOIJ-WXXKFALUSA-N quetiapine fumarate Chemical compound [H+].[H+].[O-]C(=O)\C=C\C([O-])=O.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 ZTHJULTYCAQOIJ-WXXKFALUSA-N 0.000 claims description 2
- 239000002287 radioligand Substances 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- 229940044551 receptor antagonist Drugs 0.000 claims description 2
- 230000000306 recurrent effect Effects 0.000 claims description 2
- 230000015909 regulation of biological process Effects 0.000 claims description 2
- 239000003488 releasing hormone Substances 0.000 claims description 2
- 229940023942 remeron Drugs 0.000 claims description 2
- 230000001850 reproductive effect Effects 0.000 claims description 2
- 229960003147 reserpine Drugs 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 235000020944 retinol Nutrition 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 230000002441 reversible effect Effects 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 claims description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 claims description 2
- 102200044943 rs121913400 Human genes 0.000 claims description 2
- VQOQDABVGWLROX-UHFFFAOYSA-N rwj-51204 Chemical compound O=C1CCN2C3=CC=C(F)C=C3N(COCC)C2=C1C(=O)NC1=CC=CC=C1F VQOQDABVGWLROX-UHFFFAOYSA-N 0.000 claims description 2
- JJSYXNQGLHBRRK-SFEDZAPPSA-N ryanodine Chemical compound O([C@@H]1[C@]([C@@]2([C@]3(O)[C@]45O[C@@]2(O)C[C@]([C@]4(CC[C@H](C)[C@H]5O)O)(C)[C@@]31O)C)(O)C(C)C)C(=O)C1=CC=CN1 JJSYXNQGLHBRRK-SFEDZAPPSA-N 0.000 claims description 2
- 210000003079 salivary gland Anatomy 0.000 claims description 2
- 239000004576 sand Substances 0.000 claims description 2
- 201000000306 sarcoidosis Diseases 0.000 claims description 2
- 235000019512 sardine Nutrition 0.000 claims description 2
- LIFDPEORUVTOCP-UHFFFAOYSA-N saripidem Chemical compound N1=C2C=CC=CN2C(CN(C)C(=O)CCC)=C1C1=CC=C(Cl)C=C1 LIFDPEORUVTOCP-UHFFFAOYSA-N 0.000 claims description 2
- 229950007359 saripidem Drugs 0.000 claims description 2
- 230000002000 scavenging effect Effects 0.000 claims description 2
- 230000000698 schizophrenic effect Effects 0.000 claims description 2
- 239000013535 sea water Substances 0.000 claims description 2
- 239000000932 sedative agent Substances 0.000 claims description 2
- 230000001624 sedative effect Effects 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 claims description 2
- 208000013223 septicemia Diseases 0.000 claims description 2
- 229940035004 seroquel Drugs 0.000 claims description 2
- 239000003762 serotonin receptor affecting agent Substances 0.000 claims description 2
- 229960002073 sertraline Drugs 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 230000036332 sexual response Effects 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 230000005808 skin problem Effects 0.000 claims description 2
- 230000007958 sleep Effects 0.000 claims description 2
- 230000008477 smooth muscle tissue growth Effects 0.000 claims description 2
- 239000001540 sodium lactate Substances 0.000 claims description 2
- 229940005581 sodium lactate Drugs 0.000 claims description 2
- 235000011088 sodium lactate Nutrition 0.000 claims description 2
- 229940054269 sodium pyruvate Drugs 0.000 claims description 2
- 235000014347 soups Nutrition 0.000 claims description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims description 2
- 230000007103 stamina Effects 0.000 claims description 2
- 239000003270 steroid hormone Substances 0.000 claims description 2
- 230000000365 steroidogenetic effect Effects 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 150000003432 sterols Chemical class 0.000 claims description 2
- 235000003702 sterols Nutrition 0.000 claims description 2
- 229960002385 streptomycin sulfate Drugs 0.000 claims description 2
- 229960000973 sulfadimethoxine Drugs 0.000 claims description 2
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 claims description 2
- 230000003319 supportive effect Effects 0.000 claims description 2
- IBAUKGNDWVSETP-UHFFFAOYSA-N suproclone Chemical compound C1CN(C(=O)CC)CCN1C(=O)OC1C(SCCS2)=C2C(=O)N1C1=CC=C(C=CC(Cl)=N2)C2=N1 IBAUKGNDWVSETP-UHFFFAOYSA-N 0.000 claims description 2
- 229950003877 suproclone Drugs 0.000 claims description 2
- 230000002459 sustained effect Effects 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 239000010729 system oil Substances 0.000 claims description 2
- 230000009885 systemic effect Effects 0.000 claims description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 2
- 230000002123 temporal effect Effects 0.000 claims description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims description 2
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 claims description 2
- 229960002372 tetracaine Drugs 0.000 claims description 2
- 208000027223 tetraploidy syndrome Diseases 0.000 claims description 2
- XCTYLCDETUVOIP-UHFFFAOYSA-N thiethylperazine Chemical compound C12=CC(SCC)=CC=C2SC2=CC=CC=C2N1CCCN1CCN(C)CC1 XCTYLCDETUVOIP-UHFFFAOYSA-N 0.000 claims description 2
- 229960004869 thiethylperazine Drugs 0.000 claims description 2
- RVBRTNPNFYFDMZ-SPIKMXEPSA-N thiethylperazine maleate Chemical compound [H+].[H+].[H+].[H+].[O-]C(=O)\C=C/C([O-])=O.[O-]C(=O)\C=C/C([O-])=O.C12=CC(SCC)=CC=C2SC2=CC=CC=C2N1CCCN1CCN(C)CC1 RVBRTNPNFYFDMZ-SPIKMXEPSA-N 0.000 claims description 2
- 229960002784 thioridazine Drugs 0.000 claims description 2
- 150000005075 thioxanthenes Chemical class 0.000 claims description 2
- 229940104230 thymidine Drugs 0.000 claims description 2
- 229940028300 tigan Drugs 0.000 claims description 2
- 229960005013 tiotixene Drugs 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 125000002640 tocopherol group Chemical class 0.000 claims description 2
- 235000019149 tocopherols Nutrition 0.000 claims description 2
- 229940041597 tofranil Drugs 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 claims description 2
- 230000002103 transcriptional effect Effects 0.000 claims description 2
- 229960003991 trazodone Drugs 0.000 claims description 2
- 229940072040 tricaine Drugs 0.000 claims description 2
- FQZJYWMRQDKBQN-UHFFFAOYSA-N tricaine methanesulfonate Chemical compound CS([O-])(=O)=O.CCOC(=O)C1=CC=CC([NH3+])=C1 FQZJYWMRQDKBQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960002324 trifluoperazine Drugs 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 125000005457 triglyceride group Chemical group 0.000 claims description 2
- FEZBIKUBAYAZIU-UHFFFAOYSA-N trimethobenzamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NCC=2C=CC(OCCN(C)C)=CC=2)=C1 FEZBIKUBAYAZIU-UHFFFAOYSA-N 0.000 claims description 2
- 229960004161 trimethobenzamide Drugs 0.000 claims description 2
- 201000008827 tuberculosis Diseases 0.000 claims description 2
- 230000004614 tumor growth Effects 0.000 claims description 2
- 229940072651 tylenol Drugs 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 229960004688 venlafaxine Drugs 0.000 claims description 2
- 102000009310 vitamin D receptors Human genes 0.000 claims description 2
- 108050000156 vitamin D receptors Proteins 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 235000020234 walnut Nutrition 0.000 claims description 2
- 235000019386 wax ester Nutrition 0.000 claims description 2
- 230000004580 weight loss Effects 0.000 claims description 2
- 235000020985 whole grains Nutrition 0.000 claims description 2
- 235000005765 wild carrot Nutrition 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 229940025158 xenazine Drugs 0.000 claims description 2
- 229960000607 ziprasidone Drugs 0.000 claims description 2
- 229940020965 zoloft Drugs 0.000 claims description 2
- 229940018503 zyban Drugs 0.000 claims description 2
- MEUAVGJWGDPTLF-UHFFFAOYSA-N 4-(5-benzenesulfonylamino-1-methyl-1h-benzoimidazol-2-ylmethyl)-benzamidine Chemical compound N=1C2=CC(NS(=O)(=O)C=3C=CC=CC=3)=CC=C2N(C)C=1CC1=CC=C(C(N)=N)C=C1 MEUAVGJWGDPTLF-UHFFFAOYSA-N 0.000 claims 1
- 102100021407 ATP-dependent RNA helicase DDX18 Human genes 0.000 claims 1
- 241001247278 Acanthopagrus schlegelii Species 0.000 claims 1
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 claims 1
- 102100039339 Atrial natriuretic peptide receptor 1 Human genes 0.000 claims 1
- 101100497223 Bacillus thuringiensis cry1Ag gene Proteins 0.000 claims 1
- 108010075228 CLOCK Proteins Proteins 0.000 claims 1
- 102000008025 CLOCK Proteins Human genes 0.000 claims 1
- 241000251476 Chimaera monstrosa Species 0.000 claims 1
- 230000010190 G1 phase Effects 0.000 claims 1
- 101001041703 Homo sapiens ATP-dependent RNA helicase DDX18 Proteins 0.000 claims 1
- 101000961044 Homo sapiens Atrial natriuretic peptide receptor 1 Proteins 0.000 claims 1
- 241000269774 Lates Species 0.000 claims 1
- 210000003763 chloroplast Anatomy 0.000 claims 1
- IBYCYJFUEJQSMK-UHFFFAOYSA-N etifoxine Chemical compound O1C(NCC)=NC2=CC=C(Cl)C=C2C1(C)C1=CC=CC=C1 IBYCYJFUEJQSMK-UHFFFAOYSA-N 0.000 claims 1
- 229960003817 etifoxine Drugs 0.000 claims 1
- 230000007775 late Effects 0.000 claims 1
- 229960002597 sulfamerazine Drugs 0.000 claims 1
- QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical compound CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 claims 1
- 229960003904 triflupromazine Drugs 0.000 claims 1
- XSCGXQMFQXDFCW-UHFFFAOYSA-N triflupromazine Chemical compound C1=C(C(F)(F)F)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 XSCGXQMFQXDFCW-UHFFFAOYSA-N 0.000 claims 1
- 239000002249 anxiolytic agent Substances 0.000 description 20
- 230000000147 hypnotic effect Effects 0.000 description 17
- 230000001773 anti-convulsant effect Effects 0.000 description 7
- 239000001961 anticonvulsive agent Substances 0.000 description 7
- 229960003965 antiepileptics Drugs 0.000 description 7
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 6
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 6
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 5
- OFBIFZUFASYYRE-UHFFFAOYSA-N flumazenil Chemical compound C1N(C)C(=O)C2=CC(F)=CC=C2N2C=NC(C(=O)OCC)=C21 OFBIFZUFASYYRE-UHFFFAOYSA-N 0.000 description 5
- BUCORZSTKDOEKQ-UHFFFAOYSA-N 7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine Chemical compound C=12C=C(Cl)C=CC2=NC(=NC)CN(O)C=1C1=CC=CC=C1 BUCORZSTKDOEKQ-UHFFFAOYSA-N 0.000 description 4
- VMIYHDSEFNYJSL-UHFFFAOYSA-N Bromazepam Chemical compound C12=CC(Br)=CC=C2NC(=O)CN=C1C1=CC=CC=N1 VMIYHDSEFNYJSL-UHFFFAOYSA-N 0.000 description 4
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 4
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 4
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 4
- KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 4
- XYGVIBXOJOOCFR-BTJKTKAUSA-N (z)-but-2-enedioic acid;8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine Chemical compound OC(=O)\C=C/C(O)=O.C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F XYGVIBXOJOOCFR-BTJKTKAUSA-N 0.000 description 3
- ZIIJJOPLRSCQNX-UHFFFAOYSA-N Flurazepam hydrochloride Chemical compound Cl.Cl.N=1CC(=O)N(CCN(CC)CC)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1F ZIIJJOPLRSCQNX-UHFFFAOYSA-N 0.000 description 3
- DIWRORZWFLOCLC-UHFFFAOYSA-N Lorazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-UHFFFAOYSA-N 0.000 description 3
- MWQCHHACWWAQLJ-UHFFFAOYSA-N Prazepam Chemical compound O=C1CN=C(C=2C=CC=CC=2)C2=CC(Cl)=CC=C2N1CC1CC1 MWQCHHACWWAQLJ-UHFFFAOYSA-N 0.000 description 3
- CXOXHMZGEKVPMT-UHFFFAOYSA-N clobazam Chemical compound O=C1CC(=O)N(C)C2=CC=C(Cl)C=C2N1C1=CC=CC=C1 CXOXHMZGEKVPMT-UHFFFAOYSA-N 0.000 description 3
- 229960004381 flumazenil Drugs 0.000 description 3
- VXRDAMSNTXUHFX-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;n,n-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide Chemical compound OC(=O)C(O)C(O)C(O)=O.N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1.N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 VXRDAMSNTXUHFX-UHFFFAOYSA-N 0.000 description 2
- XBWAZCLHZCFCGK-UHFFFAOYSA-N 7-chloro-1-methyl-5-phenyl-3,4-dihydro-2h-1,4-benzodiazepin-1-ium;chloride Chemical compound [Cl-].C12=CC(Cl)=CC=C2[NH+](C)CCN=C1C1=CC=CC=C1 XBWAZCLHZCFCGK-UHFFFAOYSA-N 0.000 description 2
- OFVXPDXXVSGEPX-UHFFFAOYSA-N Flutoprazepam Chemical compound FC1=CC=CC=C1C(C1=CC(Cl)=CC=C11)=NCC(=O)N1CC1CC1 OFVXPDXXVSGEPX-UHFFFAOYSA-N 0.000 description 2
- WYCLKVQLVUQKNZ-UHFFFAOYSA-N Halazepam Chemical compound N=1CC(=O)N(CC(F)(F)F)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 WYCLKVQLVUQKNZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960002753 cinolazepam Drugs 0.000 description 2
- XAXMYHMKTCNRRZ-UHFFFAOYSA-N cinolazepam Chemical compound C12=CC(Cl)=CC=C2N(CCC#N)C(=O)C(O)N=C1C1=CC=CC=C1F XAXMYHMKTCNRRZ-UHFFFAOYSA-N 0.000 description 2
- 229960001403 clobazam Drugs 0.000 description 2
- ZIXNZOBDFKSQTC-UHFFFAOYSA-N cloxazolam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN2CCOC21C1=CC=CC=C1Cl ZIXNZOBDFKSQTC-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 2
- 229960001578 eszopiclone Drugs 0.000 description 2
- 229960002200 flunitrazepam Drugs 0.000 description 2
- 229950009299 flutoprazepam Drugs 0.000 description 2
- 229960002158 halazepam Drugs 0.000 description 2
- PWAJCNITSBZRBL-UHFFFAOYSA-N ketazolam Chemical compound O1C(C)=CC(=O)N2CC(=O)N(C)C3=CC=C(Cl)C=C3C21C1=CC=CC=C1 PWAJCNITSBZRBL-UHFFFAOYSA-N 0.000 description 2
- FJIKWRGCXUCUIG-UHFFFAOYSA-N lormetazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1Cl FJIKWRGCXUCUIG-UHFFFAOYSA-N 0.000 description 2
- GWUSZQUVEVMBPI-UHFFFAOYSA-N nimetazepam Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1 GWUSZQUVEVMBPI-UHFFFAOYSA-N 0.000 description 2
- AKPLHCDWDRPJGD-UHFFFAOYSA-N nordazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN=C1C1=CC=CC=C1 AKPLHCDWDRPJGD-UHFFFAOYSA-N 0.000 description 2
- 229960002034 pinazepam Drugs 0.000 description 2
- MFZOSKPPVCIFMT-UHFFFAOYSA-N pinazepam Chemical compound C12=CC(Cl)=CC=C2N(CC#C)C(=O)CN=C1C1=CC=CC=C1 MFZOSKPPVCIFMT-UHFFFAOYSA-N 0.000 description 2
- 230000009290 primary effect Effects 0.000 description 2
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 2
- BMGWZHWESYHXHC-TYHJCQIPSA-N (2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O BMGWZHWESYHXHC-TYHJCQIPSA-N 0.000 description 1
- DDSDPQHQLNAGLJ-YEBWQKSTSA-N (2z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-4-ium-1-yl)methylidene]-8-nitro-4h-imidazo[1,2-a][1,4]benzodiazepin-1-one;methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1\C=C/1C(=O)N2C3=CC=C([N+]([O-])=O)C=C3C(C=3C(=CC=CC=3)Cl)=NCC2=N\1 DDSDPQHQLNAGLJ-YEBWQKSTSA-N 0.000 description 1
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- FJIKWRGCXUCUIG-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3h-1,4-benzodiazepin-2-one Chemical compound O=C([C@H](O)N=1)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1Cl FJIKWRGCXUCUIG-HNNXBMFYSA-N 0.000 description 1
- CGMJQQJSWIRRRL-UHFFFAOYSA-N 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound ClC1=CC=CC=C1C1=NCC(=O)NC2=CC=C(Br)C=C12 CGMJQQJSWIRRRL-UHFFFAOYSA-N 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- CPISGDOFEZLACH-XWUWEDPXSA-N CC(C)[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O.CSCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 Chemical compound CC(C)[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O.CSCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 CPISGDOFEZLACH-XWUWEDPXSA-N 0.000 description 1
- 241001247986 Calotropis procera Species 0.000 description 1
- 241001303562 Centrolophus niger Species 0.000 description 1
- 102000004300 GABA-A Receptors Human genes 0.000 description 1
- 108090000839 GABA-A Receptors Proteins 0.000 description 1
- 241000353204 Girella Species 0.000 description 1
- 108010027915 Glutamate Receptors Proteins 0.000 description 1
- 102000018899 Glutamate Receptors Human genes 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- IKMPWMZBZSAONZ-UHFFFAOYSA-N Quazepam Chemical compound FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12 IKMPWMZBZSAONZ-UHFFFAOYSA-N 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 229960004538 alprazolam Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000000338 anxiogenic effect Effects 0.000 description 1
- 229940072698 ativan Drugs 0.000 description 1
- 229960002729 bromazepam Drugs 0.000 description 1
- 229960004782 chlordiazepoxide Drugs 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- 229960004362 clorazepate Drugs 0.000 description 1
- XDDJGVMJFWAHJX-UHFFFAOYSA-M clorazepic acid anion Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(C(=O)[O-])N=C1C1=CC=CC=C1 XDDJGVMJFWAHJX-UHFFFAOYSA-M 0.000 description 1
- 229960003932 cloxazolam Drugs 0.000 description 1
- 239000003179 convulsant agent Substances 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- QCHSEDTUUKDTIG-UHFFFAOYSA-L dipotassium clorazepate Chemical compound [OH-].[K+].[K+].C12=CC(Cl)=CC=C2NC(=O)C(C(=O)[O-])N=C1C1=CC=CC=C1 QCHSEDTUUKDTIG-UHFFFAOYSA-L 0.000 description 1
- 229940075057 doral Drugs 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- 229960003528 flurazepam Drugs 0.000 description 1
- 229940027804 halcion Drugs 0.000 description 1
- 229960004423 ketazolam Drugs 0.000 description 1
- 229940073092 klonopin Drugs 0.000 description 1
- 229960003019 loprazolam Drugs 0.000 description 1
- UTEFBSAVJNEPTR-RGEXLXHISA-N loprazolam Chemical compound C1CN(C)CCN1\C=C/1C(=O)N2C3=CC=C([N+]([O-])=O)C=C3C(C=3C(=CC=CC=3)Cl)=NCC2=N\1 UTEFBSAVJNEPTR-RGEXLXHISA-N 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- 229960004033 lormetazepam Drugs 0.000 description 1
- 229960002225 medazepam Drugs 0.000 description 1
- GADIKQPUNWAMEB-UHFFFAOYSA-N methyl 4-ethyl-6,7-dimethoxy-9H-pyrido[5,4-b]indole-3-carboxylate Chemical compound N1C2=CC(OC)=C(OC)C=C2C2=C1C=NC(C(=O)OC)=C2CC GADIKQPUNWAMEB-UHFFFAOYSA-N 0.000 description 1
- 229960003793 midazolam Drugs 0.000 description 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 description 1
- 229950001981 nimetazepam Drugs 0.000 description 1
- 229960001454 nitrazepam Drugs 0.000 description 1
- 229960002640 nordazepam Drugs 0.000 description 1
- OQJFBUOFGHPMSR-UHFFFAOYSA-N ocinaplon Chemical compound C=1C=CC=NC=1C(=O)C(=C1N=CC=2)C=NN1C=2C1=CC=NC=C1 OQJFBUOFGHPMSR-UHFFFAOYSA-N 0.000 description 1
- 229950010328 ocinaplon Drugs 0.000 description 1
- 229960004535 oxazepam Drugs 0.000 description 1
- HIUPRQPBWVEQJJ-UHFFFAOYSA-N pagoclone Chemical compound C1=CC(Cl)=NC2=NC(N3C(C4=CC=CC=C4C3=O)CC(=O)CCC(C)C)=CC=C21 HIUPRQPBWVEQJJ-UHFFFAOYSA-N 0.000 description 1
- 229950002286 pagoclone Drugs 0.000 description 1
- DPGKFACWOCLTCA-UHFFFAOYSA-N pazinaclone Chemical compound N=1C2=NC(Cl)=CC=C2C=CC=1N(C(C1=CC=CC=C11)=O)C1CC(=O)N(CC1)CCC21OCCO2 DPGKFACWOCLTCA-UHFFFAOYSA-N 0.000 description 1
- 229950003612 pazinaclone Drugs 0.000 description 1
- 229940049721 phenazepam Drugs 0.000 description 1
- 229960004856 prazepam Drugs 0.000 description 1
- CNWSHOJSFGGNLC-UHFFFAOYSA-N premazepam Chemical compound C=1N(C)C(C)=C2C=1NC(=O)CN=C2C1=CC=CC=C1 CNWSHOJSFGGNLC-UHFFFAOYSA-N 0.000 description 1
- 229950003432 premazepam Drugs 0.000 description 1
- 229960001964 quazepam Drugs 0.000 description 1
- 229940080693 reglan Drugs 0.000 description 1
- 229940116246 restoril Drugs 0.000 description 1
- 229940098196 romazicon Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- RMXOUBDDDQUBKD-UHFFFAOYSA-N suriclone Chemical compound C1CN(C)CCN1C(=O)OC1C(SCCS2)=C2C(=O)N1C1=CC=C(C=CC(Cl)=N2)C2=N1 RMXOUBDDDQUBKD-UHFFFAOYSA-N 0.000 description 1
- 229950006866 suriclone Drugs 0.000 description 1
- 229960003188 temazepam Drugs 0.000 description 1
- IQWYAQCHYZHJOS-UHFFFAOYSA-N tetrazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CCCCC1 IQWYAQCHYZHJOS-UHFFFAOYSA-N 0.000 description 1
- 229960005214 tetrazepam Drugs 0.000 description 1
- 229940063648 tranxene Drugs 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- 229940072690 valium Drugs 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 229940074158 xanax Drugs 0.000 description 1
- VXRDAMSNTXUHFX-CEAXSRTFSA-N zolpidem tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1.N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 VXRDAMSNTXUHFX-CEAXSRTFSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Description The primary objectives of this invention is to mass produce (gametes) eggs (especially)/sperm for initiation of stem cells sources and artificial fertilization and in vitro surrogate implantation.
This technology can be used an any and all life forms (sometimes using cross sources of hormones and or hormone analogs)...
The reason we want to produce these substances externally, outside of the body is because it is invasive to remove (eg. oocytes/eggs) from the female's ovaries versus mass production of multiple external ovaries.
We need ovarian and testicular tissue. And we need to mature the tissue.
1. We could remove a sample of ovarian and testicular tissue and regenerate to its full normal size by exposing it to HOX and ECM (Extra Cellular Matrix) .
This technology can be used an any and all life forms (sometimes using cross sources of hormones and or hormone analogs)...
The reason we want to produce these substances externally, outside of the body is because it is invasive to remove (eg. oocytes/eggs) from the female's ovaries versus mass production of multiple external ovaries.
We need ovarian and testicular tissue. And we need to mature the tissue.
1. We could remove a sample of ovarian and testicular tissue and regenerate to its full normal size by exposing it to HOX and ECM (Extra Cellular Matrix) .
2. We could take an ovaries and testes from recently deceased donors and wash with detergent and use the Extra Cellular Matrix Skeleton/Scaffold and repopulate with stem cells and converted stem cells into differentiated cells that normally belong in the specific places. ECM and Hyaluronic Acid and Hyaluronan and hyaluronate (Hasl, Has2, Has3) and its fibronectin-type (collagen and also laminin) components together with HOX can be used to regenerate and grow any and all life forms.
Hyaluronic also supports virulence and could be used for further augmenting the sexual maturity and successful fertilization of healthy in vitro any and all progeny...
Hyaluronic also supports virulence and could be used for further augmenting the sexual maturity and successful fertilization of healthy in vitro any and all progeny...
3. Alternate method of proliferating any and all life. External cues originating outside the cell, (eg epidermal growth factor (EGF)), induce proliferative signaling via beta-catenin, an inside the cell protein is necessary in cell adhesion at the plasma membrane and transcription of cell cycle genes in the nucleus (especially epithelial cells). The factor Writ 3a, is an agonist of beta-catenin transcriptional activity, that induces greater signaling than either of the ligands (EGF and Writ 3a) alone.
However each uses a different sub-cellular pool of beta-catenin. WNT signaling with either Wnt3a, LiCI (causes the accumulation of beta-catenin and also is a dopamine antagonist, see Re: Induced Spawning - section below - GnRH, Gonadotrophin, and other hormones...), or the constitutively active S33Y
mutant of 13-catenin. WNT factors and (3-catenin also affect lymphocyte progenitor fate as well as stem cell self-renewal Stimulation with LiCl markedly increased the amounts of total and nonphosphorylated R-catenin in the myeloma cell lines tested.
However each uses a different sub-cellular pool of beta-catenin. WNT signaling with either Wnt3a, LiCI (causes the accumulation of beta-catenin and also is a dopamine antagonist, see Re: Induced Spawning - section below - GnRH, Gonadotrophin, and other hormones...), or the constitutively active S33Y
mutant of 13-catenin. WNT factors and (3-catenin also affect lymphocyte progenitor fate as well as stem cell self-renewal Stimulation with LiCl markedly increased the amounts of total and nonphosphorylated R-catenin in the myeloma cell lines tested.
4. Another option is with antigenic peptide p33 and a weaker agonist A4Y
ligand and mixed with LiCI or KCI, and pulsed with [ H]thymidine to proliferate all life (including human stem cells). Also IL-2 production had a large increase because of the lithium, as measured by proliferation of the IL-2-dependent, it has been postulated that GSK-3 regulates the T lymphocyte responses. GSK-3 phosphorylates NF-Atc (nuclear factor of activated T cells (NFAT)), which promotes cytoplasmic localization and also export from the nucleus. Therefore, the presence of LiCI should inactivate GSK-3, resulting in prolonged dephosphorylation of NF-ATc and sustained nuclear localization. GSK-3 plays an important role in antigen-specific T cell activation by regulating NF-ATc localization.
ligand and mixed with LiCI or KCI, and pulsed with [ H]thymidine to proliferate all life (including human stem cells). Also IL-2 production had a large increase because of the lithium, as measured by proliferation of the IL-2-dependent, it has been postulated that GSK-3 regulates the T lymphocyte responses. GSK-3 phosphorylates NF-Atc (nuclear factor of activated T cells (NFAT)), which promotes cytoplasmic localization and also export from the nucleus. Therefore, the presence of LiCI should inactivate GSK-3, resulting in prolonged dephosphorylation of NF-ATc and sustained nuclear localization. GSK-3 plays an important role in antigen-specific T cell activation by regulating NF-ATc localization.
5. Once the stem cells or any other tissue proliferated using this method is ready to be grafted back into a patient's body (eg. after regenerating the body part), we can use a beta-catenin antagonist protein E-cadherin to treat the cells to avert cancer...
6. Both 1. and 2. and 3. and 4. are grown outside the body - external ovaries/testicular organs (the result is a regenerated external (once fully regenerated, mature ovary/testes), they can be used as a sort of egg and sperm mass production factories... these can be grown in Gerard Voon's patented bioreactor that uses synthetic blood to bring oxygen and remove CO2 from the tissue/body part and either dialysis and/or functional external from the body kidney that filters waste that is also via the bioreactor filters the blood and uses it for its own survival as well; at the other end nutrients and vitamins, growth hormones and supplements are added based on the stage of growth.. .of the best recipe. In addition to ovarian and testes tissue the above techniques can be used for any and all body parts (from healthy pancreas cells (reinjected - possibly differentiated from stem precusor cells) to full regenerated pancreas to naturally produce insulin for transplant back into the patient's body (Dad)), also immune cells... glands, organs and tissues. Other uses include regenerating and culturing swallows salivary glands and solving the cues, environmental and/or hormonal cues... any and all cues that trigger swallows to make bird's nest soup... also we could regenerate Mako shark's fins separate from the body, possibly from stem cells... In the case (of growing/differentiating ovarian/testes tissue from stem cells) we need to mature the ovaries/testicles... There are both environmental and internal factors (for water bourne creatures) that are involved and even necessary for maturation.. .there are environmental factors include: (eg. simulate annual seasons - including monsoon season); most important is photoperiod (melatonin might be used to alternate use during winter and non-use during the longer lighting summer) length of daylight and (also variation in intensity and/or light pulses) relative to the length of darkness), proper stimulation olfactory organs, FEO (food entrained oscillator... proper stimulation of taste buds, food availability; water temperature; water flow rate (activity - possible impacts on metabolism )(velocity m/sec - flooding and water currents); pH/DH (water hardness); Dissolved Oxygen (mg/I); Free carbon-dioxide (mg/I); Total alkalinity (mg/I); Chlorides (mg/I); TDS (mg/I); DOM (mg/I);
Specific conductivity (mhos)/25C, some believe in the cycles of the moon, atmospheric pressure, availability and desired quality types based on the fish type of spawning substrate, availability of aquatic plants, sticks, gravel, and safe nooks and crannies, nutrition, and the presence of other fish...The effects of these external factors on the blood concentrations of substances (eg. exercise and activity and changes in PH/DH... and/or melatonin antagonists) could be used together with GnRH, gonadotrophin, vitamin A (beta carotene), retinoic acid, for maturing the gametes which is absolutely necessary for spawning/mating/sexual intercourse/breeding to result in healthy embryos (mitosis/meiosis)...
Specific conductivity (mhos)/25C, some believe in the cycles of the moon, atmospheric pressure, availability and desired quality types based on the fish type of spawning substrate, availability of aquatic plants, sticks, gravel, and safe nooks and crannies, nutrition, and the presence of other fish...The effects of these external factors on the blood concentrations of substances (eg. exercise and activity and changes in PH/DH... and/or melatonin antagonists) could be used together with GnRH, gonadotrophin, vitamin A (beta carotene), retinoic acid, for maturing the gametes which is absolutely necessary for spawning/mating/sexual intercourse/breeding to result in healthy embryos (mitosis/meiosis)...
7. Responses by gonadotrophin induced cycles, for females (vary) (some ovulating 70 eggs), we need alleles to induce the follicles to mature, it seems follicular fluid from large follicles (I-pFF), to mature oocyte cytoplasmic and nuclear maturation... It has been hypothesized that Alleles contributing to induction of follicle maturation and steriodogenesis, that (whereby) the maturation process is subject to gonadotropin inducing cycles, contribute to under environmental factors, to mature follicles, to produce estrogens to create and LH surge and thus ovulating.
8. We could also use ovarian tissue and/or full ovaries to produce eggs such as sturgeon (caviar) and turtle and/or crab eggs... this technology could be used to produce any and all eggs...
We can also use synthetic meiosis-activating sterol, derived from follicular fluid (FF-MAS).
Re: Inducing Maturity of Gametes from Ovarian and Testicular Tissue Vitamin A in the form of beta-carotene (BC) an also retinol ester, is supplied to oocytes and cumulus-granulosa via the ovarian follicles (by binding with molecules).
Vitamin A, retinoic acid are involved artificial insemination, and in artificial reproductive techniques (ART), eg.
superovulation, ovum pick up, and in vitro maturation culture. RA is possibly involved in affecting cytoplasmic maturation through gene expression of gonadotrophin receptors, midkine, cyclooxygenase-2, and nitric oxide synthase in cumulus-granulosa cells, oocytes, blastocyst, follicles, gametes (any and all ovarian and/or testes cells).
Tissues needed for the hormonal cascade are the hypothalamus, pituitary gland, and gonads...
The cascade of hormones are gonadotropin releasing hormones (GnRH), which travel from the hypothalamus to the pituitary gland... The pituitary regulates growth and reproduction (we could also use it to further enhance stem cell proliferation). Specialized pituitary cells are signalled by GnRH to release gonadotropic hormones. These gonadotropic hormones affect the gonads, that then produce steroids that regulates final maturation of the gametes.
Maturation of the egg includes vitellogenesis, in this process the yolk proteins (we could grow fully complete livers (deceased donor, detergent and ECM matrix with HOX
and/or stem cells and/or specialized cells per portion of belong on the matrix) outside the body and produce (in Gerard Voon's patented bioreactors)) externally produced yolk protein (mass production) are produced in the liver, transport it to the ovary, to produce much egg size.
The yolk is necessary for the embryo growth.
We are studying the induction and its contribution of Germinal vesicle migration and germinal vesicle breakdown (GVBD) to the gametes development.
Re: Next Stage After Gametes have Matured At this stage (when the gametes have matured) prostaglandins are produced.
They induce ovulation, rupturing of the follicle cells holding the egg. The egg makes its way to the body cavity or ovarian lumen... Interestingly after ovulation, the health of eggs can decrease.
Re: Induced Spawning In addition to viagra, cialis, water melon rind, Kapok (Ceiba pentandra) bark We can induce spawning by extracting hCG from the urine of pregnant (large sources that are easy to grow and breed) - any and all sources eg.
cows/pigs/horses/dogs/cats...
Major methods include injection of a GnRH analogue; agonist (Leutinizing Hormone Releasing Hormone, LHRHa) with dopamine possible antagonist:
Dopamine blockers and depletors include:
= metoclopramide = pimozide (Orap) = haloperidol (Haldol) = olanzapine (Zyprexa) = tetrabenazine = chlorpromazine hydrochloride (Thorazine) = domperidone = droperidol (Inapsine) = fluphenazine hydrochloride (Prolixin) = metoclopramide (Reglan) = perphenazine (Trilafon) = prochiorperazine (Compazine) = thiethylperazine (Torecan) = trimethobenzamide (Tigan) = reserpine (Serpalan) - the fish may be reacting to a change in serotonin level and injection of gonadotropin and hCG (Human Chorionic Gonadotropin), Ovopel, Ovaprim-C, Ovatide, Ovaplant, CPE
(Carp Pituitary Extract) - we also plan to use the above hormones to proliferate stem cells and/or specialized cell regeneration).
Genetic (chromosomal modification)...to induce polyploidy, gynogenesis and androgenesis can be used for all life (aiming to control sex, inhibit sexual maturation and rapid inbreeding -Thorgaard, 1986). Methods to include using temperature sock, high hydrostatic pressure and/or chemicals... on fertilized eggs. Usage of these methods at the final stages of meiosis will retain a second polar body resulting in triploids, furthermore later usage of such methods avoids first cleavage resulting in tetraploidy...
Irradiating the sperm results in gynogenic progeny (progeny having only mother's genes)... Irradiating pre fertilized eggs and then fertilizing results in androgenic progeny (progeny having only the father's genes)... Preventing first cell cleavage restores diploidy.
Methods used can obtain all-female population and/or all0female triploid populations. Start with gynogenic progeny... hormones are used to reverse the sex of the population to phenotypes of males but genetically female. These quasi-males fertilize normal female eggs, that produce all female progeny, the goal is get rid of inbreeding via gynogenic males are prevented.
These methods can be used to produce (via sample from live donor to regenerate - including stem cells - into full matured) ovarian and testicular tissue (and/or collect gametes directly from recently deceased donors) to use in in vitro fertilization.
Re: Artificial Water Bourne creatures' Gills By growing (via stem cells and/or regeneration/cloning of the body parts) or removing gills from the most suitable fish... we could filter out oxygen and release carbon dioxide for divers, submarines, underwater stations and/or use the carbon dioxide for any and all algae and plant growth.
Re: Melatonin Antagonist for growth and/or sexual maturity Bright light therapy is a popular method which prevents the conversion of serotonin to melatonin. The same results from more time in natural sunlight.
Since extending photoperiod is the primary means of inducing fish to mature and spawn (life cycles), and melatonin (produced by the pineal gland during darkness in the environment - the result of our visual receptors) is known to reduce rate of growth and sexual maturity therefore we are using melatonin antagonists including: muscarinic cholinergic antagonist;
mecamylamine, a nicotinic cholinergic antagonist; atenolol, a [3-adrenergic antagonist;
phentolamine, a nonselective a-adrenergic antagonist; prazosin, a selective a-adrenergic antagonist; haloperidol, a dopaminergic antagonist; naloxone, an opioid antagonist; and ibuprofen, a cyclooxygenase inhibitor. The following are theorized that hormones... are facilitated (some how involved) affected by the acetylcholine, dopamine, and/or prostaglandin.
Using (S20098: N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide), and a Putative Antagonist (S20928: N-[2-(1-naphthyl)ethyl]cyclobutyl carboxamide to Block the Effects of Melatonin S20098, an agonist working on melatonin receptors. S20928 have both agonist/antagonist effects, at low applications is an antagonist on melatonin receptors in the suprachiasmatic nucleus and intergeniculate leaflet.
Further Melatonin Agonists and/or Antagonists that we are using to Pharmacologically Take the place of Photoperiod Inducing Growth and Sexual Maturity PREVIOUS NAMES Mel I a Mel1 b ML2 MLIA MLIB
STRUCTURAL INFORMATION 350 as (human) 363 as (human) FULL AGONISTS Melatonin (M 5250) Melatonin (M 5250) 2-lodomelatonin (1 1899) 2-lodomelatonin (1 1899) 2-lodomelatonin (11899) 6-Chloromelatonin (C 0331) N-Propionyl melatonin N-Propionyl melatonin Melatonin (M 5250) N-Butanoyl melatonin N-Butanoyl melatonin N-Acetylserotonin (A 1824) 6-Chloromelatonin (C 0331) 6-Chloromelatonin (C 0331) 5-MCA-NAT
2-Methyl-6,7-dichloromelatonin 2-Methyl-6,7-dichloromelatonin (-)-AMMTC (-)-AMMTC
11K7 (I 5531) PARTIAL AGONISTS 5-Methoxyluzindole 5-Methoxyluzindole Not known N-Acetyltryptamine (A 7342) N-Acetyltryptamine (A 7342) ANTAGONISTS Luzindole (L 2407) Luzindole (L 2407) Luzindole (L 2407) S20928 S20928 Prazosin (P 7791) 4P-PDOT N-Acetyltryptamine (A 7342) K185 (K 1888) SIGNAL TRANSDUCTION MECHANISMS Gi (cAMP modulation) Gi (CAMP modulation) Gq/11 (increase IP3/DAG) Gq/1 1 (increase IP3/DAG) cGMP modulation RADIOLIGANDS OF CHOICE 2-[1251]-lodomelatonin 2-[1251]-lodomelatonin 2-[1251]-lodomelatonin [3H]-Melatonin [3H]-Melatonin 2-[1251]-MCA-NAT
ABBREVIATIONS
4P-ADOT: 4-Phenyl-2-acetamidotetralin (-)-AMMTC: N-Acetyl-4-aminomethyl-6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazole 4P-CADOT: 4-Phenyl-2-chloroacetamidotetralin GR 196429: N-[2-[2,3,7,8-tetrahydro-1 H-furo(2,3-g)indol-1-yl]ethyl]acetamide I IK7: N-Butanoyl-2-(2-methoxy-6H-isoindolo[2,1-a]indole-l 1-yl)ethanamine K185: N-Butanoyl-2-(5,6,7-trihydro-11-methoxybenzo[3,4]cyclohept[2,1 -a]indol-yl)ethanamine Luzindole: 2-Benzyl-N-acetyltryptamine 5-MCA-NAT: 5-Methoxycarbonylamino-N-acetyltryptamine Melatonin: 5-Methoxy-N-acetyltryptamine 4P-PDOT: 4-Phenyl-2-propionamidotetralin 8M-PDOT: 8-Methoxy-2-propionamidotetralin S20098: N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide S20928: N-[2-Naphth-1-yl-ethyl]-cyclobutyl carboxamide Melatonin Receptors Re: Fish Blocking Ca2+ As Well, Vitamin D's Role in Ca2+ absorption Calcium was blocked by diluting water, removing calcium from the diet or by long term feeding of vitamin D-deficient diet. Melatonin. production is affected by plasma Ca2+.
Another way to influence the effects of melatonin is via iontophoresis of the Ca2+ ionophore A-23187, prevents the inhibitory effect of both melatonin or Ca2+ antagonists...
Transcription factors called clock genes, which include Clock, period genes (pert, per2, and per3), cryptochromes (cryl and cry2), and Bmall, regulate hypothalamic suprachiasmatic nucleus (SCN) and in peripheral tissues. The CLOCK and BMALI proteins initiate transcription of the period (per) and cryptochrome (cry) genes, and PER and CRY regulate self transcription through an interaction with the CLOCK/BMAL1 heterodimer to regulate cellular rhythms.
The SCN regylates rhythm in a several major body parts, including brain, pineal gland, adrenal liver, heart, kidney, muscle, pancreas, lung, and oviduct, through neural networks and hormonal excretion via the cerebrospinal fluid. It is clear that the same genes that are responsible for SCN rhythmicity are rhythmically expressed throughout the body.
Anyone who has night time cravings for food must wonder, there seems to be a clinging bond between the time, darkness (lack of activity) and other cues that motivates (possibly metabolism since an early dinner), you such as your rhythm has entrained you to crave food in the same daily rhythm ... This could be the cause of FEO (food entrained oscillator)... The FEO
is an alternate circadian clock acting on any and all living organisms, in addition to suprachiasmatic nuclei (SCN).
The necessary nutrients, include metabolites, ions, vitamins, nucleotides, and amino acids can also traverse from cumulus cells to the oocyte via GJC. Variations in these nutrients inputs can impact positively and/or negatively the developments from stage to stage needs of an ovary tissue into an embryo...
Measurement of carbohydrate concentrations can be taken via Glucose, pyruvate and lactate concentrations in FF, plasma and maturation medium.
Amino acid profiles (concentrations) can be Measured In follicular fluid (FF), and/or plasma... for each oestrous stage.
Measurement of osmolality can be measured using pooled FF, independent of oestrous stage.
Amino acids EAA
L-Arginine HCI
L-Cystine L-Glutamine L-Histidine HCIIH
L-Isoleucine L-Leucine L-Lysine-HCI
L-Methionine L-Phenylalanine L-Threonine L-Tryptophan L-Tyrosine L-Valine L-Glutamine NEAR
L-Alanine L-AsparagineHO
L-Aspartic acid L-Glutamic acid Glycine L-Proline L-Serine Minimal Essential Medium (MEM) essential amino acid solution (no.
320-1130; Gibco).
b MEM nonessential amino acid solution (no. 320-1140; Gibco).
Specifically (stage by stage) Amino acids affected by oestrous stage included:
glutamate, asparagine, histidine, glutamine, threonine, arginine, taurine, alanine, tyrosine, tryptophan, methionine, valine, phenylalanine, leucine and lysine. The Stage I FF amino acid profile was very similar to that of plasma, particularly as regards aspartate, glutamate, serine, glycine, threonine, arginine, taurine, phenylalanine and isoleucine. By contrast, Stages Il-IV profiles were significantly lower than plasma for aspartate, glutamate, asparagine (Stage Ill only), serine, taurine (except Stage II), alanine (Stage II only), methionine (except Stage II), valine (except Stage II), leucine (Stage III only) and lysine (except Stage III).
Overall, plasma levels were markedly higher than those of FF for glutamate, serine and glutamine and, to a lesser extent, for asparagine, threonine, taurine, tyrosine, methionine, phenylalanine and lysine. By contrast, FF valine concentration was significantly higher than in plasma.
It is well believed that amino acids are uptaken into the oocytes by the gap junctions (gap junctional communication (GJC)).
Addtionally the GSH (glutathione) content of an oocyte is much dependent nextdoor cumulus cells, GJC is believed to contribute to GSH content in the oocyte Via passage/uptake of GSH or its substrates, cysteine and glutamine from the cumulus cells to an oocyte. The way cumulus cells regulate MPN (male pronuclei) formation is not understood.
The basic medium used for the maturation of oocytes was BSA-free Whitten's medium NaCl, KC1, KH2PO 4, MgSO 4, NaHCO 3, glucose, sodium lactate, sodium pyruvate, hemicalcium lactate, potassium penicillin, streptomycin sulfate, phenol red and supplemented with PFF (pig/cow/human) follicular fluid, TCM-199 containing hCG, eCG, glutamine, fetal calf serum...
Also, large accumulation of cumulus cells (eg. Artificial Insemination with an external ovary produced oocyte - more broadly the cumulus are responsible for Routing and Penetration of spermatoza) affects the success of penetration of spermatozoa And the large cumulus cell mass induces acrosome reaction and assists penetration into the oocyte.
(Jason 0.5%) (DLD 0.25%) (GP HW 0.25%) We can use Proton nuclear magnetic resonance ((1)H NMR) to chemically dissect any and all life fluids, including stem cell developments (proliferation stages), regeneration, meiosis, mitosis, different cells and the functions, liver and kidney filteration cells the mechanism whereby waste enters one end and is separated and the clean blood diverted back into the system, the mechanism of lung cells (including fish gills) how the absorb oxygen and release carbon dioxide and the membrane? And how this membrane performs this function... (each and every cell type and their symbiotic relationship with each and every organ and glands...
development of ovaries to oocyte, the changing make up of Newt/Salamander's (any and all amphibians (GP) regenerating tails, starfishes, jellyfish, sea cucumber, ECM/HOX changes in response to amino acids, vitamins, ions... changes, mammals/ fishesturtles (near extinct species), Focusing on follicular growth and maturation, (1)H NMR is utilized to dissect intrafollicular and circulating glycoconjugates (sugar chains and N-acetyl groups), lipoproteins (CH(3) and CH(2) groups), glucose metabolites (trimethylamines, acetate and lactate), amino acids (including the above and more specifically: (glutamine/glutamate and alanine), creatine/creatinine and polyamines). Follicular fluids is measured for oestradiol and progesterone. The intrafollicular alanine and lipoproteins (CH(3) groups) went down in the dominant follicle (the future oocyte) during growth stage, while progesterone and oestradiol showed a large increase. As detailed above gonadotrophin is used to induce ovulation;
follicular maturation is noted by lessening of glycoconjugates (sugar chains), trimethylamines and acetate, less oestradiol, also additional CH(3) groups of lipoproteins and progesterone.
Re: The Idea of Varying levels of Factors for Different Phases in Mitosis for any and all Proliferation Promoting Substances has been Previously Patented by Gerard Voon, but Below is one Example of one such Substance (Ca2+) Ca2+ ions needed for mitogenesis and increase in cytosolic Ca 2+ acts as a physiological trigger in cell proliferation, the different phases of the cell cycle present different dosage needs for Ca2+. Ryanodine and NiCl2 eliminated cytosolic Ca + and did not prevent PDGF-induced development into the Go into G, phase. Furthermore progression of cells into the S phase and the further mitosis were arrested, perhaps because S phase needs Ca 2+ and further proliferation promoting factors is regulated by Ca2+dosages and perhaps sharp changes and maintenance levels. G,/S are arrested when there is not enough Ca2+. Emptying of Ca2+ pools during Go/G, and S arrest growth while plating positive affect on G2 and M
cell cycle phases.
PDGF-induced (any and all) cells' proliferation requires the activity of SERCA
pumps to uptake Ca2+ pools the entry into the S phase.
Ca2+ timing (in correlation with the mitotic phases) seems to involve Ca2+
intracellular pools drainage and alternating usage of Ca2+ membrane to uptake the exogenous Ca2+
dependent (are necessary for) on the mitotic phase. PDGF (Platelet-derived growth factor) and possibly any and all other factors (especially for proliferation) binding to receptors at the surface of cellular membrane and are intertwined with changes in cytosolic Ca + dosages that involves a surge the a lesser steady-state elevation, involving both the drainage of Ca +
pools and uptake of Ca 2+ from the extracellular (external to the cell).
Re: Reactive Oxygen Species (ROS), reactive nitrogen species, and calcium (Ca2+) It has been suggested that plant cells sense ROS via at least three different mechanisms: (i) unidentified receptor proteins; (ii) redox-sensitive transcription factors, such as NPRI or Heat Shock Factors; and (iii) direct inhibition of phosphatases by ROS. There is a possiblilty of interactions of ROS, reactive nitrogen species, and calcium signalling.
All three are involved in control and regulation of biological processes, such as growth, cell cycle, programmed cell death, hormone signaling, biotic and abiotic stress responses and development... and any and all phenotypic responses.
ROS, reactive nitrogen species, and calcium (Ca2+) signalling are generated at a number of intracellular locations, including mitochondria, chioroplasts, peroxisomes, and at the extracellular side of the plasma membrane. These locations signal transduction events, such as mitogen-activated protein kinase cascades, eliciting specific cellular responses. The impacts of these ROS, reactive nitrogen species, and calcium signalling on cellular processes is mediated by both the perpetuation of their production and their amelioration by scavenging enzymes such as superoxide dismutase (SOD), ascorbate peroxidase (APX), and catalase (CAT). We need further study location, amplitude, and duration of ROS, reactive nitrogen species, and calcium Functioning like Ca2+ signaling ROS (And possibly nitrogen species) is controlled by the spatial and temporal nature of its pools and drainage.
Re: Some of the Fish we Plan to Apply the Above Spawning Methods and Techniques (From External Ovaries Factories to ROS... ) Scientific name Common name Acanthopagrus latus Yellowtn sea bream A. berda Picnic sea bream A. schiegeli Black sea bream A. sivicolus Southern black sea bream Anthias disper Red fish Boleophthalmus pectinirostris Pond or mud skipper Chanos chanos Milkfish Choerodon schoenleinii Black spot tusk fish Cromileptes altivelis Highfin grouper Eleutheronema tetradactylum Four finger threadfin Epinephelus akaara Red grouper E. amblycephalus* White-spotted green grouper E. awoora Yellow grouper E. coioides / suillus Red-spotted grouper E. fario Black-saddled grouper E. fuscoguttatus Tiger grouper E. lanceolatus Giant or King grouper E: malabaricus I salmonides Malabar grouper E. quoyaqnus Long-finned grouper E. tauvina Green grouper E. tukula Potato grouper E. trimaculatus Brown marbled grouper Evynnis cardinalis Golden-skinned porgy Girella melanichthys Smaliscale blackfish Girella puncta* Largescale blackfish Glossogobius giuris Flathead goby Gnathanodon speciosus Kingfish Hapalogenys nitens Beard grunt Kyphosus lembus Shortfin rudderfish Lateolabrax japonicus Japanese sea bass Lates calcarifer Asian sea bass Lethrinus nebulosus Green snapper Liza macrolepis Largescale liza Lutjanus argentimaculatus Mangrove red snapper L. erythropterus Pink snapper L. johnii John's snapper L. malabaricus Firespot snapper L. monostigma Onespot snapper L. russelli Russell's snapper L. sebae Emperor snapper L. stellatus Spotted snapper Miichthys miiuy Nibe or brown croaker Mugil cephalus Grey mullet Nibea diacanthus Speckled drum Oplegnathus punctatus Spotted knifejaw Pagrus major Red sea bream Platax orbicularis Narrow-banded batfish Plectorhynchus cinctus Three-banded grunt P. pictus Three-lipped grunt Plectropomus leopardus Coral trout Polynemus plebejus Common threadfin P. sexfilis Six threadfin Pomadasys kaakan Lined silver grunter Psettodes erumei Big-mouthed flounder Pseudosciaena crocea Large yellow croaker Rachycentron canadum Cobia or Sergeantfish Scatophagus argus Spotted scat Sciaenops ocellatus Red drum Seriola dumerilli Greater yellowtail Siganus fuscescens Dusky spinefoot S. guttaus Speckled spinefoot S. oramin Yellow-spotted spinefoot Sillago sihama Sand borer S. vermiculatus Reticulated rabbiffish Sparus sarba Silver sea bream Takifu rubripes Tiger puffer Terapon jarbua Three stripe tigerfish Trachinotus blochii Pompano Re: The Drugs Successfully Used for Aquaculture (below), we plan to test their efficacy for Any And All Life Table 1. Drugs Approved for Use in Aquatic Species*
Drug Species Indication Formalin Finfish Control of certain external protozoa and monogenetic trematodes Finfish eggs Control of fungi of the family Saprolegniaceae Penaeid shrimp Control of certain external parasites Oxytetracycline Pacific salmon Marking of skeletal tissue via medicated feed Finfish Marking of skeletal tissue via immersion Salmonids Control of ulcer disease caused by Hemophilus pisicium, furunculosis caused by Aeromonas salmonicida, bacterial hemorrhagic septicemia caused by A liquefaciens and pseudomonas disease.
Catfish Control of bacterial hemorrhagic septicemia caused by A liquefaciens and pseudomonas disease Lobster Control of gaffkemia caused by Aerococcus viridans Sulfadimethoxine/ Salmonids Control of furunculosis caused by Aeromonas ormetoprim salmonicida Catfish Control of enteric septicemia caused by Edwardsiella ictaluri Sulfamerazinet Rainbow, brook, Control of furunculosis and brown trout Tricaine Fish, amphibians, Temporary immobilization as an aid in handling Methanesulfonate and other poikilotherms Chorionic Finfish Spawning aid Gonadotropin *Data from FDA Center for Veterinary Medicine Web site.7 tNot currently marketed.
Re: Sites and Some Hormones that Achieve our Desire to Mature Sperm and Eggs and Induce Spawning Induction of spawning by the injection of 8,11,14-eicosatrienoic acid into the coelomic cavity, shows that the natural sperm maturation factor and spawning hormone.
Alternately females, injected with female prostomial homogenate into the coelomic cavity induces oocyte maturation and subsequent spawning. Oocytes, on the other hand, although maturing in the presence of CMF (Coelomic Maturation Factor), do not mature in the presence of prostomial homogenate.
Oocyte maturation and subsequent spawning is under the control of 2 hormones:
(1) a substance from the prostomium, Prostomal Maturation Hormone (PMH), which induces the production of (2) CMF which acts on the oocyte. PMH is required for oocyte maturation...
Re: Other Chemicals to be Used on any and all Life for Sexual Maturation/Proliferation and/or Breeding/Spawning (On Both Males and Females) Tetracaine, procaine, propranolol, oxprenolol, lanthanum chloride, ionophore A23187, DL-dithiothreitol, arachidonic acid and ammonium ions (ammonium sulphate) were also all tested for their ability to induce maturation... Also possibly injection with 5-hydroxytryptamine (5-HT) into the gonads... serotonin (and any and all psychiatric drugs including viagra and/or cialis) can be applied to induce spawning/breeding... (We could possibly use Antho-RFamide, a neuropeptide situated in ciliated neurons within follicle epithelia, also causes exfoliation of the follicle epithelium from spawned follicles). Photoperiod/intensity augments the potency of Antho-RFamide. The actin-binding toxin phalloidin substantially reduced the incidence of Antho-Rfamide.
Re: Other Alternate Serotonin Drugs that may help Induce Spawning Serotonin levels increase with of tryptophan. Increasing intake foods high in tryptophan, do affect sretonin levels due to competition with other amino acids. Stamina and aerobic exercise improves mood, by increasing in serotonin (endorphins?) levels. Endorphins (endogenous opioid polypeptide compounds). Produced by the pituitary gland and the hypothalamus in vertebrates during strenuous exercise, excitement,, and orgasm; and they resemble the opiates in their abilities to produce analgesia and a sense of well-being. Endorphins work as "natural fever relievers", whose effects may be enhanced by other medications. We could increase water flow rate and velocity and or exercise/activity that is enjoyable to the life form then extract the pituitary and/or hypothalamus from the exercising life form (eg.
pigs/cows/gold fish creatures that are easy, fast and large volume...) also the sources of endorphins, GnRH, Pituitary and Hypothalumus... extracts from the glands of pigs/cows/gold fish could be prepared for extraction via Gerard Voon's patented Neural Links (12% GP) to put the subject of extract in a serotonin/endorphin inducing mood... and inject to make other life (aquaculture and/or any and all life stock farming - even as a viagra and/or feel good supplement) mate... In fact we could use Neural Links directly on the life forms to induce them spawn/breed/mate/have sex (11 %)...
It is believed that a diet rich in whole grain carbohydrates and low in protein will increase serotonin by secreting insulin, which helps in amino acid competition. The danger is that increasing insulin for a long period of time can lead to insulin resistance, which are factors for some causes of obesity, type 2 diabetes, and even lower serotonin levels.
Furthermore that muscles use many amino acids but not tryptophan, allowing men to have more serotonin absorption than women.
Re: Drugs that treat the Serotonin/5-HT system include - AntiDepressants = Ambilify (Aripiprazole) = Sertraline (Zoloft) = Escitalopram (Lexapro) = Fluoxetine (Prozac) = Bupropion (Welibutrin, Zyban) = Paroxetine (Paxil) = Venlafaxine (Effexor) = Trazodone (Desyrel) = Amitriptyline (Elavil) = Citalopram (Celexa) = Duloxetine (Cymbalta) = Mirtazapine (Remeron) = Nortriptyline (Pamelor) = Imipramine (Tofranil) Also (concentrated extracts of) hypericum perforatum (St John's Wort) First Generation Antipsychotics Butyrophenones = Haloperidol (Haldol) Phenothiazines = Chlorpromazine (Thorazine) = Fluphenazine (Prolixin) - Available in decanoate (long-acting) form = Perphenazine (Trilafon) = Prochlorperazine (Compazine) = Thioridazine (Mellaril) = Trifluoperazine (Stelazine) = Mesoridazine = Promazine = Trrflupromazine (Vesprin) = Levomepromazine (Nozinan) = Promethazine (Phenergan) Thioxanthenes = Chlorprothixene = Flupenthixol (Depixol and Fluanxol) = Thiothixene (Navane) = Zuclopenthixol (Clopixol & Acuphase) Second generation antipsychotics = Clozapine (Clozaril) - treats schizophrenia, acute manic episodes, and maintenance of bipolar disorder.
= Risperidone (Risperdal) - treats Tourette Syndrome or Anxiety Disorder.
= Quetiapine (Seroquel) - Used primarily to treat bipolar disorder and schizophrenia, and "off-label" to treat chronic insomnia and restless legs syndrome; it is a powerful sedative = Ziprasidone (Geodon) - Now (2006) approved to treat bipolar disorder. Dosing 20 mg twice daily initially up to 80 mg twice daily. Prolonged QT interval a concern; watch closely with patients that have heart disease; when used with other drugs that prolong QT interval potentially life-threatening.
= Amisulpride (Solian) - Selective dopamine antagonist. Higher doses (greater than 400 mg) act upon post-synaptic dopamine receptors resulting in a reduction in the positive symptoms of schizophrenia, such as psychosis. Lower doses, however, act upon dopamine autoreceptors, resulting in increased dopamine transmission, improving the negative symptoms of schizophrenia. Lower doses of amisulpride have also been shown to have anti-depressant and anxiolytic effects in non-schizophrenic patients, leading to its use in dysthymia and social anxiety disorder.
= Asenapine is a 5-HT2A- and D2-receptor antagonist under development for the treatment of schizophrenia and acute mania associated with bipolar disorder.
= Paliperidone (Invega) - Derivative of risperidone.
Third generation antipsychotics = Aripiprazole (Abilify) - reduce susceptibility to metabolic symptoms seen in some other atypical antipsychotics.[41 = Dopamine partial agonists:
= Under clinical development - Bifeprunox; norclozapine (ACP-104).
Other options = Tetrabenazine (Nitoman in Canada and Xenazine in New Zealand and some parts of Europe) is similar in function to antipsychotic drugs, though is not, in general, considered an antipsychotic itself. This is likely due to its main usefulness being the treatment of hyperkinetic movement disorders such as Huntington's Disease and Tourette syndrome, rather than for conditions such as schizophrenia. Also, rather than having the potential to cause tardive dyskinesia, which most antipsychotics have, tetrabenazine can actually be an effective treatment for the condition.
= Cannabidiol One of the main psychoactive components of cannabis. A recent study has shown cannabidiol to be as effective as atypical antipsychotics in treating schizophrenia.
Metabotropic glutamate receptor 2 agonism has been seen as a promissing strategy in the development of novel antipsychotics. The active metabolite of this prodrug targets the brain glutamate receptors mGIuR2/3 rather than dopamine receptors.
Re: Natural Humane Sources of Serotonin Serotonin are in mushrooms and plants, including fruits and vegetables.
Particularily high contents are present in nuts of the walnut (Juglans) and hickory (Carya) genuses. Serotonin are been present in plantain, pineapple, banana, kiwifruit, plums, and tomatoes. Moderate contents are present in a wide range of tested vegetables. It should be noted that serotonin, unlike its precursors 5-HTP and tryptophan, does not cross the blood-brain barrier. There are plants containing serotonin together with a family of related tryptamines that are methylated at the amino (NH2) and hydroxy (OH) groups, are N-oxides, or miss the OH group eg.
Anadenanthera genus that are used in the hallucinogen.
Re: Treatment For Anxiety that may help Spawning/Breeding/Mating/Sex and also Time of Stress for eg. Aquaculture including Transport and/or Disease and/or Majoring Cleaning of the Tank, Any time the Creatures Become Spooked:
Time to Elimination Common Peak Half-Life (h)** Approximate Drug Name IR Brand (Onset of [active Primary Effects 1 Equivalent Names* H action in Dose*** -1 hours) pi metabolite]
Xanax, Alprazolam Xanor, Tafil, 1-2 6-12 hours anxiolytic 0.5 mg Alprox, Frontal(Brazil) Lexotanil, Lexotan, Bromazepam Lexomil, 1-3 10-20 hours anxiolytic 5-6 mg Somalium, Bromam Librium, 5-30 hours Chlordiazepoxide Tropium, 1.5-4 [36-200 anxiolytic 40 mg Risolid, hours]
Klopoxid Cinolazepam Gerodorm .5-2 9 h hypnotic 40 mg Klonopin, Clonazepam Klonapin, 1-4 18-50 hours anxiolytic, 0.5 mg Rivotril, anticonvulsant lktorivil Cloxazolam Olcadil 2-5 (?) 18-50 hours anxiolytic, I mg (Brazil) anticonvulsant Clorazepate Tranxene Variable [36-100 anxiolytic, hours] anticonvulsant 15 mg Valium, Apzepam, Stesolid, 20-100 hours anxiolytic, Diazepam Vival, 1-2 [36-200] anticonvulsant, muscle 10 mg Apozepam, relaxant Hexalid, Valaxona Estazolam ProSom .5-5 10-24 h hypnotic 1-2 mg Rohypnol, 18-26 hours Flunitrazepam Fluscand, .5-3 [36-200 hypnotic 1 mg Flunipam, hours]
Ronal.
Rohydorm (Brazil) Dalmadorm, [40-250 Flurazepam Dalmane 1-1.5 hours] hypnotic 20-25 mg Flutoprazepam Restas .5-9 60-90 hours hypnotic 2-3 mg Halazepam Paxipam 1-3 [30-100 anxiolytic 20-40 mg hours]
Ketazolam Anxon 2.5-3 30-100 hours anxiolytic 15-30 mg [36-200]
Loprazolam Dormonoct .5-4 6-12 hours hypnotic 1-2 mg Ativan, Lorazepam Temesta, 2-4 10-20 hours anxiolytic,anticonvulsant 1 mg Lorabenz Loramet, Lormetazepam Noctamid, .5-2 10-12 hours hypnotic 1-2 mg Pronoctan Medazepam Nobrium ? 36-200 hours anxiolytic 10 mg Dormicum, Versed, 3 hours (1.8-6 Midazolam Hypnovel, .5-1 hours) hypnotic 5-15 mg Dormonid (Brazil) Nimetazepam Erimin .5-3 14-30 hours hypnotic 5 mg Mogadon, Nitrazepam Alodorm, .5-7 15-38 hours hypnotic 10 mg Pacisyn, Dumolid Nordazepam Madar, Stilny ? 50-120 hours anxiolytic 10 mg Seresta, Serax, Serenid, Serepax, Oxazepam Sobril, 3-4 4-15 hours anxiolytic 30 mg Oxascand, Alopam, Oxabenz, Oxapax Phenazepam ? 1.5-4 60 hours anxiolytic, 1 mg anticonvulsant Pinazepam Domar ? 40-100 hours anxiolytic 20 mg Prazepam Lysanxia, 2-6 36-200 hours anxiolytic 10-20 mg Centrax Premazepam 1 2-6 10-13 hours anxiolytic 3.75 mg Quazepam Doral 1-5 39-120 hours hypnotic 20 mg Restoril, Temazepam Normison, .5-3 8-22 hours hypnotic 20 mg Euhypnos Tetrazepam Mylostan 1-3 3-26 hours Skeletal muscle 50mg relaxant Triazolam Halcion, .5-2 2 hours hypnotic 0.25 mg Rilamir [edit] Atypical benzodiazepine receptor ligands Common Brand Elimination Half- Approximate Drug Name Life (h)** [active Primary Effects Equivalent Names*
metabolite] Dose***
Clobazam Frisium, Urbanol 8-60 hours anxiolytic, 20 mg anticonvulsant DMCM ? ? anxiogenic, N/A, not used convulsant therapeutically Flumazenil Anexate, Lanexat, 1 hour antidote N/A, typical dose Mazicon, Romazicon 0.2 - 0.6 mg Eszopiclone**** Lunesta 6 hours hypnotic 3 mg Zaleplon**** Sonata, Stamoc 2 hours hypnotic 20 mg Zolpidem**** Nytamel, Stilnoct, 2 hours hypnotic 20 mg Stilnox, Zoldem, Zolnod Imovane, Rhovane, Zopiclone**** Zileze; Zimoclone; 2 hours hypnotic 15 mg Zimovane; Zopitan;
Zorclone, Nonbenzodiazepine = Imidazopyridines o zolpidem (Ambien) o alpidem o saripidem o necopidem = Pyrazolopyrimidines o zaleplon (Sonata) o indiplon o ocinaplon = Cyclopyrrolones o eszopiclone (Lunesta) o zopiclone (Imovane) o pagoclone o suriclone o pazinaclone o suproclone = Other structural families o Etffoxine o Panadiplon o CL-218,872 o SX-3228 o L-838,417 o RWJ-51204 o Y-23684 Growth hormone (GH) also has been identified as an oocyte survival factor acting secondarily to the IGF-I pathway. Gonadotropins or growth hormones may act to promote follicle survival, in part, by altering follicular steroidogenesis (eg. human preovulatory follicles cultured in the presence of IGF-I produced more estrogen and less progesterone.
Studies conducted on preovulatory follicles suggest that, without supportive hormones such as human chorionic gonadotropin (hCG), insulin-like growth factor-I (IGF-I), and human follicle stimulating hormone (hFSH), cultured follicle cells will undergo apoptosis (previous studies have shown). Growth hormone (GH) also has been identified as an oocyte survival factor acting secondarily to the IGF-I pathway (previous studies). In some cases, there is evidence that the various gonadotropins or growth hormones may act to promote follicle survival, in part, by altering follicular steroidogenesis. For example, human preovulatory follicles cultured in the presence of IGF-I produced more estrogen and less progesterone (shown by previous studies).
In agreement with my belief that timing/concentration (leading to - response with sexual stimulation; intensity - due the levels of (various environmental cues) change in one direction and durations versus the cue's levels of change opposite in the other direction to create cycles (any and all lengths; seasonal; annual), that the fish (any and all life), naturally take in their sexual response via genetics and/or entrainment to these environmental cues (including maturation (annual cycles and the duration and rate and levels of environmental cues - some hormonal factors such hCG, IGF-I, hFSH, GnRH) - melatonin inhibitor) and seasonal-hormonal responses impact on the willingness of fish and any and all life to spawn/mate/breed/have sex) in response to environmental cues that cause late-cycle high of plasma E2 and testosterone highs may be the cause in feedback to the brain (hypothalamus, and pituitary glands), inducing synthesis and secretion of LH at the expense of FSH production. It is believed that (estradiol-17) E2 is produced in the granulosa cells by the action of the aromatase enzyme and converts testosterone to E2.
Circulating E2 and testosterone levels rise early in final maturation, while the oocyte germinal vesicle is still migrating; peak testosterone levels respond less behind peak E2 levels.
Androgen and estrogen levels both fall coincident with the peak in circulating E2 that is concurrent with GVBD (shown by previous studies) artificial induction can be accomplished using synthetic analogue of gonadotropinreleasing hormone (GnRHa). Noted that changes in circulating steroid hormones rise of internal LH in the blood plasma is induced by GnRHa (past studies).
These observations further suggest that rises in androgen and estrogen levels...
Fish have shown cyclic pattern of oogenesis and endocrine correlative cyclic pattern.
Responding to such environmental cues (eg. photothermal - diurnal and seasonal changes in water temperature and day length) and therefore reproducing in timing cycle that is entrained. Deposition of yolk granules in the growing oocytes is triggered by decreasing day length and water temperature (eg. monsoons and/or rainy season and other environmental factors caused by such seasons and the cues that belong to such seasonal changes that the fish type and entraining that they respond to). Furthermore these seasonal related cues come with a distinct rise in concentration of estradiol-17:1 (E2) and testosterone, as well as Vg.
Exogenous E2 may induce hepatic vitellogenesis suggesting its role as hormone controlling this process.
Oocyte growth begins at deposition of lipid droplets (made of wax esters, which are made from circulating triglyceride precursors) /yolk protein and yolk granules in the ooplasm. Past studies have shown that oocyte growth is correlated to yolk protein deposition in the yolk granule.
Ovarian follicles and vitellogenesis:
1. Theca is the outermost layer derived from stromal connective tissue and is made up of collagen fibers, fibroblasts, steroidogenic cells, and capillaries or other vascular components (according to past studies).
2. Germinal epithelium-derived follicle cells then flatten to form a singular granulosa cell layer under the basal lamina and on top of the cellular chorion or ZR.
3. Junctional complexes between the follicle cells allow for the extracellular passage of Vg, through the theca, basement membrane, granulosa cell layer, and ultimately to the oocyte surface.
4. The ZR then takes on a perforated form by a process known as microvillar, which emanate from both the oocyte and granulosa cells (also based on past studies).
Re: Krill (Zoo Plankton) Farming In addition to any and all oily fish sued to produce healthy fish oils...
especially we are mass producing krill and shrimp...
For their omega-3 fats, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA), but hooked together in a different form...
Fish oil is extracted from, omega-3 fatty acids are found in the triglyceride form, while krill/shrimp oil are hooked up in a double chain phospholipid structure.
The EPA leg phospholipid has a molecule known as astaxanthin, which is a very potent anti-oxidant. The phospholipid EPA and DHA in krill oil are more absorbable. Also Krill/shrimp oil enters more easily into the mitochondria and the nucleus membrane. Furthermore EPA and DHA from krill oil's phospholipid have more complex profile such as phosphatidylcholine, whose effect is reductive-stress-reducing choline, and also a natural emulsifier.
Krill oil has vitamin E, vitamin A, vitamin D and canthaxanthin, like astaxanthin. The anti-oxidant potency of krill oil is 48 times more potent than fish oil. Aparently it has 10 times more antioxidant activity than beta-carotene and as much as 1,000 times more than vitamin E.
Interestingly it is a source of alpha-tocopherol (vitamin E) and a derivative, called marine-derived tocopherol, that has antioxidant properties than alpha-tocopherol. It is postulated that tocopherols enable krill survive in the cold waters. As well they have the flavonoid luteolin. If this theory is correct it may be the only non-plant version of the substance... One claim of omega-3 of krill oil is that the phospholipid content of krill oil plays a role in omega-3 passing through the blood-brain barrier.
If we can mass produce the krill/shrimp cheaply enough they are a rich fertilizer, like fish fertilizer...
Astaxanthin is used as a feed supplement for salmon, crabs, shrimp, chickens and egg production. Regardless of the source, astaxanthin provides some important benefits beyond coloration. It also has been found to be essential for proper growth and survival.
Vitamin A
Krill Oil Phospholipids, Omega-3 rich Eicosapentaenoic Acid (EPA) Docosahexaenoic Acid (DHA) Omega-6 Fatty Acids Astaxanthin Transfat Malacostraca include:
crabs, krill, pill bugs, shrimp, and relatives Kingdom: Animalia Phylum: Arthropoda Class: Malacostraca Members of this Class UV before and/or after freezing, thaw in water prior to injection and/or freeze dry.
A number of studies have shown that krill oil is very effective in: reducing LDL-cholesterol, raising HDL-cholesterol therefore cardiovascular disease; Lowering blood sugar threfore diabetes; Treating the pain; Inflammation from rheumatoid arthritis (therefore see list of inflamatory diseases pages 23 to 25) and Aches and pains (therefore as an pain releiver eg.
substitite for tylenol/aspirin...), PMS and dysmenorrhea, adult ADHD; Healthy brain and nervous system neurodegenerative diseases and It also crosses the blood-brain barrier, which makes it available to the eye, brain and central nervous system to alleviate oxidative stress that contributes to ocular, and neurodegenerative diseases such as glaucoma and Alzheimer's;
Healthy liver function; Improved immune function; Concentration and memory;
Healthy joints.
Astaxanthin is potent antioxidant, it may be beneficial in cardiovascular, immune, inflammatory and neurodegenerative diseases. Research supports the assumption that it protects body tissues from oxidative damage.
Cod Liver versus Fish Oils are: More efficiently and more easily absorbed;
Superior antioxidant protection; Can be renewable; Does not oxidize.
Re: Any and All Shrimp especially Krill Maturation and Spawning We plan to use all the aquaculture (fish, crayfish/crawdads - arthropods, amphbians, any and all life) environmental (eg. page 1 point 6. and Re: Growth and Maturation and Re; Spawning) including temperature/PH/DH and any and all environmental conditions shock, filtration of seawater and/or (eg. simulate annual seasons - including monsoon season); most important is photoperiod (melatonin might be used to alternate use during winter and non-use during the longer lighting summer) length of daylight and (also variation in intensity and/or light pulses) relative to the length of darkness), proper stimulation olfactory organs, FEO
(food entrained oscillator... proper stimulation of taste buds, food availability; water temperature; water flow rate (activity - possible impacts on metabolism )(velocity m/sec - flooding and water currents);
pH/DH (water hardness); Dissolved Oxygen (mg/I); Free carbon-dioxide (mg/I);
Total alkalinity (mg/i); Chlorides (mg/I); TDS (mg/I); DOM (mg/I); Specific conductivity (mhos)/25C, some believe in the cycles of the moon, atmospheric pressure, availability and desired quality types based on the fish type of spawning substrate, availability of aquatic plants, sticks, gravel, and safe nooks and crannies, nutrition, and the presence of other fish.. .The effects of these external factors on the blood concentrations of substances (eg. exercise and activity and changes in PH/DH ...and/or melatonin antagonists) could be used together with GnRH, gonadotrophin, vitamin A (beta carotene), retinoic acid, for maturing the gametes which is absolutely necessary for spawning/mating/sexual intercourse/breeding to result in healthy embryos (mitosis/meiosis)...
We plan to mass produce the krill using the above breeding/spawning techniques.
One spawning method is shrimp eyestalk ablation.
We could try to grow (regenerate) the bioreactors (proliferate via ECM and/or HOX), we could even slice the krill to a survivable cellular colonies (maybe with a threshing machine with very small and fine and sharp blades) and regrow them via regeneration ECM/HOX and other technologies Gerard Voon has patented, whereby the cells are constantly renewed as an altenative artificial maturation and spawning techniques covered in this patent. (Jeff 30 of 35%) Krill can be harvested and processed for their protein (40% or more of dry weight) and lipids (about 20% in E. superba). Their exoskeleton for chitin, hydrolytic enzymes such as proteases, carbohydrases, nucleases and phospholipases, found in their digestive gland in the cephalothorax of the krill; these enzymes might be usable in producing biomass, bio fuel and bio crops ethanol...
Other uses include krill pastes or processed krill as food additives, e.g. in the form of krill oil gel capsules.
Krill are used as pastes, for food addictives oil gel in capsules enzymes, necrotic tissue and chemonucleolytic agents.
Their oils can be used as biofuel...
Algae Algae belong to a group of micro organisms known as protists. Crypthecodinium cohnil and Schizochytrium are two strains/varieties of algae currently employed for supplements of omega-3. They are proliferated in fermenters under specific environmental conditions. When ready the algae are dried and oil separated. By creating a closed system oil from the algae is contaminants free and monoculture.
Fish oil or krill oil, both have EPA and DHA, algae has the DHA. The organisms that feed on the algae retroconvert some DHA back to EPA, although more direct EPA is often needed...
However, research suggests that DHA may be the more critical of the two omega-3s for certain health benefits, especially for infants.
DHA from algae was more positive in its effects on the growth of colon cancer cells in mice than EPA, 90 percent less tumor growth. Reducing platelet aggregation or lowering blood cholesterol as combinations of EPA and DHA from fish oils. Depression may also be associated with reduced blood levels of omega-3 fatty acids and or Omega-6...
Phytoplankton Krill probably react (spawn/sexually triggered/mate/breed in response regulated to the environmental sensitivities in height and duration to the developing cycle of) the Pacific upwelling of cool waters in spring that supports the (especially sensitive to availability - eg.
feeding food frenzy of clouds of phytoplankton) and nutritional and/or odour and/or taste and/or energy associated with phytoplankton bloom. Therefore the timing (entrained, genetically versus glandular recall) bloom is linked with the hatching of krill eggs.
Re: Micro organisms Including Diatoms And Phytoplankton Have the Following Benefits to the Life that Feed on It (Shrimp and/or Krill above Especially feed on Phytoplanktoon).
= immune system enhancement = general nutrition - provide ultra-potent lipids to enhance brain function = energy - increases energy and vitality = promotes better sleep - more restful and restorative = antioxidant protection from cancers and degenerative diseases = cardiovascular health - supports a healthy heart = blood pressure control = cholesterol reduction = liver health - supports a healthy liver = neurological support - mental alertness, ADHD, Parkinsons, and general dementia = alkalizing - the balancing of body pH away from unhealthy excess acidicity = anti-inflammatory effects on membranes - promotes relief from joint pain = cell wall improvement through increased permeability and flexibility = detoxification and cleansing - supports removal of toxins from cells and organs = skin care - such as acne, psoriasis, dermatitis = better vision - more effective than Lutein = blood sugars - stabilizes blood sugar levels (aids those who are diabetic or hyperglycemic) = supports weight loss Re: Factors that Diatoms/Phytoplankton/Plankyton/Zooplankyton/Micro Organisms that are Needed for them to Thrive Most needed seems to be iron... others include temperature, salanity, transmissivity (suspended particulates), oxygen, nitrate, phosphate, silicate, CO2 partial pressure, PH, iron binding ligands...All plants benefit from active nitrate reductase, and the ability for nitrogen fixation makes them good to fertilize hydroponic waters...
The most proliferate are the heterotrophic bacteria, ciliates, and flagellates... We are studying their genes 1. to determine the genes responsible for their rapid proliferation, to insert these genes into cow/pig/chicken... via ovary/testes precusor and gamete cells to mass produce their meat, and/or we could insert these genes responsible for rapid proliferating into micro organisms that have strong enzymes (eg. from termites) for ethanol production, perhaps cutting the processing time and making the process easier. On the other hand we could insert DNA
and/or plasmid into and either pre genetically altered such as enucleated to be compatible with human DNA/plasmid (so these micro organisms: heterotrophic bacteria, ciliates, and flagellates) can reproduce with eg. human DNA, for future extarction into stem cells seed DNA
and/or any other uses for any and all life DNA... These procedures with these micro organisms, can also be used with nitrogen fixing with healthy fertility increasing microorganisms in soil, compost and/or mushrooms, any and all life (especially cells) that we want to mass produce rapidly (harnesssing the rapid rate of proliferation of these heterotrophic bacteria, ciliates, and flagellates)...
Diatoms Include = Diatom A cont. C cont.
A = Attheya longicornis = Chaetocerotaceae = Attheya septentrionalis = Clepsydra (genus) = Asterionella = Auxospore = Coscinodiscineae = Attheya = Attheya arenicola B D
= Attheya armata = Attheya decora = Bacteriastrum = Didymosphenia geminata = Attheya flexuosa = Biddulphiineae = Attheya gaussii F
C
= Frustule = Centrales = Chaetoceros P
= Chaetoceros diadema = Chaetoceros furcellatus = Pennales = Phaeodactylum tricornutum Pinnularia T
= Thalassiosira pseudonana We can collect diatoms resting spores shallower floors/beds of water...
scooping the resting spores versus trying to reach them in deeper waters. We will grow them including krill by putting silicon, nitrogen, phosphorus and iron and adjusting temperatures - we could grow them with hay fusion, filamentous algae, cladophora, vaucheria ... also dphania and brine shrimp. When it comes time for the Krill to spawn we control the the conditional factors including providing an abundance of food and we move them to a deeper pen...
Re: Easy to Grow Sources of Protein Supplements 1. Proteins extracted from Earth Worms and/or grubs - freeze dried/powdered.
2. Proteins extracted from ants, crushed/pulverized (their exoskeleton perhaps dissolved in acid and/or enzymes as long as the method of removing the exoskeleton - if need be at all does devalue the protein desired) frozen and/or freeze dried.
3. These ants and eartheworms can be fed sugar and/or restaurant waste (shredded).
4. They can all be treated to UV then (eg. flash frozen) frozen and then UV
again then thawed and fed as protein.
5. We could add algae taste and/or smell to make the above sources of food more appetizing (pellets).
Since these sources of protein are so cheap, as an alternate for human supplements/additive (pills/capsules/powder), for animal feed and/or any and all fish feed.
And or pwdered and fed to animal meat in bioreactors to mass produce mass amounts of meat cheaply, or as fertilizer and also to gro fat cells (from eg. seals, whales and walruses) to produce biofuel and also a delicacy (GP 0.5%).
Re: Micro organisms Lacto Bacillius and/or Actinomycetes, diatoms... both of which are photosynthetic bacterias -which can be used for pre digestion of feed for any and all creatures - making the food more nutritional. Lacto Bacillus also produces lactic acid from sugars, carbohydrates and yeast (which sterilizes - we could produce antibacterial hand washes/antibacterial wet tissues/gels... lactic acid could also possibly mixed with chitin and/or furanone - anti agent used against harmful organisms), lactic acid also ferments and decomposes lignin and cellulose, which can be used for any and all biocrops to turn into ethanol.
Re: Biofiims/Quorum Sensing - believed to be sensed via pheromone and/or autoinducers by secreting signal molecules; cell to cell signaling We could possibly use genes that govern high virulence (eg. E.Coli)and genetically Modify into cows/pigs/chickens/fish meats such that we can clone fast growing life forms but also the meats for food. Also we could use biofilm/quorum sensing for yeast, bacteria in cow' s mouth (that produces methane - for fuel), micro organisms found in a cow's/horses'/
gut for cellulose (eg. hay) processing - fermentation (and their enzymes), micro organisms for compost, sewage, manure, restaurant waste, possibly garbage waste; by adding sugar we turn soils fertile ... these materials can be (thoroughly/evenly/strategically) mixed with sugar/carbohydrates/starch is such a way that the clusters of waste that are easier to breakdown need less sugar, while the clusters of waste that are harder to breakdown need the supplement of higher concentration of sugar/carbohydrates/starch to give the micro organisms energy and vitality together with adequate biofilm/quorum sensing for the micro organisms to flourish.
The following (below) suggests that there are many factors affecting micro organism in the blood stream or occupying infected cells, actually some similarity to fish (any and all life) and their responses to contents (and concentration) and conditions in the water (medium)...We are using melatonin antagonist for micro organisms that are light sensitive, we also will control any and all environment factors (the same as in fish maturation) in cycles (tall rise and fall of and timing that cause cycle and durational changes), as well as the hypothalamus and pituitary gland hormones (and all their analogues) as well as LH... We could also try viagra, cialis, LHRHa (with dopamine agonist), Beta Carotene, (Vitamin A), retinoic acid, water melon rind, Kapok (Ceiba pentandra) bark....
Re: Regulation of virulence (Cited Prof. Dr. Hubert Hilbi, SSO4) - Most of which is well known and widely available in other Studies = DNA structure and transcription factors = Environment - temperature, pH, ions, osmolarity, oxygen, nutrients = Host cells - contact - intracellular environment = Cell density (quorum sensing) - autoinducer systems - processes (bioluminescence, biofilm, virulence) = Genome structure and topology = Environment - temperature, growth phase, pH, ions, osmolarity, oxygen, nutrients = Host cells - secretion-dependent regulation - intracellular environment (macrophages, amoebae) = Cell density (quorum sensing) - autoinducer systems - processes (bioluminescence, virulence, biofilm) Ceiba pentandra bark is believed to be diuretic, aphrodisiac, and to treat headache, as well as type II diabetes. We could test the effectiveness and isolate the active ingredient then commercially make the active ingredient(s) available.
Re: Photoperiod and the Natural Production and Injested Vitamin D
Tissues in the body convert Vitamin (via receptors and enzymes), from Vitamin D; 25-hydroxyvitamin D and/or 25(OH) into active ; 1,25-dihydroxyvitamin D.
Vitamin D interacts with 200 genes.
We are particularity interested in smooth muscle growth (as a perhaps cyclical response in coordination with the seasonal light and dark photoperiods) - thus the level, timing of change, steadyness (not too volatile versus times when is needs to be volatile to induce the eg. fish (any and all life)), of rate of change the duration it prolongs the high and lows in mimicing or even find a cyclical combination that works even better for sexual maturation and/or spawning/breeding/sex/mating ... if the postulation in the paragraph below is correct than it might help any and all tissue not only including the testes and the ovaries but all life and their body parts, including stem cells in Gerard Voon's bioreactor ... Perhaps the ability of Vitamin D
to help those with dysfunctioning Seasonal Affective Disorder (SAD) may help growth, sexual maturation and sex/mating/breeding/spawning...
An interesting postulation is that Vitamin D may be released naturally into the organism during Photoperiod (response to sun light), and therefore may play an opposite role than melatonin (released in darkness). Thus Vitamin D may play a role in sexual maturity and growth...
We testing the effectiveness of Vitamin D on any and all (anti inflammatory) of the below diseases:
Cardiovascular Blood Pressure Multiple Sclerosis (MS) Rheumatoid Arthritis (RA) Inflammatory Bowel Disease (IBD) Interstitial Cystitis (IC) Fibromyalgia (FM) Autonomic nervous dysfunction (AND neural-mediated hypotension);
Pyoderma Gangrenosum (PG) Chronic Fatigue (CF) and Chronic Fatigue Syndrome (CFS).
Chronic hepatitis Systemic lupus erythematosus Arthritis Thyroidosis Scleroderma Diabetes mellitus Graves' disease Beschet's disease and Graft versus host disease (graft rejection).
Chronic inflammatory pathologies such as aneurysms Hemorrhoids Sarcoidosis Chronic inflammatory bowel disease Ulcerative colitis Crohn's disease and vascular inflammatory pathologies Disseminated intravascular coagulation Atherosclerosis Kawasaki's pathology Coronary artery disease Hypertension Stroke Asthma Chronic hepatitis Multiple sclerosis Peripheral neuropathy Chronic or recurrent sore throat Laryngitis Tracheobronchitis Chronic vascular headaches (including migraines Cluster headaches and tension headaches) and pneumonia Neurodegenerative diseases including Demyelinating diseasessuch as multiple sclerosis and acute transverse myelitis;
Extrapyramidal and cerebellar disorders such as lesions of the corticospinal system;
Disorders of the basal ganglia or cerebellar disorders;
Hyperkinetic movement disorders such as Huntington's Chorea and senile chorea;
Drug-induced movement disorders such as those induced by drugs which block CNS
dopamine receptors;
Hypokinetic movement disorders such as Parkinson's disease;
Progressive supranucleo palsy;
Cerebellar and Spinocerebellar Disorders such as astructural lesions of the cerebellum;
Spinocerebellar degenerations (spinal ataxia) Friedreich's ataxia Cerebellar cortical degenerations Multiple systems degenerations (MencelDejerine-Thomas Shi-Drager and Machado Joseph)); and systemic disorders (Refsum's disease Abetalipoprotemia, ataxia telangiectasia and mitochondrial multi-system disorder);
Demyelinating core disorders such as:
Multiple sclerosis Acute transverse myelitis;
Disorders of the motor unit such as neurogenic muscular atrophies (anterior horn cell degeneration) such as Amyotrophic lateral sclerosis Infantile spinal muscular atrophy and juvenile spinal muscular atrophy);
Alzheimer's disease;
Down's Syndrome in middle age;
Diffuse Lewy body disease; Senile Dementia of Lewy body type;
Wemicke-Korsakoff syndrome;
Chronic alcoholism;
Creutzfeldt-Jakob disease;
Subacute sclerosing panencephalitis Hallerrorden-Spatz disease; and Dementia pugilistica Malignant pathologies involving tumors or other malignancies such as:
Leukemias (acute chronic myelocytic chronic lymphocytic and/or myelodyspastic syndrome);
Lymphomas (Hodgkin's and non-Hodgkin's lymphomas such as malignant lymphomas (Burkitt's lymphoma or Mycosis fungoides));
Carcinomas (such as colon carcinoma) and metastases thereof;
Cancer-related angiogenesis;
Infantile hemangiomas;
Alcohol-induced hepatitis.
Ocular neovascularization Psoriasis Duodenal ulcers Other diseases that we are testing for effectiveness include parkinsons, diabetes, osteoporosis, multiple sclerosis, breast cancer, colon cancer, prostate cancer, autoimmune disease, cardiovascular (blood clotting - posssibly in gel, powder or imbedded in gauze (perhaps with antibacterials such as furanone and/or chitin) to an open wound to prevent bleeding to death and then apply a layer of ECM/HOX for regeneration assuming that the wound is not too severe - in which case it may be better to grow an entire new limb using the ECM scaffolding and stem cells of a recently deceased body part donor disease), any and all sexually transmitted diseases, herpes... hepatitus, skin problems eg. serious acne, any and all skin conditions, depression, schizophrenia, seasonal affective disorder, peripheral artery disease, tuberculosis, cancer, periodontal disease, multiple sclerosis,...
Using all our Gerard Voon's patented inventions (Methods and Techniques, Models) Titled:
BioScience and all the above: Fish liver oils, including cod liver oil, Fatty fish species, Herring, Catfish, Salmon, cooked, Mackerel, Sardines, canned in oil, Tuna, canned in oil, Eel, One whole egg (perhaps more duck eggs because of their oiliness).
EPA healthy heart - healthy body Promotes a healthy heart and circulatory system Supports healthy homocysteine levels Supports proper immune function Promotes good mood and emotional well-being Supports joint flexibility DHA healthy mood - healthy mind Essential for memory, cognitive function, 'learning and focus Supports a healthy pregnancy Promotes good mood and emotional well-being Reduces harmful effects of stress Supports the visual and brain development of fetus' and infants GIA healthy skin & hair - healthy hormones Promotes beneficial prostaglandins that maintain hormonal balance Provides a "feel good" effect, improves mood Nourishes hair and skin Supports joint flexibility Promotes normal body fat metabolism Vitamin D Receptor will be used to help us in cell proliferation and/or differentiation (from stem cells to any and all life as well as micro organisms). We will also use its properties via Gerard Voon's patented stem cells to immune cells (adjuvant and immune cells priming as a serum for diseses with antigens or unchanging intracellular proteins - for harmful diseases that mutate their cellular antigens on their membranes; or just fortify the immune response during disease out break), Vitamin D is also involved in white blood cells eg. monocytes and activated T and B
cells.
Re: Waterboume mirco organisms (eg. diatoms) could be added with sugar (in its various forms).. .white rice... to Hydronics ... and any and all mediums.
The waterbourne micro organisms (eg. diatoms), can break down ammonia/nitrates/urea/sugars/carbohydrates/sewage/detritus/hay fusion/compost/tea manure... in the hydroponic media... to make the water fertile for plants and algae...
Re: Drawing 1. - Tall Greenhouse Solar and Mirror Invention 1. Solar Panels on the roof of the Greenhouse.
2. Mirrors on the bottom ceiling to catch reflected light from angled mirrors surrounding th greenhouse.
3. The greenhouse plants space.
4. The mirrors angled to aim sun's light at the mirrors in the ceiling (possibly parabolic).
The reason the greenhouse is so tall is to allow surrounding mirrors further out to also aim and reach the ceiling...
Re: Cure for Baldness and Fur Industry We take a newly deceased donor, we take off the scalp (and follicular skin below) hair and/or fur and all and treat its raw side with ECM/HOX (Jeff 20% of 35%) any and all proliferating factors and/or flush the skin/flesh under the hair/fur with deterregent and until only the ECM
sccafold remains add stem cells from the own patient (to avoid rejection) (to grow a whole new scalp with hair/fur or in the case of fur, we could cut off the top skin for fur/skin... (also aligators/crocodiles and/or eels...) while leaving the bottom layer of follicle base behind that we expose ECM/HOX (Jeff 10% of 35%) and/or any and all proliferation factors to regenerate the fur for human bald patients we then operate on the patient to either descalp and/or dermabrasion the patient's upper layer of then attach the new scalp to the bald patient.
We can also use synthetic meiosis-activating sterol, derived from follicular fluid (FF-MAS).
Re: Inducing Maturity of Gametes from Ovarian and Testicular Tissue Vitamin A in the form of beta-carotene (BC) an also retinol ester, is supplied to oocytes and cumulus-granulosa via the ovarian follicles (by binding with molecules).
Vitamin A, retinoic acid are involved artificial insemination, and in artificial reproductive techniques (ART), eg.
superovulation, ovum pick up, and in vitro maturation culture. RA is possibly involved in affecting cytoplasmic maturation through gene expression of gonadotrophin receptors, midkine, cyclooxygenase-2, and nitric oxide synthase in cumulus-granulosa cells, oocytes, blastocyst, follicles, gametes (any and all ovarian and/or testes cells).
Tissues needed for the hormonal cascade are the hypothalamus, pituitary gland, and gonads...
The cascade of hormones are gonadotropin releasing hormones (GnRH), which travel from the hypothalamus to the pituitary gland... The pituitary regulates growth and reproduction (we could also use it to further enhance stem cell proliferation). Specialized pituitary cells are signalled by GnRH to release gonadotropic hormones. These gonadotropic hormones affect the gonads, that then produce steroids that regulates final maturation of the gametes.
Maturation of the egg includes vitellogenesis, in this process the yolk proteins (we could grow fully complete livers (deceased donor, detergent and ECM matrix with HOX
and/or stem cells and/or specialized cells per portion of belong on the matrix) outside the body and produce (in Gerard Voon's patented bioreactors)) externally produced yolk protein (mass production) are produced in the liver, transport it to the ovary, to produce much egg size.
The yolk is necessary for the embryo growth.
We are studying the induction and its contribution of Germinal vesicle migration and germinal vesicle breakdown (GVBD) to the gametes development.
Re: Next Stage After Gametes have Matured At this stage (when the gametes have matured) prostaglandins are produced.
They induce ovulation, rupturing of the follicle cells holding the egg. The egg makes its way to the body cavity or ovarian lumen... Interestingly after ovulation, the health of eggs can decrease.
Re: Induced Spawning In addition to viagra, cialis, water melon rind, Kapok (Ceiba pentandra) bark We can induce spawning by extracting hCG from the urine of pregnant (large sources that are easy to grow and breed) - any and all sources eg.
cows/pigs/horses/dogs/cats...
Major methods include injection of a GnRH analogue; agonist (Leutinizing Hormone Releasing Hormone, LHRHa) with dopamine possible antagonist:
Dopamine blockers and depletors include:
= metoclopramide = pimozide (Orap) = haloperidol (Haldol) = olanzapine (Zyprexa) = tetrabenazine = chlorpromazine hydrochloride (Thorazine) = domperidone = droperidol (Inapsine) = fluphenazine hydrochloride (Prolixin) = metoclopramide (Reglan) = perphenazine (Trilafon) = prochiorperazine (Compazine) = thiethylperazine (Torecan) = trimethobenzamide (Tigan) = reserpine (Serpalan) - the fish may be reacting to a change in serotonin level and injection of gonadotropin and hCG (Human Chorionic Gonadotropin), Ovopel, Ovaprim-C, Ovatide, Ovaplant, CPE
(Carp Pituitary Extract) - we also plan to use the above hormones to proliferate stem cells and/or specialized cell regeneration).
Genetic (chromosomal modification)...to induce polyploidy, gynogenesis and androgenesis can be used for all life (aiming to control sex, inhibit sexual maturation and rapid inbreeding -Thorgaard, 1986). Methods to include using temperature sock, high hydrostatic pressure and/or chemicals... on fertilized eggs. Usage of these methods at the final stages of meiosis will retain a second polar body resulting in triploids, furthermore later usage of such methods avoids first cleavage resulting in tetraploidy...
Irradiating the sperm results in gynogenic progeny (progeny having only mother's genes)... Irradiating pre fertilized eggs and then fertilizing results in androgenic progeny (progeny having only the father's genes)... Preventing first cell cleavage restores diploidy.
Methods used can obtain all-female population and/or all0female triploid populations. Start with gynogenic progeny... hormones are used to reverse the sex of the population to phenotypes of males but genetically female. These quasi-males fertilize normal female eggs, that produce all female progeny, the goal is get rid of inbreeding via gynogenic males are prevented.
These methods can be used to produce (via sample from live donor to regenerate - including stem cells - into full matured) ovarian and testicular tissue (and/or collect gametes directly from recently deceased donors) to use in in vitro fertilization.
Re: Artificial Water Bourne creatures' Gills By growing (via stem cells and/or regeneration/cloning of the body parts) or removing gills from the most suitable fish... we could filter out oxygen and release carbon dioxide for divers, submarines, underwater stations and/or use the carbon dioxide for any and all algae and plant growth.
Re: Melatonin Antagonist for growth and/or sexual maturity Bright light therapy is a popular method which prevents the conversion of serotonin to melatonin. The same results from more time in natural sunlight.
Since extending photoperiod is the primary means of inducing fish to mature and spawn (life cycles), and melatonin (produced by the pineal gland during darkness in the environment - the result of our visual receptors) is known to reduce rate of growth and sexual maturity therefore we are using melatonin antagonists including: muscarinic cholinergic antagonist;
mecamylamine, a nicotinic cholinergic antagonist; atenolol, a [3-adrenergic antagonist;
phentolamine, a nonselective a-adrenergic antagonist; prazosin, a selective a-adrenergic antagonist; haloperidol, a dopaminergic antagonist; naloxone, an opioid antagonist; and ibuprofen, a cyclooxygenase inhibitor. The following are theorized that hormones... are facilitated (some how involved) affected by the acetylcholine, dopamine, and/or prostaglandin.
Using (S20098: N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide), and a Putative Antagonist (S20928: N-[2-(1-naphthyl)ethyl]cyclobutyl carboxamide to Block the Effects of Melatonin S20098, an agonist working on melatonin receptors. S20928 have both agonist/antagonist effects, at low applications is an antagonist on melatonin receptors in the suprachiasmatic nucleus and intergeniculate leaflet.
Further Melatonin Agonists and/or Antagonists that we are using to Pharmacologically Take the place of Photoperiod Inducing Growth and Sexual Maturity PREVIOUS NAMES Mel I a Mel1 b ML2 MLIA MLIB
STRUCTURAL INFORMATION 350 as (human) 363 as (human) FULL AGONISTS Melatonin (M 5250) Melatonin (M 5250) 2-lodomelatonin (1 1899) 2-lodomelatonin (1 1899) 2-lodomelatonin (11899) 6-Chloromelatonin (C 0331) N-Propionyl melatonin N-Propionyl melatonin Melatonin (M 5250) N-Butanoyl melatonin N-Butanoyl melatonin N-Acetylserotonin (A 1824) 6-Chloromelatonin (C 0331) 6-Chloromelatonin (C 0331) 5-MCA-NAT
2-Methyl-6,7-dichloromelatonin 2-Methyl-6,7-dichloromelatonin (-)-AMMTC (-)-AMMTC
11K7 (I 5531) PARTIAL AGONISTS 5-Methoxyluzindole 5-Methoxyluzindole Not known N-Acetyltryptamine (A 7342) N-Acetyltryptamine (A 7342) ANTAGONISTS Luzindole (L 2407) Luzindole (L 2407) Luzindole (L 2407) S20928 S20928 Prazosin (P 7791) 4P-PDOT N-Acetyltryptamine (A 7342) K185 (K 1888) SIGNAL TRANSDUCTION MECHANISMS Gi (cAMP modulation) Gi (CAMP modulation) Gq/11 (increase IP3/DAG) Gq/1 1 (increase IP3/DAG) cGMP modulation RADIOLIGANDS OF CHOICE 2-[1251]-lodomelatonin 2-[1251]-lodomelatonin 2-[1251]-lodomelatonin [3H]-Melatonin [3H]-Melatonin 2-[1251]-MCA-NAT
ABBREVIATIONS
4P-ADOT: 4-Phenyl-2-acetamidotetralin (-)-AMMTC: N-Acetyl-4-aminomethyl-6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazole 4P-CADOT: 4-Phenyl-2-chloroacetamidotetralin GR 196429: N-[2-[2,3,7,8-tetrahydro-1 H-furo(2,3-g)indol-1-yl]ethyl]acetamide I IK7: N-Butanoyl-2-(2-methoxy-6H-isoindolo[2,1-a]indole-l 1-yl)ethanamine K185: N-Butanoyl-2-(5,6,7-trihydro-11-methoxybenzo[3,4]cyclohept[2,1 -a]indol-yl)ethanamine Luzindole: 2-Benzyl-N-acetyltryptamine 5-MCA-NAT: 5-Methoxycarbonylamino-N-acetyltryptamine Melatonin: 5-Methoxy-N-acetyltryptamine 4P-PDOT: 4-Phenyl-2-propionamidotetralin 8M-PDOT: 8-Methoxy-2-propionamidotetralin S20098: N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide S20928: N-[2-Naphth-1-yl-ethyl]-cyclobutyl carboxamide Melatonin Receptors Re: Fish Blocking Ca2+ As Well, Vitamin D's Role in Ca2+ absorption Calcium was blocked by diluting water, removing calcium from the diet or by long term feeding of vitamin D-deficient diet. Melatonin. production is affected by plasma Ca2+.
Another way to influence the effects of melatonin is via iontophoresis of the Ca2+ ionophore A-23187, prevents the inhibitory effect of both melatonin or Ca2+ antagonists...
Transcription factors called clock genes, which include Clock, period genes (pert, per2, and per3), cryptochromes (cryl and cry2), and Bmall, regulate hypothalamic suprachiasmatic nucleus (SCN) and in peripheral tissues. The CLOCK and BMALI proteins initiate transcription of the period (per) and cryptochrome (cry) genes, and PER and CRY regulate self transcription through an interaction with the CLOCK/BMAL1 heterodimer to regulate cellular rhythms.
The SCN regylates rhythm in a several major body parts, including brain, pineal gland, adrenal liver, heart, kidney, muscle, pancreas, lung, and oviduct, through neural networks and hormonal excretion via the cerebrospinal fluid. It is clear that the same genes that are responsible for SCN rhythmicity are rhythmically expressed throughout the body.
Anyone who has night time cravings for food must wonder, there seems to be a clinging bond between the time, darkness (lack of activity) and other cues that motivates (possibly metabolism since an early dinner), you such as your rhythm has entrained you to crave food in the same daily rhythm ... This could be the cause of FEO (food entrained oscillator)... The FEO
is an alternate circadian clock acting on any and all living organisms, in addition to suprachiasmatic nuclei (SCN).
The necessary nutrients, include metabolites, ions, vitamins, nucleotides, and amino acids can also traverse from cumulus cells to the oocyte via GJC. Variations in these nutrients inputs can impact positively and/or negatively the developments from stage to stage needs of an ovary tissue into an embryo...
Measurement of carbohydrate concentrations can be taken via Glucose, pyruvate and lactate concentrations in FF, plasma and maturation medium.
Amino acid profiles (concentrations) can be Measured In follicular fluid (FF), and/or plasma... for each oestrous stage.
Measurement of osmolality can be measured using pooled FF, independent of oestrous stage.
Amino acids EAA
L-Arginine HCI
L-Cystine L-Glutamine L-Histidine HCIIH
L-Isoleucine L-Leucine L-Lysine-HCI
L-Methionine L-Phenylalanine L-Threonine L-Tryptophan L-Tyrosine L-Valine L-Glutamine NEAR
L-Alanine L-AsparagineHO
L-Aspartic acid L-Glutamic acid Glycine L-Proline L-Serine Minimal Essential Medium (MEM) essential amino acid solution (no.
320-1130; Gibco).
b MEM nonessential amino acid solution (no. 320-1140; Gibco).
Specifically (stage by stage) Amino acids affected by oestrous stage included:
glutamate, asparagine, histidine, glutamine, threonine, arginine, taurine, alanine, tyrosine, tryptophan, methionine, valine, phenylalanine, leucine and lysine. The Stage I FF amino acid profile was very similar to that of plasma, particularly as regards aspartate, glutamate, serine, glycine, threonine, arginine, taurine, phenylalanine and isoleucine. By contrast, Stages Il-IV profiles were significantly lower than plasma for aspartate, glutamate, asparagine (Stage Ill only), serine, taurine (except Stage II), alanine (Stage II only), methionine (except Stage II), valine (except Stage II), leucine (Stage III only) and lysine (except Stage III).
Overall, plasma levels were markedly higher than those of FF for glutamate, serine and glutamine and, to a lesser extent, for asparagine, threonine, taurine, tyrosine, methionine, phenylalanine and lysine. By contrast, FF valine concentration was significantly higher than in plasma.
It is well believed that amino acids are uptaken into the oocytes by the gap junctions (gap junctional communication (GJC)).
Addtionally the GSH (glutathione) content of an oocyte is much dependent nextdoor cumulus cells, GJC is believed to contribute to GSH content in the oocyte Via passage/uptake of GSH or its substrates, cysteine and glutamine from the cumulus cells to an oocyte. The way cumulus cells regulate MPN (male pronuclei) formation is not understood.
The basic medium used for the maturation of oocytes was BSA-free Whitten's medium NaCl, KC1, KH2PO 4, MgSO 4, NaHCO 3, glucose, sodium lactate, sodium pyruvate, hemicalcium lactate, potassium penicillin, streptomycin sulfate, phenol red and supplemented with PFF (pig/cow/human) follicular fluid, TCM-199 containing hCG, eCG, glutamine, fetal calf serum...
Also, large accumulation of cumulus cells (eg. Artificial Insemination with an external ovary produced oocyte - more broadly the cumulus are responsible for Routing and Penetration of spermatoza) affects the success of penetration of spermatozoa And the large cumulus cell mass induces acrosome reaction and assists penetration into the oocyte.
(Jason 0.5%) (DLD 0.25%) (GP HW 0.25%) We can use Proton nuclear magnetic resonance ((1)H NMR) to chemically dissect any and all life fluids, including stem cell developments (proliferation stages), regeneration, meiosis, mitosis, different cells and the functions, liver and kidney filteration cells the mechanism whereby waste enters one end and is separated and the clean blood diverted back into the system, the mechanism of lung cells (including fish gills) how the absorb oxygen and release carbon dioxide and the membrane? And how this membrane performs this function... (each and every cell type and their symbiotic relationship with each and every organ and glands...
development of ovaries to oocyte, the changing make up of Newt/Salamander's (any and all amphibians (GP) regenerating tails, starfishes, jellyfish, sea cucumber, ECM/HOX changes in response to amino acids, vitamins, ions... changes, mammals/ fishesturtles (near extinct species), Focusing on follicular growth and maturation, (1)H NMR is utilized to dissect intrafollicular and circulating glycoconjugates (sugar chains and N-acetyl groups), lipoproteins (CH(3) and CH(2) groups), glucose metabolites (trimethylamines, acetate and lactate), amino acids (including the above and more specifically: (glutamine/glutamate and alanine), creatine/creatinine and polyamines). Follicular fluids is measured for oestradiol and progesterone. The intrafollicular alanine and lipoproteins (CH(3) groups) went down in the dominant follicle (the future oocyte) during growth stage, while progesterone and oestradiol showed a large increase. As detailed above gonadotrophin is used to induce ovulation;
follicular maturation is noted by lessening of glycoconjugates (sugar chains), trimethylamines and acetate, less oestradiol, also additional CH(3) groups of lipoproteins and progesterone.
Re: The Idea of Varying levels of Factors for Different Phases in Mitosis for any and all Proliferation Promoting Substances has been Previously Patented by Gerard Voon, but Below is one Example of one such Substance (Ca2+) Ca2+ ions needed for mitogenesis and increase in cytosolic Ca 2+ acts as a physiological trigger in cell proliferation, the different phases of the cell cycle present different dosage needs for Ca2+. Ryanodine and NiCl2 eliminated cytosolic Ca + and did not prevent PDGF-induced development into the Go into G, phase. Furthermore progression of cells into the S phase and the further mitosis were arrested, perhaps because S phase needs Ca 2+ and further proliferation promoting factors is regulated by Ca2+dosages and perhaps sharp changes and maintenance levels. G,/S are arrested when there is not enough Ca2+. Emptying of Ca2+ pools during Go/G, and S arrest growth while plating positive affect on G2 and M
cell cycle phases.
PDGF-induced (any and all) cells' proliferation requires the activity of SERCA
pumps to uptake Ca2+ pools the entry into the S phase.
Ca2+ timing (in correlation with the mitotic phases) seems to involve Ca2+
intracellular pools drainage and alternating usage of Ca2+ membrane to uptake the exogenous Ca2+
dependent (are necessary for) on the mitotic phase. PDGF (Platelet-derived growth factor) and possibly any and all other factors (especially for proliferation) binding to receptors at the surface of cellular membrane and are intertwined with changes in cytosolic Ca + dosages that involves a surge the a lesser steady-state elevation, involving both the drainage of Ca +
pools and uptake of Ca 2+ from the extracellular (external to the cell).
Re: Reactive Oxygen Species (ROS), reactive nitrogen species, and calcium (Ca2+) It has been suggested that plant cells sense ROS via at least three different mechanisms: (i) unidentified receptor proteins; (ii) redox-sensitive transcription factors, such as NPRI or Heat Shock Factors; and (iii) direct inhibition of phosphatases by ROS. There is a possiblilty of interactions of ROS, reactive nitrogen species, and calcium signalling.
All three are involved in control and regulation of biological processes, such as growth, cell cycle, programmed cell death, hormone signaling, biotic and abiotic stress responses and development... and any and all phenotypic responses.
ROS, reactive nitrogen species, and calcium (Ca2+) signalling are generated at a number of intracellular locations, including mitochondria, chioroplasts, peroxisomes, and at the extracellular side of the plasma membrane. These locations signal transduction events, such as mitogen-activated protein kinase cascades, eliciting specific cellular responses. The impacts of these ROS, reactive nitrogen species, and calcium signalling on cellular processes is mediated by both the perpetuation of their production and their amelioration by scavenging enzymes such as superoxide dismutase (SOD), ascorbate peroxidase (APX), and catalase (CAT). We need further study location, amplitude, and duration of ROS, reactive nitrogen species, and calcium Functioning like Ca2+ signaling ROS (And possibly nitrogen species) is controlled by the spatial and temporal nature of its pools and drainage.
Re: Some of the Fish we Plan to Apply the Above Spawning Methods and Techniques (From External Ovaries Factories to ROS... ) Scientific name Common name Acanthopagrus latus Yellowtn sea bream A. berda Picnic sea bream A. schiegeli Black sea bream A. sivicolus Southern black sea bream Anthias disper Red fish Boleophthalmus pectinirostris Pond or mud skipper Chanos chanos Milkfish Choerodon schoenleinii Black spot tusk fish Cromileptes altivelis Highfin grouper Eleutheronema tetradactylum Four finger threadfin Epinephelus akaara Red grouper E. amblycephalus* White-spotted green grouper E. awoora Yellow grouper E. coioides / suillus Red-spotted grouper E. fario Black-saddled grouper E. fuscoguttatus Tiger grouper E. lanceolatus Giant or King grouper E: malabaricus I salmonides Malabar grouper E. quoyaqnus Long-finned grouper E. tauvina Green grouper E. tukula Potato grouper E. trimaculatus Brown marbled grouper Evynnis cardinalis Golden-skinned porgy Girella melanichthys Smaliscale blackfish Girella puncta* Largescale blackfish Glossogobius giuris Flathead goby Gnathanodon speciosus Kingfish Hapalogenys nitens Beard grunt Kyphosus lembus Shortfin rudderfish Lateolabrax japonicus Japanese sea bass Lates calcarifer Asian sea bass Lethrinus nebulosus Green snapper Liza macrolepis Largescale liza Lutjanus argentimaculatus Mangrove red snapper L. erythropterus Pink snapper L. johnii John's snapper L. malabaricus Firespot snapper L. monostigma Onespot snapper L. russelli Russell's snapper L. sebae Emperor snapper L. stellatus Spotted snapper Miichthys miiuy Nibe or brown croaker Mugil cephalus Grey mullet Nibea diacanthus Speckled drum Oplegnathus punctatus Spotted knifejaw Pagrus major Red sea bream Platax orbicularis Narrow-banded batfish Plectorhynchus cinctus Three-banded grunt P. pictus Three-lipped grunt Plectropomus leopardus Coral trout Polynemus plebejus Common threadfin P. sexfilis Six threadfin Pomadasys kaakan Lined silver grunter Psettodes erumei Big-mouthed flounder Pseudosciaena crocea Large yellow croaker Rachycentron canadum Cobia or Sergeantfish Scatophagus argus Spotted scat Sciaenops ocellatus Red drum Seriola dumerilli Greater yellowtail Siganus fuscescens Dusky spinefoot S. guttaus Speckled spinefoot S. oramin Yellow-spotted spinefoot Sillago sihama Sand borer S. vermiculatus Reticulated rabbiffish Sparus sarba Silver sea bream Takifu rubripes Tiger puffer Terapon jarbua Three stripe tigerfish Trachinotus blochii Pompano Re: The Drugs Successfully Used for Aquaculture (below), we plan to test their efficacy for Any And All Life Table 1. Drugs Approved for Use in Aquatic Species*
Drug Species Indication Formalin Finfish Control of certain external protozoa and monogenetic trematodes Finfish eggs Control of fungi of the family Saprolegniaceae Penaeid shrimp Control of certain external parasites Oxytetracycline Pacific salmon Marking of skeletal tissue via medicated feed Finfish Marking of skeletal tissue via immersion Salmonids Control of ulcer disease caused by Hemophilus pisicium, furunculosis caused by Aeromonas salmonicida, bacterial hemorrhagic septicemia caused by A liquefaciens and pseudomonas disease.
Catfish Control of bacterial hemorrhagic septicemia caused by A liquefaciens and pseudomonas disease Lobster Control of gaffkemia caused by Aerococcus viridans Sulfadimethoxine/ Salmonids Control of furunculosis caused by Aeromonas ormetoprim salmonicida Catfish Control of enteric septicemia caused by Edwardsiella ictaluri Sulfamerazinet Rainbow, brook, Control of furunculosis and brown trout Tricaine Fish, amphibians, Temporary immobilization as an aid in handling Methanesulfonate and other poikilotherms Chorionic Finfish Spawning aid Gonadotropin *Data from FDA Center for Veterinary Medicine Web site.7 tNot currently marketed.
Re: Sites and Some Hormones that Achieve our Desire to Mature Sperm and Eggs and Induce Spawning Induction of spawning by the injection of 8,11,14-eicosatrienoic acid into the coelomic cavity, shows that the natural sperm maturation factor and spawning hormone.
Alternately females, injected with female prostomial homogenate into the coelomic cavity induces oocyte maturation and subsequent spawning. Oocytes, on the other hand, although maturing in the presence of CMF (Coelomic Maturation Factor), do not mature in the presence of prostomial homogenate.
Oocyte maturation and subsequent spawning is under the control of 2 hormones:
(1) a substance from the prostomium, Prostomal Maturation Hormone (PMH), which induces the production of (2) CMF which acts on the oocyte. PMH is required for oocyte maturation...
Re: Other Chemicals to be Used on any and all Life for Sexual Maturation/Proliferation and/or Breeding/Spawning (On Both Males and Females) Tetracaine, procaine, propranolol, oxprenolol, lanthanum chloride, ionophore A23187, DL-dithiothreitol, arachidonic acid and ammonium ions (ammonium sulphate) were also all tested for their ability to induce maturation... Also possibly injection with 5-hydroxytryptamine (5-HT) into the gonads... serotonin (and any and all psychiatric drugs including viagra and/or cialis) can be applied to induce spawning/breeding... (We could possibly use Antho-RFamide, a neuropeptide situated in ciliated neurons within follicle epithelia, also causes exfoliation of the follicle epithelium from spawned follicles). Photoperiod/intensity augments the potency of Antho-RFamide. The actin-binding toxin phalloidin substantially reduced the incidence of Antho-Rfamide.
Re: Other Alternate Serotonin Drugs that may help Induce Spawning Serotonin levels increase with of tryptophan. Increasing intake foods high in tryptophan, do affect sretonin levels due to competition with other amino acids. Stamina and aerobic exercise improves mood, by increasing in serotonin (endorphins?) levels. Endorphins (endogenous opioid polypeptide compounds). Produced by the pituitary gland and the hypothalamus in vertebrates during strenuous exercise, excitement,, and orgasm; and they resemble the opiates in their abilities to produce analgesia and a sense of well-being. Endorphins work as "natural fever relievers", whose effects may be enhanced by other medications. We could increase water flow rate and velocity and or exercise/activity that is enjoyable to the life form then extract the pituitary and/or hypothalamus from the exercising life form (eg.
pigs/cows/gold fish creatures that are easy, fast and large volume...) also the sources of endorphins, GnRH, Pituitary and Hypothalumus... extracts from the glands of pigs/cows/gold fish could be prepared for extraction via Gerard Voon's patented Neural Links (12% GP) to put the subject of extract in a serotonin/endorphin inducing mood... and inject to make other life (aquaculture and/or any and all life stock farming - even as a viagra and/or feel good supplement) mate... In fact we could use Neural Links directly on the life forms to induce them spawn/breed/mate/have sex (11 %)...
It is believed that a diet rich in whole grain carbohydrates and low in protein will increase serotonin by secreting insulin, which helps in amino acid competition. The danger is that increasing insulin for a long period of time can lead to insulin resistance, which are factors for some causes of obesity, type 2 diabetes, and even lower serotonin levels.
Furthermore that muscles use many amino acids but not tryptophan, allowing men to have more serotonin absorption than women.
Re: Drugs that treat the Serotonin/5-HT system include - AntiDepressants = Ambilify (Aripiprazole) = Sertraline (Zoloft) = Escitalopram (Lexapro) = Fluoxetine (Prozac) = Bupropion (Welibutrin, Zyban) = Paroxetine (Paxil) = Venlafaxine (Effexor) = Trazodone (Desyrel) = Amitriptyline (Elavil) = Citalopram (Celexa) = Duloxetine (Cymbalta) = Mirtazapine (Remeron) = Nortriptyline (Pamelor) = Imipramine (Tofranil) Also (concentrated extracts of) hypericum perforatum (St John's Wort) First Generation Antipsychotics Butyrophenones = Haloperidol (Haldol) Phenothiazines = Chlorpromazine (Thorazine) = Fluphenazine (Prolixin) - Available in decanoate (long-acting) form = Perphenazine (Trilafon) = Prochlorperazine (Compazine) = Thioridazine (Mellaril) = Trifluoperazine (Stelazine) = Mesoridazine = Promazine = Trrflupromazine (Vesprin) = Levomepromazine (Nozinan) = Promethazine (Phenergan) Thioxanthenes = Chlorprothixene = Flupenthixol (Depixol and Fluanxol) = Thiothixene (Navane) = Zuclopenthixol (Clopixol & Acuphase) Second generation antipsychotics = Clozapine (Clozaril) - treats schizophrenia, acute manic episodes, and maintenance of bipolar disorder.
= Risperidone (Risperdal) - treats Tourette Syndrome or Anxiety Disorder.
= Quetiapine (Seroquel) - Used primarily to treat bipolar disorder and schizophrenia, and "off-label" to treat chronic insomnia and restless legs syndrome; it is a powerful sedative = Ziprasidone (Geodon) - Now (2006) approved to treat bipolar disorder. Dosing 20 mg twice daily initially up to 80 mg twice daily. Prolonged QT interval a concern; watch closely with patients that have heart disease; when used with other drugs that prolong QT interval potentially life-threatening.
= Amisulpride (Solian) - Selective dopamine antagonist. Higher doses (greater than 400 mg) act upon post-synaptic dopamine receptors resulting in a reduction in the positive symptoms of schizophrenia, such as psychosis. Lower doses, however, act upon dopamine autoreceptors, resulting in increased dopamine transmission, improving the negative symptoms of schizophrenia. Lower doses of amisulpride have also been shown to have anti-depressant and anxiolytic effects in non-schizophrenic patients, leading to its use in dysthymia and social anxiety disorder.
= Asenapine is a 5-HT2A- and D2-receptor antagonist under development for the treatment of schizophrenia and acute mania associated with bipolar disorder.
= Paliperidone (Invega) - Derivative of risperidone.
Third generation antipsychotics = Aripiprazole (Abilify) - reduce susceptibility to metabolic symptoms seen in some other atypical antipsychotics.[41 = Dopamine partial agonists:
= Under clinical development - Bifeprunox; norclozapine (ACP-104).
Other options = Tetrabenazine (Nitoman in Canada and Xenazine in New Zealand and some parts of Europe) is similar in function to antipsychotic drugs, though is not, in general, considered an antipsychotic itself. This is likely due to its main usefulness being the treatment of hyperkinetic movement disorders such as Huntington's Disease and Tourette syndrome, rather than for conditions such as schizophrenia. Also, rather than having the potential to cause tardive dyskinesia, which most antipsychotics have, tetrabenazine can actually be an effective treatment for the condition.
= Cannabidiol One of the main psychoactive components of cannabis. A recent study has shown cannabidiol to be as effective as atypical antipsychotics in treating schizophrenia.
Metabotropic glutamate receptor 2 agonism has been seen as a promissing strategy in the development of novel antipsychotics. The active metabolite of this prodrug targets the brain glutamate receptors mGIuR2/3 rather than dopamine receptors.
Re: Natural Humane Sources of Serotonin Serotonin are in mushrooms and plants, including fruits and vegetables.
Particularily high contents are present in nuts of the walnut (Juglans) and hickory (Carya) genuses. Serotonin are been present in plantain, pineapple, banana, kiwifruit, plums, and tomatoes. Moderate contents are present in a wide range of tested vegetables. It should be noted that serotonin, unlike its precursors 5-HTP and tryptophan, does not cross the blood-brain barrier. There are plants containing serotonin together with a family of related tryptamines that are methylated at the amino (NH2) and hydroxy (OH) groups, are N-oxides, or miss the OH group eg.
Anadenanthera genus that are used in the hallucinogen.
Re: Treatment For Anxiety that may help Spawning/Breeding/Mating/Sex and also Time of Stress for eg. Aquaculture including Transport and/or Disease and/or Majoring Cleaning of the Tank, Any time the Creatures Become Spooked:
Time to Elimination Common Peak Half-Life (h)** Approximate Drug Name IR Brand (Onset of [active Primary Effects 1 Equivalent Names* H action in Dose*** -1 hours) pi metabolite]
Xanax, Alprazolam Xanor, Tafil, 1-2 6-12 hours anxiolytic 0.5 mg Alprox, Frontal(Brazil) Lexotanil, Lexotan, Bromazepam Lexomil, 1-3 10-20 hours anxiolytic 5-6 mg Somalium, Bromam Librium, 5-30 hours Chlordiazepoxide Tropium, 1.5-4 [36-200 anxiolytic 40 mg Risolid, hours]
Klopoxid Cinolazepam Gerodorm .5-2 9 h hypnotic 40 mg Klonopin, Clonazepam Klonapin, 1-4 18-50 hours anxiolytic, 0.5 mg Rivotril, anticonvulsant lktorivil Cloxazolam Olcadil 2-5 (?) 18-50 hours anxiolytic, I mg (Brazil) anticonvulsant Clorazepate Tranxene Variable [36-100 anxiolytic, hours] anticonvulsant 15 mg Valium, Apzepam, Stesolid, 20-100 hours anxiolytic, Diazepam Vival, 1-2 [36-200] anticonvulsant, muscle 10 mg Apozepam, relaxant Hexalid, Valaxona Estazolam ProSom .5-5 10-24 h hypnotic 1-2 mg Rohypnol, 18-26 hours Flunitrazepam Fluscand, .5-3 [36-200 hypnotic 1 mg Flunipam, hours]
Ronal.
Rohydorm (Brazil) Dalmadorm, [40-250 Flurazepam Dalmane 1-1.5 hours] hypnotic 20-25 mg Flutoprazepam Restas .5-9 60-90 hours hypnotic 2-3 mg Halazepam Paxipam 1-3 [30-100 anxiolytic 20-40 mg hours]
Ketazolam Anxon 2.5-3 30-100 hours anxiolytic 15-30 mg [36-200]
Loprazolam Dormonoct .5-4 6-12 hours hypnotic 1-2 mg Ativan, Lorazepam Temesta, 2-4 10-20 hours anxiolytic,anticonvulsant 1 mg Lorabenz Loramet, Lormetazepam Noctamid, .5-2 10-12 hours hypnotic 1-2 mg Pronoctan Medazepam Nobrium ? 36-200 hours anxiolytic 10 mg Dormicum, Versed, 3 hours (1.8-6 Midazolam Hypnovel, .5-1 hours) hypnotic 5-15 mg Dormonid (Brazil) Nimetazepam Erimin .5-3 14-30 hours hypnotic 5 mg Mogadon, Nitrazepam Alodorm, .5-7 15-38 hours hypnotic 10 mg Pacisyn, Dumolid Nordazepam Madar, Stilny ? 50-120 hours anxiolytic 10 mg Seresta, Serax, Serenid, Serepax, Oxazepam Sobril, 3-4 4-15 hours anxiolytic 30 mg Oxascand, Alopam, Oxabenz, Oxapax Phenazepam ? 1.5-4 60 hours anxiolytic, 1 mg anticonvulsant Pinazepam Domar ? 40-100 hours anxiolytic 20 mg Prazepam Lysanxia, 2-6 36-200 hours anxiolytic 10-20 mg Centrax Premazepam 1 2-6 10-13 hours anxiolytic 3.75 mg Quazepam Doral 1-5 39-120 hours hypnotic 20 mg Restoril, Temazepam Normison, .5-3 8-22 hours hypnotic 20 mg Euhypnos Tetrazepam Mylostan 1-3 3-26 hours Skeletal muscle 50mg relaxant Triazolam Halcion, .5-2 2 hours hypnotic 0.25 mg Rilamir [edit] Atypical benzodiazepine receptor ligands Common Brand Elimination Half- Approximate Drug Name Life (h)** [active Primary Effects Equivalent Names*
metabolite] Dose***
Clobazam Frisium, Urbanol 8-60 hours anxiolytic, 20 mg anticonvulsant DMCM ? ? anxiogenic, N/A, not used convulsant therapeutically Flumazenil Anexate, Lanexat, 1 hour antidote N/A, typical dose Mazicon, Romazicon 0.2 - 0.6 mg Eszopiclone**** Lunesta 6 hours hypnotic 3 mg Zaleplon**** Sonata, Stamoc 2 hours hypnotic 20 mg Zolpidem**** Nytamel, Stilnoct, 2 hours hypnotic 20 mg Stilnox, Zoldem, Zolnod Imovane, Rhovane, Zopiclone**** Zileze; Zimoclone; 2 hours hypnotic 15 mg Zimovane; Zopitan;
Zorclone, Nonbenzodiazepine = Imidazopyridines o zolpidem (Ambien) o alpidem o saripidem o necopidem = Pyrazolopyrimidines o zaleplon (Sonata) o indiplon o ocinaplon = Cyclopyrrolones o eszopiclone (Lunesta) o zopiclone (Imovane) o pagoclone o suriclone o pazinaclone o suproclone = Other structural families o Etffoxine o Panadiplon o CL-218,872 o SX-3228 o L-838,417 o RWJ-51204 o Y-23684 Growth hormone (GH) also has been identified as an oocyte survival factor acting secondarily to the IGF-I pathway. Gonadotropins or growth hormones may act to promote follicle survival, in part, by altering follicular steroidogenesis (eg. human preovulatory follicles cultured in the presence of IGF-I produced more estrogen and less progesterone.
Studies conducted on preovulatory follicles suggest that, without supportive hormones such as human chorionic gonadotropin (hCG), insulin-like growth factor-I (IGF-I), and human follicle stimulating hormone (hFSH), cultured follicle cells will undergo apoptosis (previous studies have shown). Growth hormone (GH) also has been identified as an oocyte survival factor acting secondarily to the IGF-I pathway (previous studies). In some cases, there is evidence that the various gonadotropins or growth hormones may act to promote follicle survival, in part, by altering follicular steroidogenesis. For example, human preovulatory follicles cultured in the presence of IGF-I produced more estrogen and less progesterone (shown by previous studies).
In agreement with my belief that timing/concentration (leading to - response with sexual stimulation; intensity - due the levels of (various environmental cues) change in one direction and durations versus the cue's levels of change opposite in the other direction to create cycles (any and all lengths; seasonal; annual), that the fish (any and all life), naturally take in their sexual response via genetics and/or entrainment to these environmental cues (including maturation (annual cycles and the duration and rate and levels of environmental cues - some hormonal factors such hCG, IGF-I, hFSH, GnRH) - melatonin inhibitor) and seasonal-hormonal responses impact on the willingness of fish and any and all life to spawn/mate/breed/have sex) in response to environmental cues that cause late-cycle high of plasma E2 and testosterone highs may be the cause in feedback to the brain (hypothalamus, and pituitary glands), inducing synthesis and secretion of LH at the expense of FSH production. It is believed that (estradiol-17) E2 is produced in the granulosa cells by the action of the aromatase enzyme and converts testosterone to E2.
Circulating E2 and testosterone levels rise early in final maturation, while the oocyte germinal vesicle is still migrating; peak testosterone levels respond less behind peak E2 levels.
Androgen and estrogen levels both fall coincident with the peak in circulating E2 that is concurrent with GVBD (shown by previous studies) artificial induction can be accomplished using synthetic analogue of gonadotropinreleasing hormone (GnRHa). Noted that changes in circulating steroid hormones rise of internal LH in the blood plasma is induced by GnRHa (past studies).
These observations further suggest that rises in androgen and estrogen levels...
Fish have shown cyclic pattern of oogenesis and endocrine correlative cyclic pattern.
Responding to such environmental cues (eg. photothermal - diurnal and seasonal changes in water temperature and day length) and therefore reproducing in timing cycle that is entrained. Deposition of yolk granules in the growing oocytes is triggered by decreasing day length and water temperature (eg. monsoons and/or rainy season and other environmental factors caused by such seasons and the cues that belong to such seasonal changes that the fish type and entraining that they respond to). Furthermore these seasonal related cues come with a distinct rise in concentration of estradiol-17:1 (E2) and testosterone, as well as Vg.
Exogenous E2 may induce hepatic vitellogenesis suggesting its role as hormone controlling this process.
Oocyte growth begins at deposition of lipid droplets (made of wax esters, which are made from circulating triglyceride precursors) /yolk protein and yolk granules in the ooplasm. Past studies have shown that oocyte growth is correlated to yolk protein deposition in the yolk granule.
Ovarian follicles and vitellogenesis:
1. Theca is the outermost layer derived from stromal connective tissue and is made up of collagen fibers, fibroblasts, steroidogenic cells, and capillaries or other vascular components (according to past studies).
2. Germinal epithelium-derived follicle cells then flatten to form a singular granulosa cell layer under the basal lamina and on top of the cellular chorion or ZR.
3. Junctional complexes between the follicle cells allow for the extracellular passage of Vg, through the theca, basement membrane, granulosa cell layer, and ultimately to the oocyte surface.
4. The ZR then takes on a perforated form by a process known as microvillar, which emanate from both the oocyte and granulosa cells (also based on past studies).
Re: Krill (Zoo Plankton) Farming In addition to any and all oily fish sued to produce healthy fish oils...
especially we are mass producing krill and shrimp...
For their omega-3 fats, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA), but hooked together in a different form...
Fish oil is extracted from, omega-3 fatty acids are found in the triglyceride form, while krill/shrimp oil are hooked up in a double chain phospholipid structure.
The EPA leg phospholipid has a molecule known as astaxanthin, which is a very potent anti-oxidant. The phospholipid EPA and DHA in krill oil are more absorbable. Also Krill/shrimp oil enters more easily into the mitochondria and the nucleus membrane. Furthermore EPA and DHA from krill oil's phospholipid have more complex profile such as phosphatidylcholine, whose effect is reductive-stress-reducing choline, and also a natural emulsifier.
Krill oil has vitamin E, vitamin A, vitamin D and canthaxanthin, like astaxanthin. The anti-oxidant potency of krill oil is 48 times more potent than fish oil. Aparently it has 10 times more antioxidant activity than beta-carotene and as much as 1,000 times more than vitamin E.
Interestingly it is a source of alpha-tocopherol (vitamin E) and a derivative, called marine-derived tocopherol, that has antioxidant properties than alpha-tocopherol. It is postulated that tocopherols enable krill survive in the cold waters. As well they have the flavonoid luteolin. If this theory is correct it may be the only non-plant version of the substance... One claim of omega-3 of krill oil is that the phospholipid content of krill oil plays a role in omega-3 passing through the blood-brain barrier.
If we can mass produce the krill/shrimp cheaply enough they are a rich fertilizer, like fish fertilizer...
Astaxanthin is used as a feed supplement for salmon, crabs, shrimp, chickens and egg production. Regardless of the source, astaxanthin provides some important benefits beyond coloration. It also has been found to be essential for proper growth and survival.
Vitamin A
Krill Oil Phospholipids, Omega-3 rich Eicosapentaenoic Acid (EPA) Docosahexaenoic Acid (DHA) Omega-6 Fatty Acids Astaxanthin Transfat Malacostraca include:
crabs, krill, pill bugs, shrimp, and relatives Kingdom: Animalia Phylum: Arthropoda Class: Malacostraca Members of this Class UV before and/or after freezing, thaw in water prior to injection and/or freeze dry.
A number of studies have shown that krill oil is very effective in: reducing LDL-cholesterol, raising HDL-cholesterol therefore cardiovascular disease; Lowering blood sugar threfore diabetes; Treating the pain; Inflammation from rheumatoid arthritis (therefore see list of inflamatory diseases pages 23 to 25) and Aches and pains (therefore as an pain releiver eg.
substitite for tylenol/aspirin...), PMS and dysmenorrhea, adult ADHD; Healthy brain and nervous system neurodegenerative diseases and It also crosses the blood-brain barrier, which makes it available to the eye, brain and central nervous system to alleviate oxidative stress that contributes to ocular, and neurodegenerative diseases such as glaucoma and Alzheimer's;
Healthy liver function; Improved immune function; Concentration and memory;
Healthy joints.
Astaxanthin is potent antioxidant, it may be beneficial in cardiovascular, immune, inflammatory and neurodegenerative diseases. Research supports the assumption that it protects body tissues from oxidative damage.
Cod Liver versus Fish Oils are: More efficiently and more easily absorbed;
Superior antioxidant protection; Can be renewable; Does not oxidize.
Re: Any and All Shrimp especially Krill Maturation and Spawning We plan to use all the aquaculture (fish, crayfish/crawdads - arthropods, amphbians, any and all life) environmental (eg. page 1 point 6. and Re: Growth and Maturation and Re; Spawning) including temperature/PH/DH and any and all environmental conditions shock, filtration of seawater and/or (eg. simulate annual seasons - including monsoon season); most important is photoperiod (melatonin might be used to alternate use during winter and non-use during the longer lighting summer) length of daylight and (also variation in intensity and/or light pulses) relative to the length of darkness), proper stimulation olfactory organs, FEO
(food entrained oscillator... proper stimulation of taste buds, food availability; water temperature; water flow rate (activity - possible impacts on metabolism )(velocity m/sec - flooding and water currents);
pH/DH (water hardness); Dissolved Oxygen (mg/I); Free carbon-dioxide (mg/I);
Total alkalinity (mg/i); Chlorides (mg/I); TDS (mg/I); DOM (mg/I); Specific conductivity (mhos)/25C, some believe in the cycles of the moon, atmospheric pressure, availability and desired quality types based on the fish type of spawning substrate, availability of aquatic plants, sticks, gravel, and safe nooks and crannies, nutrition, and the presence of other fish.. .The effects of these external factors on the blood concentrations of substances (eg. exercise and activity and changes in PH/DH ...and/or melatonin antagonists) could be used together with GnRH, gonadotrophin, vitamin A (beta carotene), retinoic acid, for maturing the gametes which is absolutely necessary for spawning/mating/sexual intercourse/breeding to result in healthy embryos (mitosis/meiosis)...
We plan to mass produce the krill using the above breeding/spawning techniques.
One spawning method is shrimp eyestalk ablation.
We could try to grow (regenerate) the bioreactors (proliferate via ECM and/or HOX), we could even slice the krill to a survivable cellular colonies (maybe with a threshing machine with very small and fine and sharp blades) and regrow them via regeneration ECM/HOX and other technologies Gerard Voon has patented, whereby the cells are constantly renewed as an altenative artificial maturation and spawning techniques covered in this patent. (Jeff 30 of 35%) Krill can be harvested and processed for their protein (40% or more of dry weight) and lipids (about 20% in E. superba). Their exoskeleton for chitin, hydrolytic enzymes such as proteases, carbohydrases, nucleases and phospholipases, found in their digestive gland in the cephalothorax of the krill; these enzymes might be usable in producing biomass, bio fuel and bio crops ethanol...
Other uses include krill pastes or processed krill as food additives, e.g. in the form of krill oil gel capsules.
Krill are used as pastes, for food addictives oil gel in capsules enzymes, necrotic tissue and chemonucleolytic agents.
Their oils can be used as biofuel...
Algae Algae belong to a group of micro organisms known as protists. Crypthecodinium cohnil and Schizochytrium are two strains/varieties of algae currently employed for supplements of omega-3. They are proliferated in fermenters under specific environmental conditions. When ready the algae are dried and oil separated. By creating a closed system oil from the algae is contaminants free and monoculture.
Fish oil or krill oil, both have EPA and DHA, algae has the DHA. The organisms that feed on the algae retroconvert some DHA back to EPA, although more direct EPA is often needed...
However, research suggests that DHA may be the more critical of the two omega-3s for certain health benefits, especially for infants.
DHA from algae was more positive in its effects on the growth of colon cancer cells in mice than EPA, 90 percent less tumor growth. Reducing platelet aggregation or lowering blood cholesterol as combinations of EPA and DHA from fish oils. Depression may also be associated with reduced blood levels of omega-3 fatty acids and or Omega-6...
Phytoplankton Krill probably react (spawn/sexually triggered/mate/breed in response regulated to the environmental sensitivities in height and duration to the developing cycle of) the Pacific upwelling of cool waters in spring that supports the (especially sensitive to availability - eg.
feeding food frenzy of clouds of phytoplankton) and nutritional and/or odour and/or taste and/or energy associated with phytoplankton bloom. Therefore the timing (entrained, genetically versus glandular recall) bloom is linked with the hatching of krill eggs.
Re: Micro organisms Including Diatoms And Phytoplankton Have the Following Benefits to the Life that Feed on It (Shrimp and/or Krill above Especially feed on Phytoplanktoon).
= immune system enhancement = general nutrition - provide ultra-potent lipids to enhance brain function = energy - increases energy and vitality = promotes better sleep - more restful and restorative = antioxidant protection from cancers and degenerative diseases = cardiovascular health - supports a healthy heart = blood pressure control = cholesterol reduction = liver health - supports a healthy liver = neurological support - mental alertness, ADHD, Parkinsons, and general dementia = alkalizing - the balancing of body pH away from unhealthy excess acidicity = anti-inflammatory effects on membranes - promotes relief from joint pain = cell wall improvement through increased permeability and flexibility = detoxification and cleansing - supports removal of toxins from cells and organs = skin care - such as acne, psoriasis, dermatitis = better vision - more effective than Lutein = blood sugars - stabilizes blood sugar levels (aids those who are diabetic or hyperglycemic) = supports weight loss Re: Factors that Diatoms/Phytoplankton/Plankyton/Zooplankyton/Micro Organisms that are Needed for them to Thrive Most needed seems to be iron... others include temperature, salanity, transmissivity (suspended particulates), oxygen, nitrate, phosphate, silicate, CO2 partial pressure, PH, iron binding ligands...All plants benefit from active nitrate reductase, and the ability for nitrogen fixation makes them good to fertilize hydroponic waters...
The most proliferate are the heterotrophic bacteria, ciliates, and flagellates... We are studying their genes 1. to determine the genes responsible for their rapid proliferation, to insert these genes into cow/pig/chicken... via ovary/testes precusor and gamete cells to mass produce their meat, and/or we could insert these genes responsible for rapid proliferating into micro organisms that have strong enzymes (eg. from termites) for ethanol production, perhaps cutting the processing time and making the process easier. On the other hand we could insert DNA
and/or plasmid into and either pre genetically altered such as enucleated to be compatible with human DNA/plasmid (so these micro organisms: heterotrophic bacteria, ciliates, and flagellates) can reproduce with eg. human DNA, for future extarction into stem cells seed DNA
and/or any other uses for any and all life DNA... These procedures with these micro organisms, can also be used with nitrogen fixing with healthy fertility increasing microorganisms in soil, compost and/or mushrooms, any and all life (especially cells) that we want to mass produce rapidly (harnesssing the rapid rate of proliferation of these heterotrophic bacteria, ciliates, and flagellates)...
Diatoms Include = Diatom A cont. C cont.
A = Attheya longicornis = Chaetocerotaceae = Attheya septentrionalis = Clepsydra (genus) = Asterionella = Auxospore = Coscinodiscineae = Attheya = Attheya arenicola B D
= Attheya armata = Attheya decora = Bacteriastrum = Didymosphenia geminata = Attheya flexuosa = Biddulphiineae = Attheya gaussii F
C
= Frustule = Centrales = Chaetoceros P
= Chaetoceros diadema = Chaetoceros furcellatus = Pennales = Phaeodactylum tricornutum Pinnularia T
= Thalassiosira pseudonana We can collect diatoms resting spores shallower floors/beds of water...
scooping the resting spores versus trying to reach them in deeper waters. We will grow them including krill by putting silicon, nitrogen, phosphorus and iron and adjusting temperatures - we could grow them with hay fusion, filamentous algae, cladophora, vaucheria ... also dphania and brine shrimp. When it comes time for the Krill to spawn we control the the conditional factors including providing an abundance of food and we move them to a deeper pen...
Re: Easy to Grow Sources of Protein Supplements 1. Proteins extracted from Earth Worms and/or grubs - freeze dried/powdered.
2. Proteins extracted from ants, crushed/pulverized (their exoskeleton perhaps dissolved in acid and/or enzymes as long as the method of removing the exoskeleton - if need be at all does devalue the protein desired) frozen and/or freeze dried.
3. These ants and eartheworms can be fed sugar and/or restaurant waste (shredded).
4. They can all be treated to UV then (eg. flash frozen) frozen and then UV
again then thawed and fed as protein.
5. We could add algae taste and/or smell to make the above sources of food more appetizing (pellets).
Since these sources of protein are so cheap, as an alternate for human supplements/additive (pills/capsules/powder), for animal feed and/or any and all fish feed.
And or pwdered and fed to animal meat in bioreactors to mass produce mass amounts of meat cheaply, or as fertilizer and also to gro fat cells (from eg. seals, whales and walruses) to produce biofuel and also a delicacy (GP 0.5%).
Re: Micro organisms Lacto Bacillius and/or Actinomycetes, diatoms... both of which are photosynthetic bacterias -which can be used for pre digestion of feed for any and all creatures - making the food more nutritional. Lacto Bacillus also produces lactic acid from sugars, carbohydrates and yeast (which sterilizes - we could produce antibacterial hand washes/antibacterial wet tissues/gels... lactic acid could also possibly mixed with chitin and/or furanone - anti agent used against harmful organisms), lactic acid also ferments and decomposes lignin and cellulose, which can be used for any and all biocrops to turn into ethanol.
Re: Biofiims/Quorum Sensing - believed to be sensed via pheromone and/or autoinducers by secreting signal molecules; cell to cell signaling We could possibly use genes that govern high virulence (eg. E.Coli)and genetically Modify into cows/pigs/chickens/fish meats such that we can clone fast growing life forms but also the meats for food. Also we could use biofilm/quorum sensing for yeast, bacteria in cow' s mouth (that produces methane - for fuel), micro organisms found in a cow's/horses'/
gut for cellulose (eg. hay) processing - fermentation (and their enzymes), micro organisms for compost, sewage, manure, restaurant waste, possibly garbage waste; by adding sugar we turn soils fertile ... these materials can be (thoroughly/evenly/strategically) mixed with sugar/carbohydrates/starch is such a way that the clusters of waste that are easier to breakdown need less sugar, while the clusters of waste that are harder to breakdown need the supplement of higher concentration of sugar/carbohydrates/starch to give the micro organisms energy and vitality together with adequate biofilm/quorum sensing for the micro organisms to flourish.
The following (below) suggests that there are many factors affecting micro organism in the blood stream or occupying infected cells, actually some similarity to fish (any and all life) and their responses to contents (and concentration) and conditions in the water (medium)...We are using melatonin antagonist for micro organisms that are light sensitive, we also will control any and all environment factors (the same as in fish maturation) in cycles (tall rise and fall of and timing that cause cycle and durational changes), as well as the hypothalamus and pituitary gland hormones (and all their analogues) as well as LH... We could also try viagra, cialis, LHRHa (with dopamine agonist), Beta Carotene, (Vitamin A), retinoic acid, water melon rind, Kapok (Ceiba pentandra) bark....
Re: Regulation of virulence (Cited Prof. Dr. Hubert Hilbi, SSO4) - Most of which is well known and widely available in other Studies = DNA structure and transcription factors = Environment - temperature, pH, ions, osmolarity, oxygen, nutrients = Host cells - contact - intracellular environment = Cell density (quorum sensing) - autoinducer systems - processes (bioluminescence, biofilm, virulence) = Genome structure and topology = Environment - temperature, growth phase, pH, ions, osmolarity, oxygen, nutrients = Host cells - secretion-dependent regulation - intracellular environment (macrophages, amoebae) = Cell density (quorum sensing) - autoinducer systems - processes (bioluminescence, virulence, biofilm) Ceiba pentandra bark is believed to be diuretic, aphrodisiac, and to treat headache, as well as type II diabetes. We could test the effectiveness and isolate the active ingredient then commercially make the active ingredient(s) available.
Re: Photoperiod and the Natural Production and Injested Vitamin D
Tissues in the body convert Vitamin (via receptors and enzymes), from Vitamin D; 25-hydroxyvitamin D and/or 25(OH) into active ; 1,25-dihydroxyvitamin D.
Vitamin D interacts with 200 genes.
We are particularity interested in smooth muscle growth (as a perhaps cyclical response in coordination with the seasonal light and dark photoperiods) - thus the level, timing of change, steadyness (not too volatile versus times when is needs to be volatile to induce the eg. fish (any and all life)), of rate of change the duration it prolongs the high and lows in mimicing or even find a cyclical combination that works even better for sexual maturation and/or spawning/breeding/sex/mating ... if the postulation in the paragraph below is correct than it might help any and all tissue not only including the testes and the ovaries but all life and their body parts, including stem cells in Gerard Voon's bioreactor ... Perhaps the ability of Vitamin D
to help those with dysfunctioning Seasonal Affective Disorder (SAD) may help growth, sexual maturation and sex/mating/breeding/spawning...
An interesting postulation is that Vitamin D may be released naturally into the organism during Photoperiod (response to sun light), and therefore may play an opposite role than melatonin (released in darkness). Thus Vitamin D may play a role in sexual maturity and growth...
We testing the effectiveness of Vitamin D on any and all (anti inflammatory) of the below diseases:
Cardiovascular Blood Pressure Multiple Sclerosis (MS) Rheumatoid Arthritis (RA) Inflammatory Bowel Disease (IBD) Interstitial Cystitis (IC) Fibromyalgia (FM) Autonomic nervous dysfunction (AND neural-mediated hypotension);
Pyoderma Gangrenosum (PG) Chronic Fatigue (CF) and Chronic Fatigue Syndrome (CFS).
Chronic hepatitis Systemic lupus erythematosus Arthritis Thyroidosis Scleroderma Diabetes mellitus Graves' disease Beschet's disease and Graft versus host disease (graft rejection).
Chronic inflammatory pathologies such as aneurysms Hemorrhoids Sarcoidosis Chronic inflammatory bowel disease Ulcerative colitis Crohn's disease and vascular inflammatory pathologies Disseminated intravascular coagulation Atherosclerosis Kawasaki's pathology Coronary artery disease Hypertension Stroke Asthma Chronic hepatitis Multiple sclerosis Peripheral neuropathy Chronic or recurrent sore throat Laryngitis Tracheobronchitis Chronic vascular headaches (including migraines Cluster headaches and tension headaches) and pneumonia Neurodegenerative diseases including Demyelinating diseasessuch as multiple sclerosis and acute transverse myelitis;
Extrapyramidal and cerebellar disorders such as lesions of the corticospinal system;
Disorders of the basal ganglia or cerebellar disorders;
Hyperkinetic movement disorders such as Huntington's Chorea and senile chorea;
Drug-induced movement disorders such as those induced by drugs which block CNS
dopamine receptors;
Hypokinetic movement disorders such as Parkinson's disease;
Progressive supranucleo palsy;
Cerebellar and Spinocerebellar Disorders such as astructural lesions of the cerebellum;
Spinocerebellar degenerations (spinal ataxia) Friedreich's ataxia Cerebellar cortical degenerations Multiple systems degenerations (MencelDejerine-Thomas Shi-Drager and Machado Joseph)); and systemic disorders (Refsum's disease Abetalipoprotemia, ataxia telangiectasia and mitochondrial multi-system disorder);
Demyelinating core disorders such as:
Multiple sclerosis Acute transverse myelitis;
Disorders of the motor unit such as neurogenic muscular atrophies (anterior horn cell degeneration) such as Amyotrophic lateral sclerosis Infantile spinal muscular atrophy and juvenile spinal muscular atrophy);
Alzheimer's disease;
Down's Syndrome in middle age;
Diffuse Lewy body disease; Senile Dementia of Lewy body type;
Wemicke-Korsakoff syndrome;
Chronic alcoholism;
Creutzfeldt-Jakob disease;
Subacute sclerosing panencephalitis Hallerrorden-Spatz disease; and Dementia pugilistica Malignant pathologies involving tumors or other malignancies such as:
Leukemias (acute chronic myelocytic chronic lymphocytic and/or myelodyspastic syndrome);
Lymphomas (Hodgkin's and non-Hodgkin's lymphomas such as malignant lymphomas (Burkitt's lymphoma or Mycosis fungoides));
Carcinomas (such as colon carcinoma) and metastases thereof;
Cancer-related angiogenesis;
Infantile hemangiomas;
Alcohol-induced hepatitis.
Ocular neovascularization Psoriasis Duodenal ulcers Other diseases that we are testing for effectiveness include parkinsons, diabetes, osteoporosis, multiple sclerosis, breast cancer, colon cancer, prostate cancer, autoimmune disease, cardiovascular (blood clotting - posssibly in gel, powder or imbedded in gauze (perhaps with antibacterials such as furanone and/or chitin) to an open wound to prevent bleeding to death and then apply a layer of ECM/HOX for regeneration assuming that the wound is not too severe - in which case it may be better to grow an entire new limb using the ECM scaffolding and stem cells of a recently deceased body part donor disease), any and all sexually transmitted diseases, herpes... hepatitus, skin problems eg. serious acne, any and all skin conditions, depression, schizophrenia, seasonal affective disorder, peripheral artery disease, tuberculosis, cancer, periodontal disease, multiple sclerosis,...
Using all our Gerard Voon's patented inventions (Methods and Techniques, Models) Titled:
BioScience and all the above: Fish liver oils, including cod liver oil, Fatty fish species, Herring, Catfish, Salmon, cooked, Mackerel, Sardines, canned in oil, Tuna, canned in oil, Eel, One whole egg (perhaps more duck eggs because of their oiliness).
EPA healthy heart - healthy body Promotes a healthy heart and circulatory system Supports healthy homocysteine levels Supports proper immune function Promotes good mood and emotional well-being Supports joint flexibility DHA healthy mood - healthy mind Essential for memory, cognitive function, 'learning and focus Supports a healthy pregnancy Promotes good mood and emotional well-being Reduces harmful effects of stress Supports the visual and brain development of fetus' and infants GIA healthy skin & hair - healthy hormones Promotes beneficial prostaglandins that maintain hormonal balance Provides a "feel good" effect, improves mood Nourishes hair and skin Supports joint flexibility Promotes normal body fat metabolism Vitamin D Receptor will be used to help us in cell proliferation and/or differentiation (from stem cells to any and all life as well as micro organisms). We will also use its properties via Gerard Voon's patented stem cells to immune cells (adjuvant and immune cells priming as a serum for diseses with antigens or unchanging intracellular proteins - for harmful diseases that mutate their cellular antigens on their membranes; or just fortify the immune response during disease out break), Vitamin D is also involved in white blood cells eg. monocytes and activated T and B
cells.
Re: Waterboume mirco organisms (eg. diatoms) could be added with sugar (in its various forms).. .white rice... to Hydronics ... and any and all mediums.
The waterbourne micro organisms (eg. diatoms), can break down ammonia/nitrates/urea/sugars/carbohydrates/sewage/detritus/hay fusion/compost/tea manure... in the hydroponic media... to make the water fertile for plants and algae...
Re: Drawing 1. - Tall Greenhouse Solar and Mirror Invention 1. Solar Panels on the roof of the Greenhouse.
2. Mirrors on the bottom ceiling to catch reflected light from angled mirrors surrounding th greenhouse.
3. The greenhouse plants space.
4. The mirrors angled to aim sun's light at the mirrors in the ceiling (possibly parabolic).
The reason the greenhouse is so tall is to allow surrounding mirrors further out to also aim and reach the ceiling...
Re: Cure for Baldness and Fur Industry We take a newly deceased donor, we take off the scalp (and follicular skin below) hair and/or fur and all and treat its raw side with ECM/HOX (Jeff 20% of 35%) any and all proliferating factors and/or flush the skin/flesh under the hair/fur with deterregent and until only the ECM
sccafold remains add stem cells from the own patient (to avoid rejection) (to grow a whole new scalp with hair/fur or in the case of fur, we could cut off the top skin for fur/skin... (also aligators/crocodiles and/or eels...) while leaving the bottom layer of follicle base behind that we expose ECM/HOX (Jeff 10% of 35%) and/or any and all proliferation factors to regenerate the fur for human bald patients we then operate on the patient to either descalp and/or dermabrasion the patient's upper layer of then attach the new scalp to the bald patient.
Claims (4)
This technology can be used an any and all life forms (sometimes using cross sources of hormones and or hormone analogs)...
The reason we want to produce these substances extemally, outside of the body is because it is invasive to remove (eg. oocytes/eggs) from the female's ovaries versus mass production of multiple external ovaries.
We need ovarian and testicular tissue. And we need to mature the tissue.
1. We could remove a sample of ovarian and testicular tissue and regenerate to its full normal size by exposing it to HOX and ECM (Extra Cellular Matrix) .
2. We could take an ovaries and testes from recently deceased donors and wash with detergent and use the Extra Cellular Matrix Skeleton/Scaffold and repopulate with stem cells and converted stem cells into differentiated cells that normally belong in the specific places. ECM and Hyaluronic Acid and Hyaluronan and hyaluronate (Has1, Has2, Has3) and its fibronectin-type (collagen and also laminin) components together with HOX can be used to regenerate and grow any and all life forms. Hyaluronic also supports virulence and could be used for further augmenting the sexual maturity and successful fertilization of healthy in vitro any and all progeny...
3. Alternate method of proliferating any and all life. External cues originating outside the cell, (eg epidermal growth factor (EGF)), induce proliferative signaling via beta-catenin, an inside the cell protein is necessary in cell adhesion at the plasma membrane and transcription of cell cycle genes in the nucleus (especially epithelial cells). The factor Wnt 3a, is an agonist of beta-catenin transcriptional activity, that induces greater signaling than either of the ligands (EGF and Wnt 3a) alone. However each uses a different sub-cellular pool of beta-catenin. WNT signaling with either Wnt3a, LiCl (causes the accumulation of beta-catenin and also is a dopamine antagonist, see Re:
Induced Spawning - section below - GnRH, Gonadotrophin, and other hormones...
), or the constitutively active S33Y mutant of .beta.-catenin. WNT factors and .beta.-catenin also affect lymphocyte progenitor fate as well as stem cell self-renewal Stimulation with LiCl markedly increased the amounts of total and nonphosphoryiated .beta.-catenin in the myeloma cell lines tested.
4. Another option is with antigenic peptide p33 and a weaker agonist A4Y
ligand and mixed with LiCI or KCI, and pulsed with [ H]thymidine to proliferate all life (including human stem cells). Also IL-2 production had a large increase because of the lithium, as measured by proliferation of the IL-2-dependent, it has been postulated that regulates the T lymphocyte responses. GSK-3 phosphorylates NF-Atc (nuclear factor of activated T cells (NFAT)), which promotes cytoplasmic localization and also export from the nucleus. Therefore, the presence of LiCi should inactivate GSK-3, resulting in prolonged dephosphorylation of NF-ATc and sustained nuclear localization. GSK-plays an important role in antigen-specific T cell activation by regulating NF-ATc localization.
5. Once the stem cells or any other tissue proliferated using this method is ready to be grafted back into a patient's body (eg. after regenerating the body part), we can use a beta-catenin antagonist protein E-cadherin to treat the cells to avert cancer...
6. Both 1. and 2. and 3. and 4. are grown outside the body - extemal ovaries/testicular organs (the result is a regenerated extemal (once fully regenerated, mature ovary/testes), they can be used as a sort of egg and sperm mass production factories ... these can be grown in Gerard Voon's patented bioreactor that uses synthetic blood to bring oxygen and remove CO2 from the tissue/body part and either dialysis and/or functional external from the body kidney that filters waste that is also via the bioreactor filters the blood and uses it for its own survival as well; at the other end nutrients and vitamins, growth hormones and supplements are added based on the stage of growth...of the best recipe. In addition to ovarian and testes tissue the above techniques can be used for any and all body parts (from healthy pancreas cells (reinjected - possibly differentiated from stem precusor cells) to full regenerated pancreas to naturally produce insulin for transplant back into the patient's body (Dad)), also immune cells... glands, organs and tissues. Other uses include regenerating and culturing swallows salivary glands and solving the cues, environmental and/or hormonal cues...any and all cues that trigger swallows to make bird's nest soup...also we could regenerate Mako shark's fins separate from the body, possibly from stem cells... In the case (of growing/differentiating ovarian/testes tissue from stem cells) we need to mature the ovaries/testicles ... There are both environmental and internal factors (for water bourne creatures) that are involved and even necessary for maturation ... there are environmental factors include: (eg. simulate annual seasons - including monsoon season); most important is photoperiod (melatonin might be used to alternate use during winter and non-use during the longer lighting summer) length of daylight and (also variation in intensity and/or light pulses) relative to the length of darkness), proper stimulation olfactory organs, FEO (food entrained oscillator... proper stimulation of taste buds, food availability; water temperature; water flow rate (activity -possible impacts on metabolism )(velocity m/sec - flooding and water currents); pH/DH (water hardness);
Dissolved Oxygen (mg/l); Free carbon-dioxide (mg/l); Total alkalinity (mg/l);
Chlorides (mg/l); TDS (mg/l); DOM (mg/l); Specific conductivity (mhos)/25C, some believe in the cycles of the moon, atmospheric pressure, availability and desired quality types based on the fish type of spawning substrate, availability of aquatic plants, sticks, gravel, and safe nooks and crannies, nutrition, and the presence of other fish...The effects of these external factors on the blood concentrations of substances (eg. exercise and activity and changes in PH/DH ... and/or melatonin antagonists) could be used together with GnRH, gonadotrophin, vitamin A (beta carotene), retinoic acid, for maturing the gametes which is absolutely necessary for spawning/mating/sexual intercourse/breeding to result in healthy embryos (mitosis/meiosis)...
7. Responses by gonadotrophin induced cycles, for females (vary) (some ovulating 70 eggs), we need alleles to induce the follicles to mature, it seems follicular fluid from large follicles (1-pFF), to mature oocyte cytoplasmic and nuclear maturation... It has been hypothesized that Alleles contributing to induction of follicle maturation and steriodogenesis, that (whereby) the maturation process is subject to gonadotropin inducing cycles, contribute to under environmental factors, to mature follicles, to produce estrogens to create and LH surge and thus ovulating.
8. We could also use ovarian tissue and/or full ovaries to produce eggs such as sturgeon (caviar) and turtle and/or crab eggs...this technology could be used to produce any and all eggs...
We can also use synthetic meiosis-activating sterol, derived from follicular fluid (FF-MAS).
Re: Inducing Maturity of Gametes from Ovarian and Testicular Tissue Vitamin A in the form of beta-carotene (BC) an also retinol ester, is supplied to oocytes and cumulus-granulosa via the ovarian follicles (by binding with molecules).
Vitamin A, retinoic acid are involved artificial insemination, and in artificial reproductive techniques (ART), eg.
superovulation, ovum pick up, and in vitro maturation culture. RA is possibly involved in affecting cytoplasmic maturation through gene expression of gonadotrophin receptors, midkine, cyclooxygenase-2, and nitric oxide synthase in cumulus-granulosa cells, oocytes, blastocyst, follicles, gametes (any and all ovarian and/or testes cells).
Tissues needed for the hormonal cascade are the hypothalamus, pituitary gland, and gonads...
The cascade of hormones are gonadotropin releasing hormones (GnRH), which travel from the hypothalamus to the pituitary gland...The pituitary regulates growth and reproduction (we could also use it to further enhance stem cell proliferation). Specialized pituitary cells are signalled by GnRH to release gonadotropic hormones. These gonadotropic hormones affect the gonads, that then produce steroids that regulates final maturation of the gametes.
Maturation of the egg includes vitellogenesis, in this process the yolk proteins (we could grow fully complete livers (deceased donor, detergent and ECM matrix with HOX
and/or stem cells and/or specialized cells per portion of belong on the matrix) outside the body and produce (in Gerard Voon's patented bioreactors)) externally produced yolk protein (mass production) are produced in the liver, transport it to the ovary, to produce much egg size.
The yolk is necessary for the embryo growth.
We are studying the induction and its contribution of Germinal vesicle migration and germinal vesicle breakdown (GVBD) to the gametes development.
Re: Next Stage After Gametes have Matured At this stage (when the gametes have matured) prostaglandins are produced.
They induce ovulation, rupturing of the follicle cells holding the egg. The egg makes its way to the body cavity or ovarian lumen... Interestingly after ovulation, the health of eggs can decrease.
Re: Induced Spawning In addition to viagra, cialis, water melon rind, Kapok (Ceiba pentandra) bark We can induce spawning by extracting hCG from the urine of pregnant (large sources that are easy to grow and breed) - any and all sources eg.
cows/pigs/horses/dogs/cats...
Major methods include injection of a GnRH analogue; agonist (Leutinizing Hormone Releasing Hormone, LHRHa) with dopamine possible antagonist:
Dopamine blockers and depletors include:
.cndot. metoclopramide .cndot. pimozide (Orap) .cndot. haloperidol (Haldol) .cndot. olanzapine (Zyprexa) .cndot. tetrabenazine .cndot. chlorpromazine hydrochloride (Thorazine) .cndot. domperidone .cndot. droperidol (Inapsine) .cndot. fluphenazine hydrochloride (Prolixin) .cndot. metoclopramide (Regian) .cndot. perphenazine (Trilafon) .cndot. prochlorperazine (Compazine) .cndot. thiethylperazine (Torecan) .cndot. trimethobenzamide (Tigan) .cndot. reserpine (Serpalan) - the fish may be reacting to a change in serotonin level and injection of gonadotropin and hCG (Human Chorionic Gonadotropin), Ovopel, Ovaprim-C, Ovatide, Ovaplant, CPE
(Carp Pituitary Extract) - we also plan to use the above hormones to proliferate stem cells and/or specialized cell regeneration).
Genetic (chromosomal modification)...to induce polyploidy, gynogenesis and androgenesis can be used for all life (aiming to control sex, inhibit sexual maturation and rapid inbreeding -Thorgaard, 1986). Methods to include using temperature sock, high hydrostatic pressure and/or chemicals... on fertilized eggs. Usage of these methods at the final stages of meiosis will retain a second polar body resulting in triploids, furthermore later usage of such methods avoids first cleavage resulting in tetraploidy...
Irradiating the sperm results in gynogenic progeny (progeny having only mother's genes) ... Irradiating pre fertilized eggs and then fertilizing results in androgenic progeny (progeny having only the father's genes)... Preventing first cell cleavage restores diploidy.
Methods used can obtain all-female population and/or all0female triploid populations. Start with gynogenic progeny...hormones are used to reverse the sex of the population to phenotypes of males but genetically female. These quasi-males fertilize normal female eggs, that produce all female progeny, the goal is get rid of inbreeding via gynogenic males are prevented.
These methods can be used to produce (via sample from live donor to regenerate - including stem cells - into full matured) ovarian and testicular tissue (and/or collect gametes directly from recently deceased donors) to use in in vitro fertilization.
Re: Artificial Water Bourne creatures' Gills By growing (via stem cells and/or regeneration/cloning of the body parts) or removing gills from the most suitable fish...we could filter out oxygen and release carbon dioxide for divers, submarines, underwater stations and/or use the carbon dioxide for any and all algae and plant growth.
Re: Melatonin Antagonist for growth and/or sexual maturity Bright light therapy is a popular method which prevents the conversion of serotonin to melatonin. The same results from more time in natural sunlight.
Since extending photoperiod is the primary means of inducing fish to mature and spawn (life cycles), and melatonin (produced by the pineal gland during darkness in the environment - the result of our visual receptors) is known to reduce rate of growth and sexual maturity therefore we are using melatonin antagonists including: muscarinic cholinergic antagonist;
mecamylamine, a nicotinic cholinergic antagonist; atenolol, a .beta.-adrenergic antagonist;
phentolamine, a nonselective a-adrenergic antagonist; prazosin, a selective a-adrenergic antagonist; haloperidol, a dopaminergic antagonist; naloxone, an opioid antagonist; and ibuprofen, a cyclooxygenase inhibitor. The following are theorized that hormones... are facilitated (some how involved) affected by the acetylcholine, dopamine, and/or prostagiandin.
Using (S20098: N-[2-(7-methoxy-l-naphthyl)ethyl]acetamide), and a Putative Antagonist (S20928: N-[2-(1-naphthyl)ethyl]cyclobutyl carboxamide to Block the Effects of Melatonin S20098, an agonist working on melatonin receptors. S20928 have both agonist/antagonist effects, at low applications is an antagonist on melatonin receptors in the suprachiasmatic nucleus and intergeniculate leaflet.
Further Melatonin Agonists and/or Antagonists that we are using to Pharmacologically Take the place of Photoperiod Inducing Growth and Sexual Maturity PREVIOUS NAMES Mel1 a Mel1b ML2 STRUCTURAL INFORMATION 350 aa (human) 363 aa (human) FULL AGONISTS Melatonin (M 5250) Melatonin (M 5250) 2-lodomelatonin (11899) 2-lodomelatonin (11899) 2-lodomelatonin (11899) 6-Chloromelatonin (C 0331) N-Propionyl melatonin N-Propionyl melatonin Melatonin (M 5250) N-Butanoyl melatonin N-Butanoyl melatonin N-Acetylserotonin (A 1824) 6-Chloromelatonin (C 0331) 6-Chloromelatonin (C 0331) 5-MCA-NAT
2-Methyl-6,7-dichloromelatonin 2-Methyl-6,7-dichloromelatonin (-)-AMMTC (-)-AMMTC
IIK7 (I 5531) PARTIAL AGONISTS 5-Methoxyluzindole 5-Methoxyluzindole Not known N-Acetyltryptamine (A 7342) N-Acetyltryptamine (A 7342) ANTAGONISTS Luzindole (L 2407) Luzindole (L 2407) Luzindole (L 2407) S20928 S20928 Prazosin (P 7791) 4P-PDOT N-Acetyltryptamine (A 7342) K185 (K 1888) SIGNAL TRANSDUCTION MECHANISMS Gi (cAMP modulation) Gi (cAMP modulation) Gq/11 (increase IP3/DAG) Gq/11 (increase IP3/DAG) cGMP modulation RADIOLIGANDS OF CHOICE 2-[1251]-lodomelatonin 2-[1251]-lodomelatonin 2-[1251]-lodomelatonin [3H]-Melatonin [3H]-Melatonin 2-[1251]-MCA-NAT
ABBREVIATIONS
4P-ADOT: 4-Phenyl-2-acetamidotetralin (-)-AMMTC: N-Acetyl-4-aminomethyl-6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazole 4P-CADOT: 4-Phenyl-2-chloroacetamidotetralin GR 196429: N-[2-[2,3,7,8-tetrahydro-1 H-furo(2,3-g)indol-1-yl]ethyl]acetamide IIK7: N-Butanoyl-2-(2-methoxy-6H-isoindolo[2,1-a]indole-11-yl)ethanamine K185: N-Butanoyl-2-(5,6,7-trihydro-11-methoxybenzo[3,4]cyclohept[2,1-a]indol-l3-yl)ethanamine Luzindole: 2-Benzyl-N-acetyltryptamine 5-MCA-NAT: 5-Methoxycarbonylamino-N-acetyltryptamine Melatonin: 5-Methoxy-N-acetyltryptamine 4P-PDOT: 4-Phenyl-2-propionamidotetralin 8M-PDOT: 8-Methoxy-2-propionamidotetralin S20098: N-[2-(7-Methoxy-l-naphthalenyl)ethyl]acetamide S20928: N-[2-Naphth-1-yl-ethyl]-cyclobutyl carboxamide Melatonin Receptors Re: Fish Blocking Ca2+ As Well, Vitamin D's Role in Ca2+ absorption Calcium was blocked by diluting water, removing calcium from the diet or by long term feeding of vitamin D-deficient diet. Melatonin production is affected by plasma Ca2+.
Another way to influence the effects of melatonin is via iontophoresis of the Ca2+ ionophore A-23187, prevents the inhibitory effect of both melatonin or Ca2+ antagonists...
Transcription factors called clock genes, which include Clock, period genes (per1, per2, and per3), cryptochromes (cry1 and cry2), and Bmall, regulate hypothalamic suprachiasmatic nucleus (SCN) and in peripheral tissues. The CLOCK and BMAL1 proteins initiate transcription of the period (per) and cryptochrome (cry) genes, and PER and CRY regulate self transcription through an interaction with the CLOCK/BMAL1 heterodimer to regulate cellular rhythms.
The SCN regylates rhythm in a several major body parts, including brain, pineal gland, adrenal liver, heart, kidney, muscle, pancreas, lung, and oviduct, through neural networks and hormonal excretion via the cerebrospinal fluid. It is clear that the same genes that are responsible for SCN rhythmicity are rhythmically expressed throughout the body.
Anyone who has night time cravings for food must wonder, there seems to be a clinging bond between the time, darkness (lack of activity) and other cues that motivates (possibly metabolism since an early dinner), you such as your rhythm has entrained you to crave food in the same daily rhythm ... This could be the cause of FEO (food entrained oscillator)...The FEO
is an alternate circadian clock acting on any and all living organisms, in addition to suprachiasmatic nuclei (SCN).
The necessary nutrients, include metabolites, ions, vitamins, nucleotides, and amino acids can also traverse from cumulus cells to the oocyte via GJC. Variations in these nutrients inputs can impact positively and/or negatively the developments from stage to stage needs of an ovary tissue into an embryo...
Measurement of carbohydrate concentrations can be taken via Glucose, pyruvate and lactate concentrations in FF, plasma and maturation medium.
Amino acid profiles (concentrations) can be Measured In follicular fluid (FF), and/or plasma...for each oestrous stage.
Measurement of osmolality can be measured using pooled FF, independent of oestrous stage.
Amino acids EAA
L-Arginine HCl L-Cystine L-Glutamine L-Histidine HCllH
L-Isoleucine L-Leucine L-Lysine-HCl L-Methionine L-Phenylalanine L-Threonine L-Tryptophan L-Tyrosine L-Valine L-Glutamine NEAA
L-Alanine L-AsparagineHO
L-Aspartic acid L-Glutamic acid Glycine L-Proline L-Serine Minimal Essential Medium (MEM) essential amino acid solution (no.
320-1130; Gibco).
b MEM nonessential amino acid solution (no. 320-1140; Gibco).
Specifically (stage by stage) Amino acids affected by oestrous stage included:
glutamate, asparagine, histidine, glutamine, threonine, arginine, taurine, alanine, tyrosine, tryptophan, methionine, valine, phenylalanine, leucine and lysine. The Stage I FF amino acid profile was very similar to that of plasma, particularly as regards aspartate, glutamate, serine, glycine, threonine, arginine, taurine, phenylaianine and isoleucine. By contrast, Stages ll-IV profiles were significantly lower than plasma for aspartate, glutamate, asparagine (Stage III only), serine, taurine (except Stage II), alanine (Stage II only), methionine (except Stage II), valine (except Stage II), leucine (Stage III only) and lysine (except Stage III).
Overall, plasma levels were markedly higher than those of FF for glutamate, serine and glutamine and, to a lesser extent, for asparagine, threonine, taurine, tyrosine, methionine, phenylalanine and lysine. By contrast, FF valine concentration was significantly higher than in plasma.
It is well believed that amino acids are uptaken into the oocytes by the gap junctions (gap junctional communication (GJC)).
Addtionally the GSH (glutathione) content of an oocyte is much dependent nextdoor cumulus cells, GJC is believed to contribute to GSH content in the oocyte Via passage/uptake of GSH or its substrates, cysteine and glutamine from the cumulus cells to an oocyte. The way cumulus cells regulate MPN (male pronuclei) formation is not understood.
The basic medium used for the maturation of oocytes was BSA-free Whitten's medium NaCI, KCI, KH2PO 4, MgSO 4, NaHCO 3, glucose, sodium lactate, sodium pyruvate, hemicalcium lactate, potassium penicillin, streptomycin sulfate, phenol red and supplemented with PFF (pig/cow/human) follicular fluid, TCM-199 containing hCG, eCG, glutamine, fetal calf serum...
Also, large accumulation of cumulus cells (eg. Artificial Insemination with an external ovary produced oocyte - more broadly the cumulus are responsible for Routing and Penetration of spermatoza) affects the success of penetration of spermatozoa And the large cumulus cell mass induces acrosome reaction and assists penetration into the oocyte.
(Jason 0.5%) (DLD 0.25%) (GP HW 0.25%) We can use Proton nuclear magnetic resonance ((1)H NMR) to chemically dissect any and all life fluids, including stem cell developments (proliferation stages), regeneration, meiosis, mitosis, different cells and the functions, liver and kidney filteration cells the mechanism whereby waste enters one end and is separated and the clean blood diverted back into the system, the mechanism of lung cells (including fish gills) how the absorb oxygen and release carbon dioxide and the membrane? And how this membrane performs this function... (each and every cell type and their symbiotic relationship with each and every organ and glands...
development of ovaries to oocyte, the changing make up of Newt/Salamander's (any and all amphibians (GP)regenerating tails, starfishes, jellyfish, sea cucumber, ECM/HOX changes in response to amino acids, vitamins, ions...changes, mammals/ fishesturties (near extinct species), Focusing on follicular growth and maturation, (1)H NMR is utilized to dissect intrafollicular and circulating glycoconjugates (sugar chains and N-acetyl groups), lipoproteins (CH(3) and CH(2) groups), glucose metabolites (trimethylamines, acetate and lactate), amino acids (including the above and more specifically: (glutamine/glutamate and alanine), creatine/creatinine and polyamines). Follicular fluids is measured for oestradiol and progesterone. The intrafollicular alanine and lipoproteins (CH(3) groups) went down in the dominant follicle (the future oocyte) during growth stage, while progesterone and oestradiol showed a large increase. As detailed above gonadotrophin is used to induce ovulation;
follicular maturation is noted by lessening of glycoconjugates (sugar chains), trimethylamines and acetate, less oestradiol, also additional CH(3) groups of lipoproteins and progesterone.
Re: The Idea of Varying levels of Factors for Different Phases in Mitosis for any and all Proliferation Promoting Substances has been Previously Patented by Gerard Voon, but Below is one Example of one such Substance (Ca2+) Ca2+ ions needed for mitogenesis and increase in cytosolic Ca2+ acts as a physiological trigger in cell proliferation, the different phases of the cell cycle present different dosage needs for Ca2+. Ryanodine and NiCl2 eliminated cytosolic Ca2+ and did not prevent PDGF-induced development into the G0 into G1 phase. Furthermore progression of cells into the S phase and the further mitosis were arrested, perhaps because S phase needs Ca2+ and further proliferation promoting factors is regulated by Ca2+dosages and perhaps sharp changes and maintenance levels. G1/S are arrested when there is not enough Ca2+. Emptying of Ca2+ pools during G0/G1 and S arrest growth while plating positive affect on G2 and M
cell cycle phases.
PDGF-induced (any and all) cells' proliferation requires the activity of SERCA
pumps to uptake Ca2+ pools the entry into the S phase.
Ca2+ timing (in correlation with the mitotic phases) seems to involve Ca2+
intracellular pools drainage and alternating usage of Ca2+ membrane to uptake the exogenous Ca2+
dependent (are necessary for) on the mitotic phase. PDGF (Platelet-derived growth factor) and possibly any and all other factors (especially for proliferation) binding to receptors at the surface of cellular membrane and are intertwined with changes in cytosolic Ca2+ dosages that involves a surge the a lesser steady-state elevation, involving both the drainage of Ca2+
pools and uptake of Ca2+ from the extracellular (external to the cell).
Re: Reactive Oxygen Species (ROS), reactive nitrogen species, and calcium (Ca2+) It has been suggested that plant cells sense ROS via at least three different mechanisms: (i) unidentified receptor proteins; (ii) redox-sensitive transcription factors, such as NPR1 or Heat Shock Factors; and (iii) direct inhibition of phosphatases by ROS. There is a possiblilty of interactions of ROS, reactive nitrogen species, and calcium signalling.
All three are involved in control and regulation of biological processes, such as growth, cell cycle, programmed cell death, hormone signaling, biotic and abiotic stress responses and development...and any and all phenotypic responses.
ROS, reactive nitrogen species, and calcium (Ca2+) signalling are generated at a number of intracellular locations, including mitochondria, chloroplasts, peroxisomes, and at the extracellular side of the plasma membrane. These locations signal transduction events, such as mitogen-activated protein kinase cascades, eliciting specific cellular responses. The impacts of these ROS, reactive nitrogen species, and calcium signalling on cellular processes is mediated by both the perpetuation of their production and their amelioration by scavenging enzymes such as superoxide dismutase (SOD), ascorbate peroxidase (APX), and catalase (CAT). We need further study location, amplitude, and duration of ROS, reactive nitrogen species, and calcium Functioning like Ca2+ signaling ROS (And possibly nitrogen species) is controlled by the spatial and temporal nature of its pools and drainage.
Re: Some of the Fish we Plan to Apply the Above Spawning Methods and Techniques (From External Ovaries Factories to ROS...) Scientific name Common name Acanthopagrus latus Yellowfin sea bream A. berda Picnic sea bream A. schlegeli Black sea bream A. sivicolus Southern black sea bream Anthias disper Red fish Boleophthalmus pectinirostris Pond or mud skipper Chanos chanos Milkfish Choerodon schoenleinii Black spot tusk fish Cromileptes altivelis Highfin grouper Eleutheronema tetradactylum Four finger threadfin Epinephelus akaara Red grouper E. amblycephalus* White-spotted green grouper E. awoora Yellow grouper E. coioides / suillus Red-spotted grouper E. fario Black-saddled grouper E. fuscoguttatus Tiger grouper E. lanceolatus Giant or King grouper E. malabaricus / salmonides Malabar grouper E. quoyaqnus Long-finned grouper E. tauvina Green grouper E. tukula Potato grouper E. trimaculatus Brown marbled grouper Evynnis cardinalis Golden-skinned porgy Girella melanichthys Smallscale blackfish Girella puncta* Largescale blackfish Glossogobius giuris Flathead goby Gnathanodon speciosus Kingfish Hapalogenys nitens Beard grunt Kyphosus lembus Shortfin rudderfish Lateolabrax japonicus Japanese sea bass Lates calcarffer Asian sea bass Lethrinus nebulosus Green snapper Liza macrolepis Largescale liza Lutjanus argentimaculatus Mangrove red snapper L. erythropterus Pink snapper L. johnii John's snapper L. malabaricus Firespot snapper L. monostigma Onespot snapper L. russelli Russell's snapper L. sebae Emperor snapper L. stellatus Spotted snapper Miichthys miiuy Nibe or brown croaker Mugil cephalus Grey mullet Nibea diacanthus Speckled drum Oplegnathus punctatus Spotted knifejaw Pagrus major Red sea bream Platax orbicularis Narrow-banded batfish Plectorhynchus cinctus Three-banded grunt P. pictus Three-lipped grunt Plectropomus leopardus Coral trout Polynemus plebejus Common threadfin P. sexfilis Six threadfin Pomadasys kaakan Lined silver grunter Psettodes erumei Big-mouthed flounder Pseudosciaena crocea Large yellow croaker Rachycentron canadum Cobia or Sergeantfish Scatophagus argus Spotted scat Sciaenops ocellatus Red drum Seriola dumerilli Greater yellowtail Siganus fuscescens Dusky spinefoot S. guttaus Speckled spinefoot S. oramin Yellow-spotted spinefoot Sillago sihama Sand borer S. vermiculatus Reticulated rabbitfish Sparus sarba Silver sea bream Takifu rubripes Tiger puffer Terapon jarbua Three stripe tigerfish Trachinotus blochii Pompano Re: The Drugs Successfully Used for Aquaculture (below), we plan to test their efficacy for Any And All Life Table 1. Drugs Approved for Use in Aquatic Species*
Drug Species Indication Formalin Finfish Control of certain external protozoa and monogenetic trematodes Finfish eggs Control of fungi of the family Saprolegniaceae Penaeid shrimp Control of certain external parasites Oxytetracycline Pacific salmon Marking of skeletal tissue via medicated feed Finfish Marking of skeletal tissue via immersion Salmonids Control of ulcer disease caused by Hemophilus pisicium, furunculosis caused by Aeromonas salmonicida, bacterial hemorrhagic septicemia caused by A liquefaciens and pseudomonas disease.
Catfish Control of bacterial hemorrhagic septicemia caused by A liquefaciens and pseudomonas disease Lobster Control of gaffkemia caused by Aerococcus viridans Sulfadimethoxine/ Salmonids Control of furunculosis caused by Aeromonas ormetoprim salmonicida Catfish Control of enteric septicemia caused by Edwardsiella ictaluri Sulfamerazine~ Rainbow, brook, Control of furunculosis and brown trout Tricaine Fish, amphibians, Temporary immobilization as an aid in handling Methanesulfonate and other poikilotherms Chorionic Finfish Spawning aid Gonadotropin *Data from FDA Center for Veterinary Medicine Web site.7 ~Not currently marketed.
Re: Sites and Some Hormones that Achieve our Desire to Mature Sperm and Eggs and Induce Spawning Induction of spawning by the injection of 8,11,14-eicosatrienoic acid into the coelomic cavity, shows that the natural sperm maturation factor and spawning hormone.
Alternately females, injected with female prostomial homogenate into the coelomic cavity induces oocyte maturation and subsequent spawning. Oocytes, on the other hand, although maturing in the presence of CMF (Coelomic Maturation Factor), do not mature in the presence of prostomial homogenate.
Oocyte maturation and subsequent spawning is under the control of 2 hormones:
(1) a substance from the prostomium, Prostomal Maturation Hormone (PMH), which induces the production of (2) CMF which acts on the oocyte. PMH is required for oocyte maturation...
Re: Other Chemicals to be Used on any and all Life for Sexual Maturation/Proliferation and/or Breeding/Spawning (On Both Males and Females) Tetracaine, procaine, propranolol, oxprenolol, lanthanum chloride, ionophore A23187, DL-dithiothreitol, arachidonic acid and ammonium ions (ammonium sulphate) were also all tested for their ability to induce maturation... Also possibly injection with 5-hydroxytryptamine (5-HT) into the gonads... serotonin (and any and all psychiatric drugs including viagra and/or cialis) can be applied to induce spawning/breeding... (We could possibly use Antho-RFamide, a neuropeptide situated in ciliated neurons within follicle epithelia, also causes exfoliation of the follicle epithelium from spawned follicles). Photoperiod/intensity augments the potency of Antho-RFamide. The actin-binding toxin phalloidin substantially reduced the incidence of Antho-Rfamide.
Re: Other Alternate Serotonin Drugs that may help Induce Spawning Serotonin levels increase with of tryptophan. Increasing intake foods high in tryptophan, do affect sretonin levels due to competition with other amino acids. Stamina and aerobic exercise improves mood, by increasing in serotonin (endorphins?) levels. Endorphins (endogenous opioid polypeptide compounds). Produced by the pituitary gland and the hypothalamus in vertebrates during strenuous exercise, excitement, and orgasm; and they resemble the opiates in their abilities to produce analgesia and a sense of well-being. Endorphins work as "natural fever relievers", whose effects may be enhanced by other medications. We could increase water flow rate and velocity and or exercise/activity that is enjoyable to the life form then extract the pituitary and/or hypothalamus from the exercising life form (eg.
pigs/cows/gold fish creatures that are easy, fast and large volume...) also the sources of endorphins, GnRH, Pituitary and Hypothalumus... extracts from the glands of pigs/cows/gold fish could be prepared for extraction via Gerard Voon's patented Neural Links (12% GP) to put the subject of extract in a serotonin/endorphin inducing mood... and inject to make other life (aquaculture and/or any and all life stock farming - even as a viagra and/or feel good supplement) mate... In fact we could use Neural Links directly on the life forms to induce them spawn/breed/mate/have sex (11%)...
It is believed that a diet rich in whole grain carbohydrates and low in protein will increase serotonin by secreting insulin, which helps in amino acid competition. The danger is that increasing insulin for a long period of time can lead to insulin resistance, which are factors for some causes of obesity, type 2 diabetes, and even lower serotonin levels.
Furthermore that muscles use many amino acids but not tryptophan, allowing men to have more serotonin absorption than women.
Re: Drugs that treat the Serotonin/5-HT system include - AntiDepressants .cndot. Ambilify (Aripiprazole) .cndot. Sertraline (Zoloft) .cndot. Escitalopram (Lexapro) .cndot. Fluoxetine (Prozac) .cndot. Bupropion (Welibutrin, Zyban) .cndot. Paroxetine (Paxil) .cndot. Venlafaxine (Effexor) .cndot. Trazodone (Desyrel) .cndot. Amitriptyline (Elavil) .cndot. Citalopram (Celexa) .cndot. Duloxetine (Cymbalta) .cndot. Mirtazapine (Remeron) .cndot. Nortriptyline (Pamelor) .cndot. Imipramine (Tofranil) Also (concentrated extracts of) hypericum perforatum (St John's Wort) First Generation Antipsychotics Butyrophenones .cndot. Haloperidol (Haldol) Phenothiazines .cndot. Chlorpromazine (Thorazine) .cndot. Fluphenazine (Prolixin) - Available in decanoate (long-acting) form .cndot. Perphenazine (Trilafon) .cndot. Prochiorperazine (Compazine) .cndot. Thioridazine (Mellaril) .cndot. Trifluoperazine (Stelazine) .cndot. Mesoridazine .cndot. Promazine .cndot. Triflupromazine (Vesprin) .cndot. Levomepromazine (Nozinan) .cndot. Promethazine (Phenergan) Thioxanthenes .cndot. Chlorprothixene .cndot. Flupenthixol (Depixol and Fluanxol) .cndot. Thiothixene (Navane) .cndot. Zuclopenthixol (Clopixol & Acuphase) Second generation antipsychotics .cndot. Clozapine (Clozaril) - treats schizophrenia, acute manic episodes, and maintenance of bipolar disorder.
.cndot. Risperidone (Risperdal) - treats Tourette Syndrome or Anxiety Disorder.
.cndot. Quetiapine (Seroquel) - Used primarily to treat bipolar disorder and schizophrenia, and "off-label" to treat chronic insomnia and restless legs syndrome; it is a powerful sedative .cndot. Ziprasidone (Geodon) - Now (2006) approved to treat bipolar disorder.
Dosing 20 mg twice daily initially up to 80 mg twice daily. Prolonged QT interval a concern; watch closely with patients that have heart disease; when used with other drugs that prolong QT interval potentially life-threatening.
.cndot. Amisuipride (Solian) - Selective dopamine antagonist. Higher doses (greater than 400 mg) act upon post-synaptic dopamine receptors resulting in a reduction in the positive symptoms of schizophrenia, such as psychosis. Lower doses, however, act upon dopamine autoreceptors, resulting in increased dopamine transmission, improving the negative symptoms of schizophrenia. Lower doses of amisulpride have also been shown to have anti-depressant and anxiolytic effects in non-schizophrenic patients, leading to its use in dysthymia and social anxiety disorder.
.cndot. Asenapine is a 5-HT2A- and D2-receptor antagonist under development for the treatment of schizophrenia and acute mania associated with bipolar disorder.
.cndot. Paliperidone (Invega) - Derivative of risperidone.
Third generation antipsychotics .cndot. Aripiprazole (Abilify) - reduce susceptibility to metabolic symptoms seen in some other atypical antipsychotics.[4) .cndot. Dopamine partial agonists:
.cndot. Under clinical development - Bifeprunox; nordozapine (ACP-104).
Other options .cndot. Tetrabenazine (Nitoman in Canada and Xenazine in New Zealand and some parts of Europe) is similar in function to antipsychotic drugs, though is not, in general, considered an antipsychotic itself. This is likely due to its main usefulness being the treatment of hyperkinetic movement disorders such as Huntington's Disease and Tourette syndrome, rather than for conditions such as schizophrenia. Also, rather than having the potential to cause tardive dyskinesia, which most antipsychotics have, tetrabenazine can actually be an effective treatment for the condition.
.cndot. Cannabidiol One of the main psychoactive components of cannabis. A
recent study has shown cannabidiol to be as effective as atypical antipsychotics in treating schizophrenia.
Metabotropic glutamate receptor 2 agonism has been seen as a promissing strategy in the development of novel antipsychotics. The active metabolite of this prodrug targets the brain glutamate receptors mGluR2/3 rather than dopamine receptors.
Re: Natural Humane Sources of Serotonin Serotonin are in mushrooms and plants, including fruits and vegetables.
Particularily high contents are present in nuts of the walnut (Juglans) and hickory (Carya) genuses. Serotonin are been present in plantain, pineapple, banana, kiwifruit, plums, and tomatoes. Moderate contents are present in a wide range of tested vegetables. It should be noted that serotonin, unlike its precursors 5-HTP and tryptophan, does not cross the blood-brain barrier. There are plants containing serotonin together with a family of related tryptamines that are methylated at the amino (NH2) and hydroxy (OH) groups, are N-oxides, or miss the OH group eg.
Anadenanthera genus that are used in the hallucinogen.
Re: Treatment For Anxiety that may help Spawning/Breeding/Mating/Sex and also Time of Stress for eg. Aquaculture including Transport and/or Disease and/or Majoring Cleaning of the Tank, Any time the Creatures Become Spooked:
.cndot. Imidazopyridines ~ zolpidem (Ambien) ~ alpidem ~ saripidem ~ necopidem .cndot. Pyrazolopyrimidines ~ zaleplon (Sonata) ~ indiplon ~ ocinapion .cndot. Cyclopyrrolones ~ eszopicione (Lunesta) ~ zopiclone (Imovane) ~ pagocione ~ suricione ~ pazinacione ~ suproclone .cndot. other structural families ~ Etifoxine ~ Panadiplon ~ CL-218,872 ~ SX-3228 ~ L-838,417 ~ RWJ-51204 ~ Y-23684 Growth hormone (GH) also has been identified as an oocyte survival factor acting secondarily to the IGF-I pathway. Gonadotropins or growth hormones may act to promote follicle survival, in part, by altering follicular steroidogenesis (eg. human preovulatory follicles cultured in the presence of IGF-I produced more estrogen and less progesterone.
Studies conducted on preovulatory follicles suggest that, without supportive hormones such as human chorionic gonadotropin (hCG), insulin-like growth factor-I (IGF-1), and human follicle stimulating hormone (hFSH), cultured follicle cells will undergo apoptosis (previous studies have shown). Growth hormone (GH) also has been identified as an oocyte survival factor acting secondarily to the IGF-I pathway (previous studies). In some cases, there is evidence that the various gonadotropins or growth hormones may act to promote follicle survival, in part, by altering follicular steroidogenesis. For example, human preovulatory follicles cultured in the presence of IGF-I produced more estrogen and less progesterone (shown by previous studies).
In agreement with my belief that timing/concentration (leading to - response with sexual stimulation; intensity - due the levels of (various environmental cues) change in one direction and durations versus the cue's levels of change opposite in the other direction to create cycles (any and all lengths; seasonal; annual), that the fish (any and all life), naturally take in their sexual response via genetics and/or entrainment to these environmental cues (including maturation (annual cycles and the duration and rate and levels of environmental cues - some hormonal factors such hCG, IGF-I, hFSH, GnRH) - melatonin inhibitor) and seasonal-hormonal responses impact on the willingness of fish and any and all life to spawn/mate/breed/have sex) in response to environmental cues that cause late-cycle high of plasma E2 and testosterone highs may be the cause in feedback to the brain (hypothalamus, and pituitary glands), inducing synthesis and secretion of LH at the expense of FSH production. It is believed that (estradiol-17) E2 is produced in the granulosa cells by the action of the aromatase enzyme and converts testosterone to E2.
Circulating E2 and testosterone levels rise early in final maturation, while the oocyte germinal vesicle is still migrating; peak testosterone levels respond less behind peak E2 levels.
Androgen and estrogen levels both fall coincident with the peak in circulating E2 that is concurrent with GVBD (shown by previous studies) artificial induction can be accomplished using synthetic analogue of gonadotropinreleasing hormone (GnRHa). Noted that changes in circulating steroid hormones rise of internal LH in the blood plasma is induced by GnRHa (past studies).
These observations further suggest that rises in androgen and estrogen levels...
Fish have shown cyclic pattern of oogenesis and endocrine correlative cyclic pattern.
Responding to such environmental cues (eg. photothermal - diurnal and seasonal changes in water temperature and day length) and therefore reproducing in timing cycle that is entrained. Deposition of yolk granules in the growing oocytes is triggered by decreasing day length and water temperature (eg. monsoons and/or rainy season and other environmental factors caused by such seasons and the cues that belong to such seasonal changes that the fish type and entraining that they respond to). Furthermore these seasonal related cues come with a distinct rise in concentration of estradiol-17 - ' -,(E2) and testosterone, as well as Vg.
Exogenous E2 may induce hepatic vitellogenesis suggesting its role as hormone controlling this process.
Oocyte growth begins at deposition of lipid droplets (made of wax esters, which are made from circulating triglyceride precursors) /yolk protein and yolk granules in the ooplasm. Past studies have shown that oocyte growth is correlated to yolk protein deposition in the yolk granule.
Ovarian follicles and vitellogenesis:
1. Theca is the outermost layer derived from stromal connective tissue and is made up of collagen fibers, fibroblasts, steroidogenic cells, and capillaries or other vascular components (according to past studies).
2. Germinal epithelium-derived follicle cells then flatten to form a singular granulosa cell layer under the basal lamina and on top of the cellular chorion or ZR.
3. Junctional complexes between the follicle cells allow for the extracellular passage of Vg, through the theca, basement membrane, granulosa cell layer, and ultimately to the oocyte surface.
4. The ZR then takes on a perforated form by a process known as microvillar, which emanate from both the oocyte and granulosa cells (also based on past studies).
Re: Krill (Zoo Plankton) Farming In addition to any and all oily fish sued to produce healthy fish oils...
especially we are mass producing krill and shrimp...
For their omega-3 fats, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA), but hooked together in a different form...
Fish oil is extracted from, omega-3 fatty acids are found in the triglyceride form, while krill/shrimp oil are hooked up in a double chain phospholipid structure.
The EPA leg phospholipid has a molecule known as astaxanthin, which is a very potent anti-oxidant. The phospholipid EPA and DHA in krill oil are more absorbable. Also Krill/shrimp oil enters more easily into the mitochondria and the nucleus membrane. Furthermore EPA and DHA from krill oil's phospholipid have more complex profile such as phosphatidylcholine, whose effect is reductive-stress-reducing choline, and also a natural emulsifier.
Krill oil has vitamin E, vitamin A, vitamin D and canthaxanthin, like astaxanthin. The anti-oxidant potency of krill oil is 48 times more potent than fish oil. Aparently it has 10 times more antioxidant activity than beta-carotene and as much as 1,000 times more than vitamin E.
Interestingly it is a source of alpha-tocopherol (vitamin E) and a derivative, called marine-derived tocopherol, that has antioxidant properties than alpha-tocopherol. It is postulated that tocopherols enable krill survive in the cold waters. As well they have the flavonoid luteolin. If this theory is correct it may be the only non-plant version of the substance... One claim of omega-3 of krill oil is that the phospholipid content of krill oil plays a role in omega-3 passing through the blood-brain barrier.
If we can mass produce the krill/shrimp cheaply enough they are a rich fertilizer, like fish fertilizer...
Astaxanthin is used as a feed supplement for salmon, crabs, shrimp, chickens and egg production. Regardless of the source, astaxanthin provides some important benefits beyond coloration. It also has been found to be essential for proper growth and survival.
Vitamin A
Krill Oil Phospholipids, Omega-3 rich Eicosapentaenoic Acid (EPA) Docosahexaenoic Acid (DHA) Omega-6 Fatty Acids Astaxanthin Transfat Malacostraca include:
crabs, krill, pill bugs, shrimp, and relatives Kingdom: Animalia Phylum: Arthropoda Class: Malacostraca Members of this Class UV before and/or after freezing, thaw in water prior to injection and/or freeze dry.
A number of studies have shown that krill oil is very effective in: reducing LDL-cholesterol, raising HDL-cholesterol therefore cardiovascular disease; Lowering blood sugar threfore diabetes; Treating the pain; Inflammation from rheumatoid arthritis (therefore see list of inflamatory diseases pages 23 to 25) and Aches and pains (therefore as an pain releiver eg.
substitite for tylenol/aspirin...), PMS and dysmenorrhea, adult ADHD; Healthy brain and nervous system neurodegenerative diseases and It also crosses the blood-brain barrier, which makes it available to the eye, brain and central nervous system to alleviate oxidative stress that contributes to ocular, and neurodegenerative diseases such as glaucoma and Alzheimer's;
Healthy liver function; Improved immune function; Concentration and memory;
Healthy joints.
Astaxanthin is potent antioxidant, it may be beneficial in cardiovascular, immune, inflammatory and neurodegenerative diseases. Research supports the assumption that it protects body tissues from oxidative damage.
Cod Liver versus Fish Oils are: More efficiently and more easily absorbed;
Superior antioxidant protection; Can be renewable; Does not oxidize.
Re: Any and All Shrimp especially Krill Maturation and Spawning We plan to use all the aquaculture (fish, crayfish/crawdads - arthropods, amphbians, any and all life) environmental (eg. page 1 point 6. and Re: Growth and Maturation and Re; Spawning) including temperature/PH/DH and any and all environmental conditions shock, filtration of seawater and/or (eg. simulate annual seasons - including monsoon season); most important is photoperiod (melatonin might be used to alternate use during winter and non-use during the longer lighting summer) length of daylight and (also variation in intensity and/or light pulses) relative to the length of darkness), proper stimulation olfactory organs, FEO
(food entrained oscillator... proper stimulation of taste buds, food availability; water temperature; water flow rate (activity - possible impacts on metabolism )(velocity m/sec - flooding and water currents);
pH/DH (water hardness); Dissolved Oxygen (mg/I); Free carbon-dioxide (mg/I);
Total alkalinity (mg/I); Chlorides (mg/I); TDS (mg/l); DOM (mg/I); Specific conductivity (mhos)/25C, some believe in the cycles of the moon, atmospheric pressure, availability and desired quality types based on the fish type of spawning substrate, availability of aquatic plants, sticks, gravel, and safe nooks and crannies, nutrition, and the presence of other fish...The effects of these external factors on the blood concentrations of substances (eg. exercise and activity and changes in PH/DH ... and/or melatonin antagonists) could be used together with GnRH, gonadotrophin, vitamin A (beta carotene), retinoic acid, for maturing the gametes which is absolutely necessary for spawning/mating/sexual intercourse/breeding to result in healthy embryos (mitosis/meiosis)...
We plan to mass produce the krill using the above breeding/spawning techniques.
One spawning method is shrimp eyestalk ablation.
We could try to grow (regenerate) the bioreactors (proliferate via ECM and/or HOX), we could even slice the krill to a survivable cellular colonies (maybe with a threshing machine with very small and fine and sharp blades) and regrow them via regeneration ECM/HOX and other technologies Gerard Voon has patented, whereby the cells are constantly renewed as an altenative artificial maturation and spawning techniques covered in this patent. (Jeff 30 of 35%) Krill can be harvested and processed for their protein (40% or more of dry weight) and lipids (about 20% in E. superba). Their exoskeleton for chitin, hydrolytic enzymes such as proteases, carbohydrases, nucleases and phospholipases, found in their digestive gland in the cephalothorax of the krill; these enzymes might be usable in producing biomass, bio fuel and bio crops ethanol...
Other uses include krill pastes or processed krill as food additives, e.g. in the form of krill oil gel capsules.
Krill are used as pastes, for food addictives oil gel in capsules enzymes, necrotic tissue and chemonucleolytic agents.
Their oils can be used as biofuel...
Algae Algae belong to a group of micro organisms known as protists. Crypthecodinium cohnil and Schizochytrium are two strains/varieties of algae currently employed for supplements of omega-3. They are proliferated in fermenters under specific environmental conditions. When ready the algae are dried and oil separated. By creating a closed system oil from the algae is contaminants free and monoculture.
Fish oil or krill oil, both have EPA and DHA, algae has the DHA. The organisms that feed on the algae retroconvert some DHA back to EPA, although more direct EPA is often needed...
However, research suggests that DHA may be the more critical of the two omega-3s for certain health benefits, especially for infants.
DHA from algae was more positive in its effects on the growth of colon cancer cells in mice than EPA, 90 percent less tumor growth. Reducing platelet aggregation or lowering blood cholesterol as combinations of EPA and DHA from fish oils. Depression may also be associated with reduced blood levels of omega-3 fatty acids and or Omega-6...
Phytoplankton Krill probably react (spawn/sexually triggered/mate/breed in response regulated to the environmental sensitivities in height and duration to the developing cycle of) the Pacific upwelling of cool waters in spring that supports the (especially sensitive to availability - eg.
feeding food frenzy of clouds of phytoplankton) and nutritional and/or odour and/or taste and/or energy associated with phytoplankton bloom. Therefore the timing (entrained, genetically versus glandular recall) bloom is linked with the hatching of krill eggs.
Re: Micro organisms Including Diatoms And Phytoplankton Have the Following Benefits to the Life that Feed on It (Shrimp and/or Krill above Especially feed on Phytoplanktoon).
.cndot. immune system enhancement .cndot. general nutrition - provide ultra-potent lipids to enhance brain function .cndot. energy - increases energy and vitality .cndot. promotes better sleep - more restful and restorative .cndot. antioxidant protection from cancers and degenerative diseases .cndot. cardiovascular health - supports a healthy heart .cndot. blood pressure control .cndot. cholesterol reduction .cndot. liver health - supports a healthy liver .cndot. neurological support - mental alertness, ADHD, Parkinsons, and general dementia .cndot. alkalizing - the balancing of body pH away from unhealthy excess acidicity .cndot. anti-inflammatory effects on membranes - promotes relief from joint pain .cndot. cell wall improvement through increased permeability and flexibility .cndot. detoxification and cleansing - supports removal of toxins from cells and organs .cndot. skin care - such as acne, psoriasis, dermatitis .cndot. better vision - more effective than Lutein .cndot. blood sugars - stabilizes blood sugar levels (aids those who are diabetic or hyperglycemic) .cndot. supports weight loss Re: Factors that Diatoms/Phytoplankton/Plankyton/Zooplankyton/Micro Organisms that are Needed for them to Thrive Most needed seems to be iron ... others include temperature, salanity, transmissivity (suspended particulates), oxygen, nitrate, phosphate, silicate, C02 partial pressure, PH, iron binding ligands...All plants benefit from active nitrate reductase, and the ability for nitrogen fixation makes them good to fertilize hydroponic waters...
The most proliferate are the heterotrophic bacteria, ciliates, and flagellates... We are studying their genes 1. to determine the genes responsible for their rapid proliferation, to insert these genes into cow/pig/chicken ... via ovary/testes precusor and gamete cells to mass produce their meat, and/or we could insert these genes responsible for rapid proliferating into micro organisms that have strong enzymes (eg. from termites) for ethanol production, perhaps cutting the processing time and making the process easier. On the other hand we could insert DNA
and/or plasmid into and either pre genetically altered such as enucleated to be compatible with human DNA/plasmid (so these micro organisms: heterotrophic bacteria, ciliates, and flagellates) can reproduce with eg. human DNA, for future extarction into stem cells seed DNA
and/or any other uses for any and all life DNA... These procedures with these micro organisms, can also be used with nitrogen fixing with healthy fertility increasing microorganisms in soil, compost and/or mushrooms, any and all life (especially cells) that we want to mass produce rapidly (harnesssing the rapid rate of proliferation of these heterotrophic bacteria, ciliates, and flagellates)...
Diatoms Include .cndot. Diatom A cont. C cont.
A .cndot. Attheya longicornis .cndot. Chaetocerotaceae .cndot. Attheya septentrionalis .cndot. Clepsydra (genus) .cndot. Asterionella .cndot. Auxospore .cndot. Coscinodiscineae .cndot. Attheya .cndot. Attheya arenicola B D
.cndot. Attheya armata .cndot. Attheya decora .cndot. Bacteriastrum .cndot. Didymosphenia geminata .cndot. Attheya flexuosa .cndot. Biddulphiineae .cndot. Attheya gaussii F
C
.cndot. Frustule .cndot. Centrales .cndot. Chaetoceros p .cndot. Chaetoceros diadema .cndot. Chaetoceros furcellatus .cndot. Pennales .cndot. Phaeodactylum tricornutum .cndot. Pinnularia T
.cndot. Thalassiosira pseudonana We can collect diatoms resting spores shallower floors/beds of water...scooping the resting spores versus trying to reach them in deeper waters. We will grow them including krill by putting silicon, nitrogen, phosphorus and iron and adjusting temperatures - we could grow them with hay fusion, filamentous algae, cladophora, vaucheria... also dphania and brine shrimp. When it comes time for the Krill to spawn we control the the conditional factors including providing an abundance of food and we move them to a deeper pen...
Re: Easy to Grow Sources of Protein Supplements 1. Proteins extracted from Earth Worms and/or grubs - freeze dried/powdered.
2. Proteins extracted from ants, crushed/pulverized (their exoskeleton perhaps dissolved in acid and/or enzymes as long as the method of removing the exoskeleton - if need be at all does devalue the protein desired) frozen and/or freeze dried.
3. These ants and eartheworms can be fed sugar and/or restaurant waste (shredded).
4. They can all be treated to UV then (eg. flash frozen) frozen and then UV
again then thawed and fed as protein.
5. We could add algae taste and/or smell to make the above sources of food more appetizing (pellets).
Since these sources of protein are so cheap, as an alternate for human supplements/additive (pills/capsules/powder), for animal feed and/or any and all fish feed.
And or pwdered and fed to animal meat in bioreactors to mass produce mass amounts of meat cheaply, or as fertilizer and also to gro fat cells (from eg. seals, whales and walruses) to produce biofuel and also a delicacy (GP 0.5%).
Re: Micro organisms Lacto Bacillius and/or Actinomycetes, diatoms... both of which are photosynthetic bacterias -which can be used for pre digestion of feed for any and all creatures - making the food more nutritional. Lacto Bacillus also produces lactic acid from sugars, carbohydrates and yeast (which sterilizes - we could produce antibacterial hand washes/antibacterial wet tissues/gels... lactic acid could also possibly mixed with chitin and/or furanone - anti agent used against harmful organisms), lactic acid also ferments and decomposes lignin and cellulose, which can be used for any and all biocrops to turn into ethanol.
Re: Biofilms/Quorum Sensing - believed to be sensed via pheromone and/or autoinducers by secreting signal molecules; cell to cell signaling We could possibly use genes that govern high virulence (eg. E.Coli)and genetically Modify into cows/pigs/chickens/fish meats such that we can clone fast growing life forms but also the meats for food. Also we could use biofilm/quorum sensing for yeast, bacteria in cow' s mouth (that produces methane - for fuel), micro organisms found in a cow's/horses'/
gut for cellulose (eg. hay) processing - fermentation (and their enzymes), micro organisms for compost, sewage, manure, restaurant waste, possibly garbage waste; by adding sugar we turn soils fertile...these materials can be (thoroughly/evenly/strategically) mixed with sugar/carbohydrates/starch is such a way that the clusters of waste that are easier to breakdown need less sugar, while the clusters of waste that are harder to breakdown need the supplement of higher concentration of sugar/carbohydrates/starch to give the micro organisms energy and vitality together with adequate biofilm/quorum sensing for the micro organisms to flourish.
The following (below) suggests that there are many factors affecting micro organism in the blood stream or occupying infected cells, actually some similarity to fish (any and all life) and their responses to contents (and concentration) and conditions in the water (medium)... We are using melatonin antagonist for micro organisms that are light sensitive, we also will control any and all environment factors (the same as in fish maturation) in cycles (tall rise and fall of and timing that cause cycle and durational changes), as well as the hypothalamus and pituitary gland hormones (and all their analogues) as well as LH...We could also try viagra, cialis, LHRHa (with dopamine agonist), Beta Carotene, (Vitamin A), retinoic acid, water melon rind, Kapok (Ceiba pentandra) bark.. .
Re: Regulation of virulence (Cited Prof. Dr. Hubert Hilbi, SS04) - Most of which is well known and widely available in other Studies .cndot. DNA structure and transcription factors .cndot. Environment - temperature, pH, ions, osmolarity, oxygen, nutrients .cndot. Host cells - contact - intracellular environment .cndot. Cell density (quorum sensing) - autoinducer systems - processes (bioluminescence, biofilm, virulence) .cndot. Genome structure and topology .cndot. Environment - temperature, growth phase, pH, ions, osmolarity, oxygen, nutrients .cndot. Host cells - secretion-dependent regulation - intracellular environment (macrophages, amoebae) .cndot. Cell density (quorum sensing) - autoinducer systems - processes (bioluminescence, virulence, biofilm) Ceiba pentandra bark is believed to be diuretic, aphrodisiac, and to treat headache, as well as type II diabetes. We could test the effectiveness and isolate the active ingredient then commercially make the active ingredient(s) available.
Re: Photoperiod and the Natural Production and Injested Vitamin D
Tissues in the body convert Vitamin (via receptors and enzymes), from Vitamin D; 25-hydroxyvitamin D and/or 25(OH) into active ; 1,25-dihydroxyvitamin D.
Vitamin D interacts with 200 genes.
We are particularily interested in smooth muscle growth (as a perhaps cyclical response in coordination with the seasonal light and dark photoperiods) - thus the level, timing of change, steadyness (not too volatile versus times when is needs to be volatile to induce the eg. fish (any and all life)), of rate of change the duration it prolongs the high and lows in mimicing or even find a cyclical combination that works even better for sexual maturation and/or spawning/breeding/sex/mating ... if the postulation in the paragraph below is correct than it might help any and all tissue not only including the testes and the ovaries but all life and their body parts, including stem cells in Gerard Voon's bioreactor... Perhaps the ability of Vitamin D
to help those with dysfunctioning Seasonal Affective Disorder (SAD) may help growth, sexual maturation and sex/mating/breeding/spawning...
An interesting postulation is that Vitamin D may be released naturally into the organism during Photoperiod (response to sun light), and therefore may play an opposite role than melatonin (released in darkness). Thus Vitamin D may play a role in sexual maturity and growth...
We testing the effectiveness of Vitamin D on any and all (anti inflammatory) of the below diseases:
Cardiovascular Blood Pressure Multiple Sclerosis (MS) Rheumatoid Arthritis (RA) Inflammatory Bowel Disease (IBD) Interstitial Cystitis (IC) Fibromyalgia (FM) Autonomic nervous dysfunction (AND neural-mediated hypotension);
Pyoderma Gangrenosum (PG) Chronic Fatigue (CF) and Chronic Fatigue Syndrome (CFS).
Chronic hepatitis Systemic lupus erythematosus Arthritis Thyroidosis Scieroderma Diabetes mellitus Graves' disease Beschet's disease and Graft versus host disease (graft rejection).
Chronic inflammatory pathologies such as aneurysms Hemorrhoids Sarcoidosis Chronic inflammatory bowel disease Ulcerative colitis Crohn's disease and vascular inflammatory pathologies Disseminated intravascular coagulation Atherosclerosis Kawasaki's pathology Coronary artery disease Hypertension Stroke Asthma Chronic hepatitis Multiple sclerosis Peripheral neuropathy Chronic or recurrent sore throat Laryngitis Tracheobronchitis Chronic vascular headaches (including migraines Cluster headaches and tension headaches) and pneumonia Neurodegenerative diseases including Demyelinating diseasessuch as multiple sclerosis and acute transverse myelitis;
Extrapyramidal and cerebellar disorders such as lesions of the corticospinal system;
Disorders of the basal ganglia or cerebellar disorders;
Hyperkinetic movement disorders such as Huntington's Chorea and senile chorea;
Drug-induced movement disorders such as those induced by drugs which block CNS
dopamine receptors;
Hypokinetic movement disorders such as Parkinson's disease;
Progressive supranucleo palsy;
Cerebellar and Spinocerebellar Disorders such as astructural lesions of the cerebellum;
Spinocerebellar degenerations (spinal ataxia) Friedreich's ataxia Cerebellar cortical degenerations Multiple systems degenerations (MencelDejerine-Thomas Shi-Drager and Machado Joseph)); and systemic disorders (Refsum's disease Abetalipoprotemia, ataxia telangiectasia and mitochondrial multi-system disorder);
Demyelinating core disorders such as:
Multiple sclerosis Acute transverse myelitis;
Disorders of the motor unit such as neurogenic muscular atrophies (anterior horn cell degeneration) such as Amyotrophic lateral sclerosis Infantile spinal muscular atrophy and juvenile spinal muscular atrophy);
Alzheimer's disease;
Down's Syndrome in middle age;
Diffuse Lewy body disease; Senile Dementia of Lewy body type;
Wernicke-Korsakoff syndrome;
Chronic alcoholism;
Creutzfeldt-Jakob disease;
Subacute sclerosing panencephalitis Hallerrorden-Spatz disease; and Dementia pugilistica Malignant pathologies involving tumors or other malignancies such as:
Leukemias (acute chronic myelocytic chronic lymphocytic and/or myelodyspastic syndrome);
Lymphomas (Hodgkin's and non-Hodgkin's lymphomas such as malignant lymphomas (Burkitt's lymphoma or Mycosis fungoides));
Carcinomas (such as colon carcinoma) and metastases thereof;
Cancer-related angiogenesis;
Infantile hemangiomas;
Alcohol-induced hepatitis.
Ocular neovascularization Psoriasis Duodenal ulcers Other diseases that we are testing for effectiveness include parkinsons, diabetes, osteoporosis, multiple sclerosis, breast cancer, colon cancer, prostate cancer, autoimmune disease, cardiovascular (blood clotting - posssibly in gel, powder or imbedded in gauze (perhaps with antibacterials such as furanone and/or chitin) to an open wound to prevent bleeding to death and then apply a layer of ECM/HOX for regeneration assuming that the wound is not too severe - in which case it may be better to grow an entire new limb using the ECM scaffolding and stem cells of a recently deceased body part donor disease), any and all sexually transmitted diseases, herpes...hepatitus, skin problems eg. serious acne, any and all skin conditions, depression, schizophrenia, seasonal affective disorder, peripheral artery disease, tuberculosis, cancer, periodontal disease, multiple sclerosis,...
Using all our Gerard Voon's patented inventions (Methods and Techniques, Models) Titled:
BioScience and all the above: Fish liver oils, including cod liver oil, Fatty fish species, Herring, Catfish, Salmon, cooked, Mackerel, Sardines, canned in oil, Tuna, canned in oil, Eel, One whole egg (perhaps more duck eggs because of their oiliness).
EPA healthy heart - healthy body Promotes a healthy heart and circulatory system Supports healthy homocysteine levels Supports proper immune function Promotes good mood and emotional well-being Supports joint flexibility DHA healthy mood - healthy mind Essential for memory, cognitive function, learning and focus Supports a healthy pregnancy Promotes good mood and emotional well-being Reduces harmful effects of stress Supports the visual and brain development of fetus' and infants GIA healthy skin & hair - healthy hormones Promotes beneficial prostaglandins that maintain hormonal balance Provides a "feel good" effect, improves mood Nourishes hair and skin Supports joint flexibility Promotes normal body fat metabolism Vitamin D Receptor will be used to help us in cell proliferation and/or differentiation (from stem cells to any and all life as well as micro organisms). We will also use its properties via Gerard Voon's patented stem cells to immune cells (adjuvant and immune cells priming as a serum for diseses with antigens or unchanging intracellular proteins - for harmful diseases that mutate their cellular antigens on their membranes; or just fortify the immune response during disease out break), Vitamin D is also involved in white blood cells eg. monocytes and activated T and B
cells.
Re: Waterbourne mirco organisms (eg. diatoms) could be added with sugar (in its various forms)...white rice...to Hydronics...and any and all mediums.
The waterbourne micro organisms (eg. diatoms), can break down ammonia/nitrates/urea/sugars/carbohydrates/sewage/detritus/hay fusion/compost/tea manure.. in the hydroponic media...to make the water fertile for plants and algae...
Re: Drawing 1. - Tall Greenhouse Solar and Mirror Invention
1. Solar Panels on the roof of the Greenhouse.
2. Mirrors on the bottom ceiling to catch reflected light from angled mirrors surrounding th greenhouse.
3. The greenhouse plants space.
4. The mirrors angled to aim sun's light at the mirrors in the ceiling (possibly parabolic).
The reason the greenhouse is so tall is to allow surrounding mirrors further out to also aim and reach the ceiling...
Re: Cure for Baldness and Fur Industry We take a newly deceased donor, we take off the scalp (and follicular skin below) hair and/or fur and all and treat its raw side with ECM/HOX (Jeff 20% of 35%) any and all proliferating factors and/or flush the skin/flesh under the hair/fur with deterregent and until only the ECM
sccafold remains add stem cells from the own patient (to avoid rejection) (to grow a whole new scalp with hair/fur or in the case of fur, we could cut off the top skin for fur/skin...(also aligators/crocodiles and/or eels...) while leaving the bottom layer of follicle base behind that we expose ECM/HOX (Jeff 10% of 35%) and/or any and all proliferation factors to regenerate the fur for human bald patients we then operate on the patient to either descalp and/or dermabrasion the patient's upper layer of then attach the new scalp to the bald patient.
(Jeff 2.5%)
The reason the greenhouse is so tall is to allow surrounding mirrors further out to also aim and reach the ceiling...
Re: Cure for Baldness and Fur Industry We take a newly deceased donor, we take off the scalp (and follicular skin below) hair and/or fur and all and treat its raw side with ECM/HOX (Jeff 20% of 35%) any and all proliferating factors and/or flush the skin/flesh under the hair/fur with deterregent and until only the ECM
sccafold remains add stem cells from the own patient (to avoid rejection) (to grow a whole new scalp with hair/fur or in the case of fur, we could cut off the top skin for fur/skin...(also aligators/crocodiles and/or eels...) while leaving the bottom layer of follicle base behind that we expose ECM/HOX (Jeff 10% of 35%) and/or any and all proliferation factors to regenerate the fur for human bald patients we then operate on the patient to either descalp and/or dermabrasion the patient's upper layer of then attach the new scalp to the bald patient.
(Jeff 2.5%)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2646779A CA2646779A1 (en) | 2008-11-25 | 2008-11-25 | Bioscience ix |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2646779A CA2646779A1 (en) | 2008-11-25 | 2008-11-25 | Bioscience ix |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2646779A1 true CA2646779A1 (en) | 2010-05-25 |
Family
ID=42212009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2646779A Abandoned CA2646779A1 (en) | 2008-11-25 | 2008-11-25 | Bioscience ix |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2646779A1 (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110476852A (en) * | 2019-09-18 | 2019-11-22 | 武汉双水双绿科技产业有限公司 | The cray method for culturing seedlings and rice shrimp that rice shrimp makees altogether make breeding method altogether |
| CN110607375A (en) * | 2019-10-11 | 2019-12-24 | 江苏省海洋水产研究所 | Method for rapidly identifying oplegnathus punctatus and scatophagus argus |
| CN110637765A (en) * | 2019-09-18 | 2020-01-03 | 武汉双水双绿科技产业有限公司 | A ridge utilization method of a rice-shrimp co-cropping system |
| CN111257445A (en) * | 2020-01-22 | 2020-06-09 | 上海交通大学医学院附属仁济医院 | Products and methods for monitoring the condition of pregnant women with SLE and predicting fetal outcomes |
| US10800738B2 (en) | 2017-12-05 | 2020-10-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| US10874639B2 (en) | 2017-12-05 | 2020-12-29 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| CN112314522A (en) * | 2020-11-05 | 2021-02-05 | 柳州市宏华牧业有限责任公司 | Production method of eggs with low cholesterol content and high astaxanthin content |
| CN112617011A (en) * | 2021-01-11 | 2021-04-09 | 海南大学 | Compound feed for promoting maturity of litopenaeus vannamei ovary and preparation method thereof |
| US11160758B2 (en) | 2019-06-04 | 2021-11-02 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| CN114164169A (en) * | 2021-11-30 | 2022-03-11 | 吉林医药学院 | Application and preparation of astaxanthin in promoting the development of preantral follicles in mice |
| CN114698575A (en) * | 2022-05-10 | 2022-07-05 | 湖南文理学院 | A kind of breeding method for heterologous gynogenesis of bighead carp |
| CN114931128A (en) * | 2022-06-30 | 2022-08-23 | 上海海洋大学 | Preparation method and application of hoxaa gene cluster deletion zebrafish mutant |
| CN115362961A (en) * | 2022-04-14 | 2022-11-22 | 中国水产科学研究院北戴河中心实验站 | Artificial insemination method for Trachidermus fasciatus and application thereof |
| CN116908128A (en) * | 2023-08-22 | 2023-10-20 | 中国科学院东北地理与农业生态研究所 | Kit for detecting nitrate reductase activity and detection method thereof |
| CN117347643A (en) * | 2023-12-05 | 2024-01-05 | 成都泰莱生物科技有限公司 | Metabolic marker combinations for judging benign and malignant pulmonary nodules and their screening methods and applications |
| CN118985591A (en) * | 2024-10-23 | 2024-11-22 | 中国医学科学院医学生物学研究所 | In-vitro preservation method for improving sperm motility of non-human primate |
-
2008
- 2008-11-25 CA CA2646779A patent/CA2646779A1/en not_active Abandoned
Cited By (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11767293B2 (en) | 2017-12-05 | 2023-09-26 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| US12161623B2 (en) | 2017-12-05 | 2024-12-10 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| US11517558B2 (en) | 2017-12-05 | 2022-12-06 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| US11370753B2 (en) | 2017-12-05 | 2022-06-28 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| US10800738B2 (en) | 2017-12-05 | 2020-10-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| US10874639B2 (en) | 2017-12-05 | 2020-12-29 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| US11160758B2 (en) | 2019-06-04 | 2021-11-02 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| US12161758B2 (en) | 2019-06-04 | 2024-12-10 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| US11654113B2 (en) | 2019-06-04 | 2023-05-23 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| CN110476852A (en) * | 2019-09-18 | 2019-11-22 | 武汉双水双绿科技产业有限公司 | The cray method for culturing seedlings and rice shrimp that rice shrimp makees altogether make breeding method altogether |
| CN110637765A (en) * | 2019-09-18 | 2020-01-03 | 武汉双水双绿科技产业有限公司 | A ridge utilization method of a rice-shrimp co-cropping system |
| CN110607375A (en) * | 2019-10-11 | 2019-12-24 | 江苏省海洋水产研究所 | Method for rapidly identifying oplegnathus punctatus and scatophagus argus |
| CN110607375B (en) * | 2019-10-11 | 2022-12-23 | 江苏省海洋水产研究所 | Method for rapidly identifying oplegnathus punctatus and longhairy fish |
| CN111257445A (en) * | 2020-01-22 | 2020-06-09 | 上海交通大学医学院附属仁济医院 | Products and methods for monitoring the condition of pregnant women with SLE and predicting fetal outcomes |
| CN111257445B (en) * | 2020-01-22 | 2022-09-09 | 上海交通大学医学院附属仁济医院 | Product and method for SLE pregnant woman disease monitoring and fetus outcome prediction |
| CN112314522A (en) * | 2020-11-05 | 2021-02-05 | 柳州市宏华牧业有限责任公司 | Production method of eggs with low cholesterol content and high astaxanthin content |
| CN112617011A (en) * | 2021-01-11 | 2021-04-09 | 海南大学 | Compound feed for promoting maturity of litopenaeus vannamei ovary and preparation method thereof |
| CN114164169B (en) * | 2021-11-30 | 2022-09-13 | 吉林医药学院 | Application of astaxanthin in promoting development of preantral follicles of mice and preparation |
| CN114164169A (en) * | 2021-11-30 | 2022-03-11 | 吉林医药学院 | Application and preparation of astaxanthin in promoting the development of preantral follicles in mice |
| CN115362961A (en) * | 2022-04-14 | 2022-11-22 | 中国水产科学研究院北戴河中心实验站 | Artificial insemination method for Trachidermus fasciatus and application thereof |
| CN115362961B (en) * | 2022-04-14 | 2023-12-08 | 中国水产科学研究院北戴河中心实验站 | Artificial insemination method of Songjiang perch and application thereof |
| CN114698575A (en) * | 2022-05-10 | 2022-07-05 | 湖南文理学院 | A kind of breeding method for heterologous gynogenesis of bighead carp |
| CN114931128A (en) * | 2022-06-30 | 2022-08-23 | 上海海洋大学 | Preparation method and application of hoxaa gene cluster deletion zebrafish mutant |
| CN116908128A (en) * | 2023-08-22 | 2023-10-20 | 中国科学院东北地理与农业生态研究所 | Kit for detecting nitrate reductase activity and detection method thereof |
| CN116908128B (en) * | 2023-08-22 | 2024-04-19 | 中国科学院东北地理与农业生态研究所 | A kit for detecting nitrate reductase activity and a detection method thereof |
| CN117347643A (en) * | 2023-12-05 | 2024-01-05 | 成都泰莱生物科技有限公司 | Metabolic marker combinations for judging benign and malignant pulmonary nodules and their screening methods and applications |
| CN117347643B (en) * | 2023-12-05 | 2024-02-06 | 成都泰莱生物科技有限公司 | Metabolic marker combinations for judging benign and malignant pulmonary nodules and their screening methods and applications |
| CN118985591A (en) * | 2024-10-23 | 2024-11-22 | 中国医学科学院医学生物学研究所 | In-vitro preservation method for improving sperm motility of non-human primate |
| CN118985591B (en) * | 2024-10-23 | 2025-02-11 | 中国医学科学院医学生物学研究所 | In-vitro preservation method for improving sperm motility of non-human primate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2646779A1 (en) | Bioscience ix | |
| Chen et al. | Protective effect of γ-aminobutyric acid on antioxidation function in intestinal mucosa of Wenchang chicken induced by heat stress. | |
| Martins et al. | The effect of tryptophan supplemented diets on brain serotonergic activity and plasma cortisol under undisturbed and stressed conditions in grouped-housed Nile tilapia Oreochromis niloticus | |
| Gutyj et al. | Preclinical searches of the preparation Thireomagnile | |
| Herrero et al. | Response of plasma and gastrointestinal melatonin, plasma cortisol and activity rhythms of European sea bass (Dicentrarchus labrax) to dietary supplementation with tryptophan and melatonin | |
| Wei et al. | Effects of photoperiod on growth, lipid metabolism and oxidative stress of juvenile gibel carp (Carassius auratus) | |
| Trivedi et al. | Melatonin: an internal signal for daily and seasonal timing | |
| Targońska et al. | Controlled reproduction of asp, Aspius aspius (L.) using luteinizing hormone releasing hormone (LHRH) analogues with dopamine inhibitors | |
| CN101611764A (en) | A kind of compound aquatic product feeding promoting agent | |
| Das et al. | Comparative efficacy of different inducing agents on breeding performance of a near threatened cyprinid Osteobrama belangeri in captivity | |
| Simhachalam et al. | Biochemical composition and nutritional value of Streptocephalus simplex as live feed in ornamental fish culture | |
| Zheng et al. | Positive and negative innate immune responses in zebrafish under light emitting diodes conditions | |
| Chakraborty et al. | Determination of ideal stocking density for cage culture of monosex Nile tilapia (Oreochromis niloticus) in India | |
| Nandi et al. | Reproductive performance of carp, Catla catla (Ham.), reared on a formulated diet with PUFA supplementation | |
| Ebeid et al. | The impact of incorporation of organic selenium into meat on growth performance, antioxidative status, and immune response in growing rabbits | |
| CN102283169A (en) | Breathetarian breeding method | |
| Warni et al. | Mass induction of tiger barb (Puntius tetrazona) spawning via hormone immersion technique | |
| Soundarapandian et al. | Amino acid profiles of ridged swimming crab, Charybdis natator herbst | |
| Sepehrfar et al. | Role of phytochemicals in farmed fish reproductive performance: A review | |
| Shatskikh et al. | Epigenetic effects of an antioxidant composition in layer breeder diet | |
| Luz et al. | Tilapia larviculture | |
| Weiss et al. | Identification of neomales in South American catfish Rhamdia quelen on the basis of the sex ratio in the progeny | |
| Khalil et al. | Improving lambs’ temperament, performance, and fecundity under three different housing conditions via oxidative stress reduction, metabolic and growth genes regulation by turmeric supplementation | |
| Nayak et al. | Effect of combined thyroxine and cortisol treatment on hatching of eggs, post-embryonic growth and survival of larvae of Heteropneustes fossilis | |
| Hasib et al. | Utilization of sumbawa tropical forest honey Apis dorsata to improve fertility of indonesia oriental magpie robin (Copsychus saularis) as effort animal population increasement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |
Effective date: 20121126 |